assay_id,chembl_id,assay_tissue,tid,assay_category,description,relationship_type,assay_tax_id,assay_cell_type,curated_by,assay_strain,confidence_score,src_assay_id,assay_type,assay_organism,cell_id,src_id,bao_format,tissue_id,variant_id
7524,CHEMBL618647,Kidney,50597,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7525,CHEMBL618648,Kidney,50597,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7526,CHEMBL618649,Kidney,50597,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7527,CHEMBL618650,Liver,50597,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7528,CHEMBL618651,Liver,50597,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7529,CHEMBL876497,Liver,50597,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7530,CHEMBL618652,Lung,50597,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7531,CHEMBL618653,Lung,50597,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7532,CHEMBL618654,Lung,50597,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7533,CHEMBL618655,,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7534,CHEMBL618656,,50597,,Compound was tested for solubility in water,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7535,CHEMBL618657,,22229,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),U,,,Intermediate,,0,,P,,,1,BAO_0000100,,
7536,CHEMBL618658,,50597,,Solubility was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7537,CHEMBL618659,,50597,,solubility in water (ug/mL) at 37 degree C.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7538,CHEMBL618660,,50597,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7539,CHEMBL618661,,50597,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7540,CHEMBL873807,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7541,CHEMBL618662,,50597,,Half life in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7542,CHEMBL618663,,50597,,Half life period after 3 mg/kg iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7543,CHEMBL618664,,50597,,Half life period after 3 mg/kg iv administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7544,CHEMBL618665,,50597,,Half life period after 3 mg/kg iv administration in the rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7545,CHEMBL876498,,50597,,Half life period in female Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7546,CHEMBL618666,,50597,,Half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7547,CHEMBL620440,,50597,,Half-life in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7548,CHEMBL620441,,50597,,Half-life in rats with metabolic oxidation,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7549,CHEMBL620442,,50597,,Half-life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7550,CHEMBL620443,,50597,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7551,CHEMBL620444,,50597,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7552,CHEMBL620445,,50597,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7553,CHEMBL620446,,50597,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7554,CHEMBL620447,Plasma,50597,,Biological half-life measured in plasma of rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7555,CHEMBL621129,Plasma,50597,,Biological half-life measured in plasma of rat; 22-25,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7556,CHEMBL621130,Plasma,50597,,Biological half-life measured in plasma of rat; 9-16,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7557,CHEMBL873808,,50597,,Compound was evaluated for its half life when administered intravenously in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7558,CHEMBL876598,,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7559,CHEMBL621131,,50597,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7560,CHEMBL621132,,50597,,Half life (T1/2) after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7561,CHEMBL621133,,50597,,Half life of compound after iv administration of 20 mg/kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7562,CHEMBL621312,,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7563,CHEMBL621313,,50597,,Half life of compound was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7564,CHEMBL621314,Blood,50597,,Half life of compound was determined in rat blood,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7565,CHEMBL621315,,50597,,Half life at 1 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7566,CHEMBL621316,,50597,,Half life at 10 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7567,CHEMBL621317,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7568,CHEMBL621318,,50597,,Half life in rats in hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7569,CHEMBL621319,,50597,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7570,CHEMBL621377,,50597,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7571,CHEMBL621378,,50597,,Half life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7572,CHEMBL876599,,50597,,Half life after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7573,CHEMBL621379,,50597,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7574,CHEMBL621380,Plasma,50597,,Half life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7575,CHEMBL621381,Plasma,50597,,Half life in rat plasma; Not detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7576,CHEMBL618515,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7577,CHEMBL618516,,50597,,Half life period of compound was determined after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7578,CHEMBL618517,,50597,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7579,CHEMBL618518,,50597,,Half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7580,CHEMBL618519,,50597,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7581,CHEMBL618698,,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7582,CHEMBL618862,,50597,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7583,CHEMBL618863,,50597,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7584,CHEMBL618864,,50597,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7585,CHEMBL618865,,50597,,Half life time in rat the dose of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7586,CHEMBL618866,,50597,,Half-life 24 hr after 10 mg/kg iv administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7587,CHEMBL618867,,50597,,Half-life 24 hr after 2 mg/kg iv administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7588,CHEMBL875828,,50597,,Half-life consistent with the observed metabolic steady state in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7589,CHEMBL618868,,50597,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7590,CHEMBL618869,,50597,,Half-life for oxidative metabolic stability was determined using male human,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7591,CHEMBL618870,,50597,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7592,CHEMBL618871,Plasma,50597,,Half-life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7593,CHEMBL618872,Plasma,50597,,Half-life in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7594,CHEMBL873816,,50597,,Half-life in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7595,CHEMBL618873,,22224,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7596,CHEMBL621602,,22224,,Area under curve after oral dose of 0.1 mg//kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7597,CHEMBL621603,,22224,,Area under curve after oral dose of 0.3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7598,CHEMBL621604,,22224,,Area under curve after oral dose of 1 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7599,CHEMBL621605,,22224,,Area under curve after oral dose of 10 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7600,CHEMBL621606,,22224,,Area under curve after oral dose of 23.4 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7601,CHEMBL621607,,22224,,Area under curve after oral dose of 3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7602,CHEMBL621608,,22224,,Area under curve after oral dose of 3.87 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7603,CHEMBL621609,,22224,,Area under curve was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7604,CHEMBL621610,,22224,,Area under curve at a dose of 10 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7605,CHEMBL621611,,50597,,Area under curve was determined; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7606,CHEMBL621612,,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7607,CHEMBL622308,,50597,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7608,CHEMBL622309,,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7609,CHEMBL622310,,50597,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7610,CHEMBL622311,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7611,CHEMBL622312,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7612,CHEMBL622931,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7613,CHEMBL622932,,50597,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7614,CHEMBL622736,Plasma,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7615,CHEMBL622737,Plasma,50597,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7616,CHEMBL622738,Plasma,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7617,CHEMBL622739,Plasma,50597,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7618,CHEMBL622740,Plasma,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7619,CHEMBL622741,Plasma,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7620,CHEMBL622742,Plasma,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7621,CHEMBL622743,Plasma,50597,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7622,CHEMBL622744,Plasma,50594,,AUC in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
7623,CHEMBL624134,,22224,,Area under curve was measured from the graph obtained from concentration Vs time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7624,CHEMBL624135,,22224,,Area under curve value of compound per hour after oral administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7625,CHEMBL624136,,50597,,Area under curve was determined after oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7626,CHEMBL624137,,50597,,Area under curve was determined after oral administration in rats; No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7627,CHEMBL624320,,50597,,Area under curve was determined after oral administration in rats;No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7628,CHEMBL624321,,50588,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7629,CHEMBL624322,,50597,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7630,CHEMBL624323,,50597,,Area under curve was determined for the compound after iv dose of 5.06 in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7631,CHEMBL624324,,50597,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7632,CHEMBL624325,,50597,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7633,CHEMBL624326,,50597,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7634,CHEMBL624327,,50597,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7635,CHEMBL624328,,50597,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7636,CHEMBL627848,,50588,,Area under curve was determined in Dogs after peroral administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7637,CHEMBL627849,,50597,,Area under curve was determined in Rats after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7638,CHEMBL627850,,50597,,Area under curve was determined in carotid blood of rat when administered intradermally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7639,CHEMBL627851,,50597,,Area under curve was determined in portal blood of rat when administered intradermally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7640,CHEMBL627852,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7641,CHEMBL627853,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7642,CHEMBL627854,,50594,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7643,CHEMBL627855,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7644,CHEMBL627856,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7645,CHEMBL875339,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7646,CHEMBL627857,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7647,CHEMBL627858,Spleen,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7648,CHEMBL627859,Blood,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7649,CHEMBL627860,Brain,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
7650,CHEMBL627019,Heart,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7651,CHEMBL627020,Liver,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7652,CHEMBL627021,Lung,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7653,CHEMBL627022,Muscle tissue,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7654,CHEMBL627023,,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7655,CHEMBL627024,Spleen,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7656,CHEMBL627025,Thyroid gland,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
7657,CHEMBL627026,Kidney,50597,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7658,CHEMBL627027,Blood,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7659,CHEMBL627028,Brain,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
7660,CHEMBL627029,Heart,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7661,CHEMBL627030,Kidney,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7662,CHEMBL627031,Liver,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7663,CHEMBL627032,Lung,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7664,CHEMBL627033,Muscle tissue,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7665,CHEMBL627034,,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7666,CHEMBL627035,Spleen,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7667,CHEMBL627036,Thyroid gland,50597,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
7668,CHEMBL875340,Blood,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7669,CHEMBL627037,Heart,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7670,CHEMBL627038,Kidney,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7671,CHEMBL627039,Liver,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7672,CHEMBL627040,Muscle tissue,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7673,CHEMBL624663,Spleen,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7674,CHEMBL625963,Thyroid gland,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
7675,CHEMBL876799,Brain,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
7676,CHEMBL626133,Lung,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
7677,CHEMBL626134,,50597,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7678,CHEMBL626135,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7679,CHEMBL626136,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7680,CHEMBL626137,,50597,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7681,CHEMBL626138,,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7682,CHEMBL626139,,50597,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7683,CHEMBL626140,,50597,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7684,CHEMBL626141,,50597,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7685,CHEMBL626142,,50597,,C24h in rat p.o. at 20 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7686,CHEMBL627930,Muscle tissue,50597,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7687,CHEMBL627931,Muscle tissue,50597,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7688,CHEMBL627932,Muscle tissue,50597,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
7689,CHEMBL627933,Spleen,50597,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7690,CHEMBL627934,Spleen,50597,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7691,CHEMBL627935,Spleen,50597,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
7692,CHEMBL627936,Blood,50597,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7693,CHEMBL627937,Blood,50597,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7694,CHEMBL627938,Blood,50597,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7695,CHEMBL627939,Blood,50597,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7696,CHEMBL627940,Blood,50597,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7697,CHEMBL627941,Blood,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7698,CHEMBL876800,Blood,50597,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7699,CHEMBL627942,Blood,50597,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7700,CHEMBL627943,Blood,50597,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7701,CHEMBL627944,Blood,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7702,CHEMBL627945,Blood,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7703,CHEMBL628584,Blood,50597,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7704,CHEMBL628585,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7705,CHEMBL628586,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7706,CHEMBL628587,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7707,CHEMBL628588,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7708,CHEMBL628589,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7709,CHEMBL625304,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7710,CHEMBL625305,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7711,CHEMBL625306,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7712,CHEMBL625307,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7713,CHEMBL625308,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7714,CHEMBL627740,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7715,CHEMBL627741,Blood,50597,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7716,CHEMBL627742,Blood,50597,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7717,CHEMBL627743,Blood,50597,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7718,CHEMBL627744,Blood,50597,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
7719,CHEMBL627745,Bone,50597,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7720,CHEMBL627746,Bone,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7721,CHEMBL627747,Bone,50597,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7722,CHEMBL876810,Bone,50597,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7723,CHEMBL627748,Bone,50597,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7724,CHEMBL627749,Bone,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7725,CHEMBL627750,Bone,50597,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7726,CHEMBL618728,Bone,50597,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7727,CHEMBL618729,Bone,50597,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7728,CHEMBL618730,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7729,CHEMBL618731,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7730,CHEMBL618732,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7731,CHEMBL618733,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7732,CHEMBL618734,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7733,CHEMBL618735,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7734,CHEMBL876602,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7735,CHEMBL618736,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7736,CHEMBL618737,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7737,CHEMBL618738,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7738,CHEMBL618739,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7739,CHEMBL618740,Bone,50597,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7740,CHEMBL618741,Bone,50597,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7741,CHEMBL618742,Bone,50597,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7742,CHEMBL618743,Bone,50597,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
7743,CHEMBL618744,Plasma,50597,,Half-life from rat plasma at a single oral dose of 25 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7744,CHEMBL618745,,50597,,Half-life in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7745,CHEMBL620479,,50597,,Half-life in rat after peroral administration at 10 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7746,CHEMBL620480,,50597,,Half-life in rat after peroral administration at 5 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7747,CHEMBL620481,,50597,,Half-life in rat at a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7748,CHEMBL620482,,50597,,Half-life was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7749,CHEMBL876603,,50597,,Half-life was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7750,CHEMBL620483,,50597,,Half-life period for the compound was determined in rats at 50 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7751,CHEMBL620484,,50597,,Half-life period in rats after intravenous administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7752,CHEMBL620485,,50597,,Half-life period in rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7753,CHEMBL620486,,50597,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7754,CHEMBL620487,,50597,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7755,CHEMBL620488,,50597,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7756,CHEMBL620489,,50597,,Half-life time in rat the dose of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7757,CHEMBL620490,,50597,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7758,CHEMBL620491,,50597,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7759,CHEMBL876604,Plasma,50597,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7760,CHEMBL620492,,50597,,Oral half life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7761,CHEMBL620493,,50597,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7762,CHEMBL620494,,50597,,Pharmacokinetic property (t1/2) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7763,CHEMBL620495,Plasma,50597,,Plasma elimination half-life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7764,CHEMBL620496,Plasma,50597,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7765,CHEMBL620497,Plasma,50597,,Plasma half life was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7766,CHEMBL620498,Plasma,50597,,Plasma half-life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7767,CHEMBL620499,Plasma,50597,,Plasma half-life following oral administration in Fisher rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7768,CHEMBL620500,Plasma,50597,,Plasma half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7769,CHEMBL873809,Plasma,50597,,Plasmatic Half-life after intravenous administration to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7770,CHEMBL620501,,50597,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7771,CHEMBL620502,,50597,,Terminal half life after intravenous administration (1 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7772,CHEMBL620503,,50597,,Terminal half life in Rat at a oral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7773,CHEMBL620504,,50597,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7774,CHEMBL876605,,50597,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7775,CHEMBL620505,,50597,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7776,CHEMBL873811,Plasma,50597,,plasma half life was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7777,CHEMBL624016,,50597,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7778,CHEMBL624017,,50597,,Half life of compound determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7779,CHEMBL624018,,50597,,Mean residence time determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7780,CHEMBL624019,,50597,,Plasma half life determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7781,CHEMBL624020,Brain,50597,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
7782,CHEMBL624201,,50597,,Compound was evaluated for pharmacokinetic parameter maximum time period,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7783,CHEMBL872528,,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7784,CHEMBL624202,,50597,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7785,CHEMBL624203,,50597,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7786,CHEMBL624350,,50597,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7787,CHEMBL621320,,50597,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7788,CHEMBL621321,,50597,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7789,CHEMBL621322,,50597,,Maximum time (Tmax) required to reach Cmax in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7790,CHEMBL621323,,50597,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7791,CHEMBL621324,,50597,,Maximum time of clearance of compound in rats after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7792,CHEMBL621325,,50597,,Maximum time at the dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7793,CHEMBL875837,Plasma,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7794,CHEMBL621326,Plasma,50597,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7795,CHEMBL621327,,50597,,Tmax in Guinea pig (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7796,CHEMBL621328,,50597,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7797,CHEMBL621329,,50597,,Pharmacokinetic parameter (Tmax) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7798,CHEMBL621330,,50597,,Pharmacokinetic parameter (Tmax) was estimated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7799,CHEMBL621331,,50597,,Pharmacokinetic property (Tmax) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7800,CHEMBL621332,,50597,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7801,CHEMBL621333,,50597,,T max in Rat at a oral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7802,CHEMBL621334,,50597,,T max was determined at 10 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7803,CHEMBL621335,,50594,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7804,CHEMBL621336,,50588,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7805,CHEMBL621337,,50597,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7806,CHEMBL621338,,50588,,Area under curve was measured after i.v. administration into Beagle dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7807,CHEMBL875838,,50588,,Area under curve was measured after iv administration into Beagle dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7808,CHEMBL621339,,50588,,Area under curve was measured after po administration into Beagle dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7809,CHEMBL621340,,50588,,Area under curve was measured after po administration into Beagle dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7810,CHEMBL621341,,22224,,Area under curve was measured at peroral dose of 3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7811,CHEMBL621342,,22224,,Area under curve was measured by using concentration Vs time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7812,CHEMBL621343,,22224,,Area under curve was measured by using concentration Vs time; not tested,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7813,CHEMBL621344,,50594,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7814,CHEMBL621345,,50594,,Area under curve(AUC) was measured in mice after oral administration.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7815,CHEMBL621346,,22224,,Area under curve(AUC) value of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7816,CHEMBL621347,,22224,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
7817,CHEMBL621348,,50588,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7818,CHEMBL621349,Blood,22224,,Area under curve(carotid artery) was determined by the availability in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7819,CHEMBL621350,Blood,22224,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7820,CHEMBL875839,Blood,22224,,Area under curve(carotid artery) was determined by the availability in blood; No data,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7821,CHEMBL620211,Blood,22224,,Area under curve(portal vein) was determined by the availability in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7822,CHEMBL620212,Blood,22224,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7823,CHEMBL620213,Blood,22224,,Area under curve(portal vein) was determined by the availability in blood; No data,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
7824,CHEMBL620214,Plasma,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
7825,CHEMBL620215,Plasma,50797,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
7826,CHEMBL620216,Plasma,50797,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
7827,CHEMBL620888,Plasma,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
7828,CHEMBL620889,Plasma,50588,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
7829,CHEMBL620890,Plasma,22224,,Area under plasma concentration vs time curve observed in rats for 0-3 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
7830,CHEMBL620891,Plasma,50597,,Area under plasma time curve determined in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7831,CHEMBL620892,,22224,,Area under the MAP curve measured over 5 min.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7832,CHEMBL621079,,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7833,CHEMBL621080,,50594,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
7834,CHEMBL621081,,50588,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7835,CHEMBL621082,,100712,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
7836,CHEMBL621083,,50597,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7837,CHEMBL621084,,50588,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7838,CHEMBL621085,,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7839,CHEMBL621086,,50588,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7840,CHEMBL621087,,50588,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7841,CHEMBL622607,,50588,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7842,CHEMBL622608,,50588,,Serum AUC in marmosets (IV dose),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7843,CHEMBL624481,,22224,,Area under the curve after intravenous administration at a dose of 10 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7844,CHEMBL624482,,22224,,Area under the curve after intravenous administration at a dose of 2 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7845,CHEMBL624483,,22224,,Area under the curve after intravenous administration at a dose of 4 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7846,CHEMBL624484,,22224,,Area under the curve after intravenous administration at a dose of 40 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7847,CHEMBL624485,,22224,,Area under the curve after intravenous administration at a dose of 5 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7848,CHEMBL624486,,50597,,Area under the curve for fumarate salt was evaluated in F344 Rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7849,CHEMBL624487,,22224,,Area under the curve for the compound was calculated.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7850,CHEMBL624488,,22224,,Area under the curve in concentration/ time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7851,CHEMBL624489,,50597,,Area under the curve administered intraintestinal in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7852,CHEMBL625184,,50597,,Area under the curve administered intravenously in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7853,CHEMBL625185,,22224,,Area under the curve during intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7854,CHEMBL875954,,22224,,Area under the curve during intravenous administration; Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7855,CHEMBL625186,,22224,,Area under the curve during systemic administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7856,CHEMBL625187,,22224,,Area under the curve during systemic administration; Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7857,CHEMBL625188,,22224,,Area under the curve was calculated for the compound.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
7858,CHEMBL625189,,50588,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7859,CHEMBL625190,,50588,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
7860,CHEMBL621733,,50597,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7861,CHEMBL621734,,50597,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7862,CHEMBL621735,,50597,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7863,CHEMBL621736,Plasma,50597,,Clearance of the drug was measured in the plasma of rat; No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7864,CHEMBL621737,Plasma,50597,,The pharmacokinetic parameter plasma clearance in vivo in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7865,CHEMBL621738,,50597,,Plasma clearance at the dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7866,CHEMBL622806,,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7867,CHEMBL623519,,50597,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7868,CHEMBL623520,,50597,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7869,CHEMBL623521,,50597,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7870,CHEMBL623522,,50597,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7871,CHEMBL623523,,50597,,Clearance rate in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7872,CHEMBL623690,,50597,,Clearance rate in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7873,CHEMBL623691,,50597,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7874,CHEMBL623692,,50597,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7875,CHEMBL623693,,50597,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7876,CHEMBL623694,,50597,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7877,CHEMBL623695,,50597,,Clearance of compound after iv administration of 20 mg/kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7878,CHEMBL623696,,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7879,CHEMBL623697,,50597,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7880,CHEMBL623698,Plasma,22224,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,9544.0,,Intermediate,,0,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
7881,CHEMBL623699,Plasma,22224,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7882,CHEMBL623700,,50597,,Mean (%CV) PK parameters for CL(mL/min/kg).,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7883,CHEMBL623701,,50597,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7884,CHEMBL623702,Plasma,50597,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7885,CHEMBL623703,,50597,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7886,CHEMBL623704,,50597,,Plasma clearance in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7887,CHEMBL623705,,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7888,CHEMBL623706,,50597,,Plasma clearance in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7889,CHEMBL623707,,50597,,Plasma clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7890,CHEMBL623708,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7891,CHEMBL623709,,50597,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7892,CHEMBL623710,,50597,,Plasma clearance in rat by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7893,CHEMBL623711,,50597,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7894,CHEMBL623712,,50597,,Plasma clearance in rat p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7895,CHEMBL623713,,50597,,Plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7896,CHEMBL623714,,50597,,Plasma clearance was determined; ND denotes no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7897,CHEMBL623715,,50597,,Plasma clearance was determined; ND denotes not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7898,CHEMBL623716,,50597,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7899,CHEMBL622980,,50597,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7900,CHEMBL622981,,50597,,Plasma administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7901,CHEMBL622982,,50597,,Plasma clearance of the compound in female Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7902,CHEMBL622983,,50597,,Plasma clearance was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7903,CHEMBL622984,,50597,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7904,CHEMBL622985,,50597,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7905,CHEMBL623631,Plasma,50597,,plasma clearance was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7906,CHEMBL623632,,50597,,In vivo CL/F determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7907,CHEMBL623633,Plasma,50597,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7908,CHEMBL623634,Plasma,50597,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7909,CHEMBL623635,,50597,,Compound was tested for the lower blood clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7910,CHEMBL621195,,50597,,Evaluated for the low clearance in rat (in vivo),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7911,CHEMBL621196,,50597,,Pharmacokinetic property (CLb)of the compound was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7912,CHEMBL875287,,50597,,Rapid clearance after intravenous administration in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7913,CHEMBL621197,,50597,,Clearance measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7914,CHEMBL621198,Plasma,50597,,Compound was evaluated for plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7915,CHEMBL621199,Plasma,50597,,Low plasma clearance was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7916,CHEMBL621200,,50597,,Pharmacokinetic property (Clp) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7917,CHEMBL621201,,50597,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7918,CHEMBL621202,,50597,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7919,CHEMBL621203,,50597,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7920,CHEMBL621204,,50597,,Plasma clearance after IV dosing at 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7921,CHEMBL621205,Heart,50597,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7922,CHEMBL621206,Heart,50597,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7923,CHEMBL621207,Heart,50597,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7924,CHEMBL621208,Heart,50597,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7925,CHEMBL621209,Heart,50597,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7926,CHEMBL876484,Heart,50597,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7927,CHEMBL621210,Heart,50597,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7928,CHEMBL621211,Heart,50597,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7929,CHEMBL621212,Heart,50597,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7930,CHEMBL621213,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7931,CHEMBL621214,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7932,CHEMBL621215,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7933,CHEMBL621216,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7934,CHEMBL621217,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7935,CHEMBL621218,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7936,CHEMBL621219,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7937,CHEMBL621220,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7938,CHEMBL621221,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7939,CHEMBL621222,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7940,CHEMBL621223,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7941,CHEMBL876485,Heart,50597,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7942,CHEMBL621224,Heart,50597,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7943,CHEMBL621225,Heart,50597,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7944,CHEMBL621226,Heart,50597,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
7945,CHEMBL621227,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7946,CHEMBL621228,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7947,CHEMBL621229,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7948,CHEMBL621230,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7949,CHEMBL621231,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7950,CHEMBL621232,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7951,CHEMBL621233,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7952,CHEMBL621234,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7953,CHEMBL621235,Kidney,50597,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7954,CHEMBL621236,Kidney,50597,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7955,CHEMBL621237,Kidney,50597,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7956,CHEMBL876486,Kidney,50597,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
7957,CHEMBL622436,Intestine,50597,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
7958,CHEMBL622437,Intestine,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
7959,CHEMBL622438,Intestine,50597,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
7960,CHEMBL622439,Liver,50597,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7961,CHEMBL622440,Liver,50597,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7962,CHEMBL622441,Liver,50597,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7963,CHEMBL622442,Liver,50597,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7964,CHEMBL622443,Liver,50597,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7965,CHEMBL622444,Liver,50597,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7966,CHEMBL622445,Liver,50597,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7967,CHEMBL622446,Liver,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7968,CHEMBL622447,Liver,50597,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7969,CHEMBL622448,Liver,50597,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7970,CHEMBL622449,Liver,50597,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7971,CHEMBL622450,Liver,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7972,CHEMBL622451,Liver,50597,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7973,CHEMBL622452,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7974,CHEMBL622453,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7975,CHEMBL622454,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7976,CHEMBL622455,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7977,CHEMBL876024,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
7978,CHEMBL622456,,50597,,T max was determined at 3 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7979,CHEMBL622457,,50597,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7980,CHEMBL622458,,50597,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7981,CHEMBL622459,,50597,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7982,CHEMBL873343,,50597,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7983,CHEMBL622460,,50597,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7984,CHEMBL622461,Plasma,50597,,Time for maximum plasma concentration determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7985,CHEMBL622462,Plasma,50597,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7986,CHEMBL622463,,50597,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7987,CHEMBL622464,,50597,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7988,CHEMBL622465,,50597,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7989,CHEMBL622466,,50597,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7990,CHEMBL622467,,50597,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7991,CHEMBL622468,Plasma,50597,,Time of maximum plasma concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7992,CHEMBL876025,Plasma,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7993,CHEMBL622469,Plasma,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7994,CHEMBL622470,Plasma,50597,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7995,CHEMBL622471,,50597,,Time required to reach maximum concentration (Cmax) after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
7996,CHEMBL622472,Plasma,50597,,Time required to reach maximum concentration in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7997,CHEMBL622473,Plasma,50597,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7998,CHEMBL624282,Plasma,50597,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
7999,CHEMBL624283,Plasma,50597,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8000,CHEMBL624284,Plasma,50597,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8001,CHEMBL624285,Plasma,50597,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8002,CHEMBL624286,,50597,,Time to reach Cmax after oral administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8003,CHEMBL624287,,50597,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8004,CHEMBL624288,,50597,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8005,CHEMBL624289,Plasma,50597,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8006,CHEMBL873344,Plasma,50597,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8007,CHEMBL619623,,50597,,Tmax after peroral administration (10 mg/kg) was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8008,CHEMBL621399,,50597,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8009,CHEMBL621400,,50597,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8010,CHEMBL621401,,50597,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8011,CHEMBL621402,,50597,,Tmax was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8012,CHEMBL621403,,50597,,Tmax was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8013,CHEMBL621121,,50597,,Tmax after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8014,CHEMBL872525,,50597,,Tmax after peroral administration in rats at 2.4 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8015,CHEMBL621122,,50597,,Tmax in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8016,CHEMBL621123,,50597,,Tmax in rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8017,CHEMBL621124,,50597,,Tmax in rat by po administration at a dose of 40 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8018,CHEMBL621125,,50597,,Tmax in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8019,CHEMBL621126,,50597,,Tmax was measured in rats after peroral administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8020,CHEMBL621127,,50597,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8021,CHEMBL621128,,50597,,Tmax value after administration of 20 mg/Kg oral dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8022,CHEMBL618263,,50597,,Tmax value at a dose of 10 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8023,CHEMBL618264,,50597,,Tmax value at a dose of 100 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8024,CHEMBL618265,,50597,,Tmax value at a dose of 50 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8025,CHEMBL618266,Plasma,50597,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8026,CHEMBL618267,,50597,,time required to reach maximum concentration (Cmax) after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8027,CHEMBL618450,Urine,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
8028,CHEMBL618451,Urine,50597,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
8029,CHEMBL618452,,50597,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8030,CHEMBL618453,Urine,50597,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
8031,CHEMBL618454,Urine,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
8032,CHEMBL618455,Urine,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
8033,CHEMBL618456,,50597,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8034,CHEMBL618457,,50597,,Compound distribution in rat tissues was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8035,CHEMBL618458,,50597,,Volume of distribution was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8036,CHEMBL618459,,50597,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8037,CHEMBL876733,,50597,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8038,CHEMBL618460,,50588,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
8039,CHEMBL618461,,50597,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8040,CHEMBL618462,,22224,,Area under the curve was determined after oral administration (300 uM/Kg),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8041,CHEMBL618463,,50597,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8042,CHEMBL618464,,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8043,CHEMBL618465,,50597,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8044,CHEMBL618466,,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8045,CHEMBL618467,,50597,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8046,CHEMBL618468,,50597,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8047,CHEMBL618469,Plasma,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
8048,CHEMBL618470,Plasma,50588,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
8049,CHEMBL618471,,22224,,Plasma drug AUC in rat (PO dose),U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
8050,CHEMBL618472,,50594,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8051,CHEMBL618473,,22224,,Area under was determined at a dose of 30 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
8052,CHEMBL621699,,50506,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
8053,CHEMBL621700,,50597,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8054,CHEMBL621701,,50597,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8055,CHEMBL621702,,50506,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
8056,CHEMBL621703,,50588,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
8057,CHEMBL621704,,50588,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
8058,CHEMBL624259,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8059,CHEMBL624260,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8060,CHEMBL624430,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8061,CHEMBL624431,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8062,CHEMBL624432,,50597,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8063,CHEMBL624433,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8064,CHEMBL624434,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8065,CHEMBL624435,,50597,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8066,CHEMBL618570,,50594,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8067,CHEMBL618571,,50594,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8068,CHEMBL618572,,50594,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8069,CHEMBL618573,,50594,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8070,CHEMBL619267,,50594,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8071,CHEMBL619431,,50594,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8072,CHEMBL619432,,50594,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8073,CHEMBL619433,,50594,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8074,CHEMBL619434,Plasma,22224,,AUC in mice after oral dose (50 mg/kg),U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
8075,CHEMBL619435,Serum,50594,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1977.0,
8076,CHEMBL619436,Plasma,22224,,AUC (0-4 hr) ug/ml/h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
8077,CHEMBL619437,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8078,CHEMBL619438,,22224,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
8079,CHEMBL619439,,50594,,Compound was evaluated for Area under curve in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8080,CHEMBL619440,,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8081,CHEMBL619441,,22224,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
8082,CHEMBL619442,,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8083,CHEMBL875156,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8084,CHEMBL619443,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8085,CHEMBL619444,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8086,CHEMBL623464,,22224,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8087,CHEMBL623465,,50594,,Compound was evaluated for area under curve when administered through oral route in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8088,CHEMBL623466,,50597,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8089,CHEMBL623467,,50597,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8090,CHEMBL623468,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8091,CHEMBL622660,,50597,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8092,CHEMBL622661,,50597,,Plasma clearance rate in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8093,CHEMBL622662,,50597,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
8094,CHEMBL622663,,50597,,Pharmacokinetic property (total body clearance) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8095,CHEMBL622664,,50597,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8096,CHEMBL622665,,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8097,CHEMBL622666,,50597,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8098,CHEMBL621615,,50597,,Cl in rat i.v. at 2 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8099,CHEMBL621616,,50597,,Clearance of compound after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8100,CHEMBL621617,,50597,,Clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8101,CHEMBL621618,,50597,,Clearance by intravenous administration of 3.4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8102,CHEMBL621619,,50597,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8103,CHEMBL621620,,50597,,Clearance rate after i.v. administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8104,CHEMBL621786,,50597,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8105,CHEMBL621787,,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8106,CHEMBL621788,,50597,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8107,CHEMBL621789,,50597,,Clearance (Cl) after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8108,CHEMBL621790,,50597,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8109,CHEMBL621791,Plasma,50597,,Compound was tested for plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8110,CHEMBL621792,,50597,,In vitro microsome metabolism clearance in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8111,CHEMBL621793,,50597,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8112,CHEMBL621794,,50597,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8113,CHEMBL621795,Plasma,50597,,In vivo plasma clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8114,CHEMBL621796,,50597,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8115,CHEMBL621797,Liver,50597,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,N,10116.0,Hepatocyte,Intermediate,,1,,A,Rattus norvegicus,401.0,1,BAO_0000218,2107.0,
8116,CHEMBL621798,,50597,,Pharmacokinetic property (Plasma clearance) was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8117,CHEMBL621799,,50597,,Pharmacokinetic property (clearance) in rat i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8118,CHEMBL621800,,50597,,"Plasma Clearance was evaluated in rats, iv",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8119,CHEMBL621801,,50597,,Plasma clearance (in vivo) in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8120,CHEMBL621802,,50597,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8121,CHEMBL618596,,50597,,Plasma clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8122,CHEMBL618597,,50597,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8123,CHEMBL618598,,50597,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8124,CHEMBL618599,,50597,,Plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8125,CHEMBL618600,,50597,,Plasma clearance rate determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8126,CHEMBL618601,,50597,,Plasma clearance was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8127,CHEMBL618602,,50597,,Plasma clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8128,CHEMBL618603,,50597,,Plasma clearance value in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8129,CHEMBL618604,Liver,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8130,CHEMBL618605,,50597,,Clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8131,CHEMBL618606,,50597,,Total body clearance in rat i.v. at 2 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8132,CHEMBL618607,,50597,,Clearance of compound in rats after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8133,CHEMBL618608,,50597,,Clearance after iv administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8134,CHEMBL618609,,50597,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8135,CHEMBL618610,,50597,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8136,CHEMBL618611,,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8137,CHEMBL618612,,50597,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8138,CHEMBL618613,,50597,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8139,CHEMBL621076,,50597,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8140,CHEMBL621077,,50597,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8141,CHEMBL621078,,50597,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8142,CHEMBL621251,,50597,,Clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8143,CHEMBL621252,,50597,,Clearance in rat after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8144,CHEMBL621253,,50597,,Clearance in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8145,CHEMBL621254,,50597,,Clearance rate following an oral dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8146,CHEMBL621255,,50597,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8147,CHEMBL621256,Plasma,50597,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8148,CHEMBL621257,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8149,CHEMBL621258,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8150,CHEMBL621259,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8151,CHEMBL621260,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8152,CHEMBL876494,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8153,CHEMBL621261,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8154,CHEMBL621262,Liver,50597,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8155,CHEMBL621263,Liver,50597,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8156,CHEMBL621264,Liver,50597,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8157,CHEMBL621265,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8158,CHEMBL621266,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8159,CHEMBL621267,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8160,CHEMBL621268,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8161,CHEMBL621269,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8162,CHEMBL621270,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8163,CHEMBL621271,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8164,CHEMBL621272,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8165,CHEMBL621273,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8166,CHEMBL621274,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8167,CHEMBL876495,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8168,CHEMBL621275,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8169,CHEMBL621276,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8170,CHEMBL621277,Muscle tissue,50597,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8171,CHEMBL621278,Intestine,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8172,CHEMBL621279,Intestine,50597,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8173,CHEMBL621280,Intestine,50597,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8174,CHEMBL621281,Spleen,50597,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8175,CHEMBL621282,Spleen,50597,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8176,CHEMBL621283,Spleen,50597,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8177,CHEMBL621284,Spleen,50597,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8178,CHEMBL621285,Spleen,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8179,CHEMBL621286,Spleen,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8180,CHEMBL623220,Spleen,50597,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8181,CHEMBL623221,Spleen,50597,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8182,CHEMBL876029,Spleen,50597,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8183,CHEMBL623222,Stomach,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8184,CHEMBL623223,Stomach,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8185,CHEMBL621445,Stomach,50597,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8186,CHEMBL621446,Blood,50597,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8187,CHEMBL621447,Blood,50597,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8188,CHEMBL619681,Blood,50597,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8189,CHEMBL619682,Blood,50597,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8190,CHEMBL619683,Blood,50597,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8191,CHEMBL619684,Brain,50597,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8192,CHEMBL619685,Brain,50597,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8193,CHEMBL619686,Brain,50597,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8194,CHEMBL619687,Brain,50597,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8195,CHEMBL619688,Brain,50597,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8196,CHEMBL619689,Heart,50597,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8197,CHEMBL619690,Heart,50597,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8198,CHEMBL619691,Heart,50597,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8199,CHEMBL619692,,50597,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8200,CHEMBL619693,,50597,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8201,CHEMBL619694,,50597,,Vc value after IV dose at a dose of 5 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8202,CHEMBL619695,,50597,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8203,CHEMBL619696,,50597,,Compound was evaluated for pharmacokinetic parameter volume of distribution,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8204,CHEMBL619697,,50597,,Compound was evaluated for volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8205,CHEMBL619698,,50597,,Steady state volume distribution was determined; steady state(ss),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8206,CHEMBL619699,,50597,,Steady state volume of distribution after iv administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8207,CHEMBL619700,,50597,,Steady state volume of distribution dosing at 3 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8208,CHEMBL619701,,50597,,The compound was evaluated for volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8209,CHEMBL619702,,50597,,The compound was tested for volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8210,CHEMBL620335,,50597,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8211,CHEMBL620336,,50597,,Volume distribution (VD) after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8212,CHEMBL620337,,50597,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8213,CHEMBL620520,,50597,,Volume distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8214,CHEMBL620521,,50597,,Volume distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8215,CHEMBL875825,,50597,,Volume distribution in rat after peroral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8216,CHEMBL620522,,50597,,Volume distribution in rat after peroral administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8217,CHEMBL620523,,50597,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8218,CHEMBL620524,,50597,,Volume of distribution in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8219,CHEMBL620525,,50597,,Volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8220,CHEMBL620526,,50597,,Volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8221,CHEMBL620527,,50597,,Volume of distribution in rat by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8222,CHEMBL620528,,50597,,Volume of distribution in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8223,CHEMBL620529,,50597,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8224,CHEMBL620530,,50597,,Volume distribution at the dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8225,CHEMBL620531,,50597,,Steady state volume of distribution was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8226,CHEMBL620532,,22224,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,U,9544.0,,Intermediate,,0,,A,Macaca mulatta,,1,BAO_0000218,,
8227,CHEMBL620533,,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
8228,CHEMBL620534,,22224,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
8229,CHEMBL620535,,50597,,Mean (%CV) PK parameters for Vdss(mL/kg).,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8230,CHEMBL875826,,50597,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8231,CHEMBL620536,,50597,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8232,CHEMBL620537,,50597,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8233,CHEMBL618526,,50597,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8234,CHEMBL618527,,50597,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8235,CHEMBL618528,,50597,,Pharmacokinetic property (Vdss) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8236,CHEMBL618529,,50597,,Pharmacokinetic property (vdss) was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8237,CHEMBL618530,,50597,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8238,CHEMBL618531,,50597,,Volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8239,CHEMBL618532,,50597,,The pharmacokinetic parameter volume of distribution in vivo in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8240,CHEMBL618533,,50597,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
8241,CHEMBL618534,,50597,,Vdss in rat i.v. at 2 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8242,CHEMBL618535,,50597,,Volume distribution after intravenous administration (1 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8243,CHEMBL618536,,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8244,CHEMBL618537,,50597,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8245,CHEMBL618538,,50597,,Volume distribution at a dose of 10 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8246,CHEMBL618539,,50597,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8247,CHEMBL618540,,50597,,Volume distribution was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8248,CHEMBL618541,,50597,,Volume distribution was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8249,CHEMBL618542,,50597,,Volume of distribution after intravenous administration was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8250,CHEMBL622544,,50597,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8251,CHEMBL622545,,50597,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8252,CHEMBL622546,,50597,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8253,CHEMBL622547,,50597,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8254,CHEMBL622548,,50597,,Volume of distribution in steady state was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8255,CHEMBL622549,,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8256,CHEMBL622550,,50597,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8257,CHEMBL622551,,50594,,Compound was evaluated for area under curve when administered through oral route to mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8258,CHEMBL622552,,50597,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8259,CHEMBL622553,,50597,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8260,CHEMBL622554,,22224,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
8261,CHEMBL622555,,50588,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
8262,CHEMBL622556,,50594,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8263,CHEMBL622557,,50594,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8264,CHEMBL622558,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8265,CHEMBL622559,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8266,CHEMBL622560,,50588,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
8267,CHEMBL622561,,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8268,CHEMBL622562,,50597,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8269,CHEMBL622563,,50597,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8270,CHEMBL622564,,22224,,Concentration of compound in Central nervous system,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8271,CHEMBL622565,,22224,,Concentration of compound in Central nervous system; Not detectable,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8272,CHEMBL622566,,50594,,"Concentration of diester in the blood, following oral administration in mice",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8273,CHEMBL624515,,50594,,"Concentration of monoester in the blood, following oral administration in mice",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8274,CHEMBL624516,,50594,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8275,CHEMBL624517,,22224,,Evaluated for Pharmacokinetic property: Area under the curve,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
8276,CHEMBL624518,,50594,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8277,CHEMBL624519,,100710,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8278,CHEMBL624520,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8279,CHEMBL624521,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8280,CHEMBL624522,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8281,CHEMBL624523,,100710,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8282,CHEMBL624409,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8283,CHEMBL624410,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8284,CHEMBL624411,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8285,CHEMBL623531,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8286,CHEMBL623532,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8287,CHEMBL623533,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8288,CHEMBL623534,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
8289,CHEMBL623535,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8290,CHEMBL623536,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8291,CHEMBL623537,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8292,CHEMBL623538,,50594,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8293,CHEMBL623539,,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8294,CHEMBL623540,,50594,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8295,CHEMBL623541,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8296,CHEMBL623542,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8297,CHEMBL623543,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8298,CHEMBL623544,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8299,CHEMBL623545,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8300,CHEMBL623546,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8301,CHEMBL623547,Plasma,50597,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8302,CHEMBL623548,,50597,,High i.v. clearance in Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8303,CHEMBL623549,Liver,50597,,In vitro clearance in rat liver microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8304,CHEMBL623550,Liver,50597,,Intrinsic clearance in rat liver microsomes was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8305,CHEMBL875276,Liver,50597,,Intrinsic clearance in rat hepatocytes was determined,N,10116.0,Hepatocyte,Intermediate,,1,,A,Rattus norvegicus,401.0,1,BAO_0000218,2107.0,
8306,CHEMBL621872,,50597,,Plasma Clearance was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8307,CHEMBL621873,,50597,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8308,CHEMBL621874,,50597,,Plasma clearance in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8309,CHEMBL621875,,50597,,Plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8310,CHEMBL621876,,50597,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8311,CHEMBL621877,,50597,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8312,CHEMBL621878,,50597,,Plasma clearance was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8313,CHEMBL621879,,50597,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8314,CHEMBL621880,Plasma,50597,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8315,CHEMBL621881,,50597,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8316,CHEMBL621882,,50597,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8317,CHEMBL875283,,50597,,Total clearance at 1 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8318,CHEMBL621883,,50597,,Total clearance at 10 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8319,CHEMBL621884,,50597,,Clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8320,CHEMBL621885,,50597,,Plasma clearance rate determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8321,CHEMBL621886,,50597,,Clearance of compound in rat was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8322,CHEMBL621887,Plasma,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8323,CHEMBL621888,,50597,,Pharmacokinetic property (blood clearance) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8324,CHEMBL621889,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8325,CHEMBL621890,,50597,,Plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8326,CHEMBL621891,Liver,50597,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8327,CHEMBL621892,,50597,,Clearance in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8328,CHEMBL621893,,50597,,Clearance rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8329,CHEMBL621894,,50597,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8330,CHEMBL621895,,50597,,Clearance rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8331,CHEMBL875284,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8332,CHEMBL618699,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8333,CHEMBL618700,,50597,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8334,CHEMBL618701,,50597,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8335,CHEMBL876600,Plasma,50597,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8336,CHEMBL618702,,50597,,Clearance of compound in rat after 1 mg/kg i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8337,CHEMBL618703,,50597,,Compound was evaluated for Hepatic clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8338,CHEMBL618704,,50597,,In vivo clearance after 5 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8339,CHEMBL618705,Plasma,50597,,Compound was tested for plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8340,CHEMBL618706,,50597,,Hepatic clearance after intravenous administration was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8341,CHEMBL618707,,50597,,Lower clearance in rat (i.v.) at 0.5 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8342,CHEMBL618708,Plasma,50597,,Pharmacokinetic parameter expressed as plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8343,CHEMBL618709,,50597,,Pharmacokinetic property (Clp) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8344,CHEMBL618710,,50597,,Plasma clearance in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8345,CHEMBL618711,,50597,,Plasma clearance (Clp) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8346,CHEMBL618712,,50597,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8347,CHEMBL618713,,50597,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8348,CHEMBL618714,,50597,,Plasma clearance after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8349,CHEMBL618715,,50597,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8350,CHEMBL618716,,50597,,Plasma clearance in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8351,CHEMBL876601,,50597,,Plasma clearance measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8352,CHEMBL618717,,50597,,Plasma clearance was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8353,CHEMBL618718,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8354,CHEMBL618719,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8355,CHEMBL618720,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8356,CHEMBL618721,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8357,CHEMBL621477,,50597,,Plasma clearance in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8358,CHEMBL621478,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8359,CHEMBL621479,,50597,,Plasma clearance was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8360,CHEMBL621480,,50597,,Plasma clearance was evaluated in rat; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8361,CHEMBL621481,,50597,,Plasma clearance rate was determined for the compound in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8362,CHEMBL621482,,50597,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8363,CHEMBL621483,,50597,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8364,CHEMBL621484,,50597,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8365,CHEMBL621485,Heart,50597,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8366,CHEMBL621486,Heart,50597,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8367,CHEMBL621487,Intestine,50597,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8368,CHEMBL621488,Intestine,50597,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8369,CHEMBL621489,Intestine,50597,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8370,CHEMBL621490,Intestine,50597,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8371,CHEMBL621491,Intestine,50597,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
8372,CHEMBL621492,Kidney,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8373,CHEMBL621493,Kidney,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8374,CHEMBL621494,Kidney,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8375,CHEMBL621495,Kidney,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8376,CHEMBL621496,Kidney,50597,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8377,CHEMBL621497,Liver,50597,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8378,CHEMBL621498,Liver,50597,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8379,CHEMBL621499,Liver,50597,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8380,CHEMBL618634,Liver,50597,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8381,CHEMBL618635,Liver,50597,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8382,CHEMBL618636,Lung,50597,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8383,CHEMBL619737,Lung,50597,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8384,CHEMBL619738,Lung,50597,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8385,CHEMBL624329,Lung,50597,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8386,CHEMBL624330,Lung,50597,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8387,CHEMBL624331,Muscle tissue,50597,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8388,CHEMBL624332,Muscle tissue,50597,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8389,CHEMBL624333,Muscle tissue,50597,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8390,CHEMBL624334,Muscle tissue,50597,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8391,CHEMBL624335,Muscle tissue,50597,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8392,CHEMBL620016,Spleen,50597,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8393,CHEMBL620169,Spleen,50597,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8394,CHEMBL620170,Spleen,50597,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8395,CHEMBL620171,Spleen,50597,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8396,CHEMBL620172,Spleen,50597,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
8397,CHEMBL620173,Stomach,50597,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8398,CHEMBL620174,Stomach,50597,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8399,CHEMBL620175,Stomach,50597,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8400,CHEMBL620176,Stomach,50597,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8401,CHEMBL620177,Stomach,50597,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
8402,CHEMBL620178,Cerebellum,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8403,CHEMBL620179,Cerebellum,50597,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8404,CHEMBL620180,,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8405,CHEMBL620181,,50597,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8406,CHEMBL620182,,50597,,Volume of distribution of compound in rats after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8407,CHEMBL620183,,50597,,Volume of distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8408,CHEMBL620184,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8409,CHEMBL620185,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8410,CHEMBL620186,,50597,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8411,CHEMBL620187,,50597,,Volume of distribution was determined in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8412,CHEMBL620188,,50597,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8413,CHEMBL620189,,50597,,Volume of distribution was reported in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8414,CHEMBL620190,,50597,,Volumes of distribution in rat after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8415,CHEMBL620191,,50597,,Volumes of distribution in rat after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8416,CHEMBL620192,,50597,,Volumes of distribution in rat after po administration; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8417,CHEMBL620193,,50597,,Pharmacokinetic property (Volume) in rat i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8418,CHEMBL620194,,50597,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8419,CHEMBL876730,,50597,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8420,CHEMBL620195,,50597,,Volume distribution in rat after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8421,CHEMBL620196,,50597,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8422,CHEMBL620197,,50597,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8423,CHEMBL620198,,50597,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8424,CHEMBL620199,,50597,,Volume of distribution in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8425,CHEMBL620200,,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8426,CHEMBL620201,,50597,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8427,CHEMBL620202,,50597,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8428,CHEMBL620203,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8429,CHEMBL620204,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8430,CHEMBL620205,,50597,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8431,CHEMBL624664,,50597,,Pharmacokinetic parameter (Vss) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8432,CHEMBL624665,,50597,,Pharmacokinetic property (Volume) in rat i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8433,CHEMBL624666,,50597,,Pharmacokinetic property (Vss) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8434,CHEMBL624667,,50597,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8435,CHEMBL624668,,50597,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8436,CHEMBL624669,,50597,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8437,CHEMBL624670,,50597,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8438,CHEMBL624671,,50597,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8439,CHEMBL624672,,50597,,Steady state volume distribution in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8440,CHEMBL624673,Plasma,50597,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8441,CHEMBL624674,,50597,,Steady state volume of distribution determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8442,CHEMBL624675,,50597,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8443,CHEMBL621728,,50597,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8444,CHEMBL621729,,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8445,CHEMBL621730,,50597,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8446,CHEMBL621731,,50597,,Volume distribution in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8447,CHEMBL621732,,50597,,Volume distribution in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8448,CHEMBL621908,,50597,,Volume in steady state distribution value was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8449,CHEMBL875347,,50597,,Volume in steady state distribution value was determined; ND denotes no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8450,CHEMBL621909,,50597,,Volume in steady state distribution value was determined; ND denotes not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8451,CHEMBL621910,,50597,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8452,CHEMBL621911,,50597,,Volume of distribution at steady state was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8453,CHEMBL621912,,50597,,Volume of distribution at steady state was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8454,CHEMBL621913,,50597,,Volume of distribution in steady state was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8455,CHEMBL621914,,50597,,Volume of distribution in steady state was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8456,CHEMBL621915,,50597,,Volume of distribution after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8457,CHEMBL621916,,50597,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8458,CHEMBL621917,Liver,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8459,CHEMBL621918,Liver,50594,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8460,CHEMBL621919,Spleen,50594,,Biodistribution of compound (oxidized form) in spleen tissue,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8461,CHEMBL621920,Spleen,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8462,CHEMBL621921,Spleen,50594,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8463,CHEMBL622401,Spleen,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8464,CHEMBL875348,Spleen,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8465,CHEMBL622402,Spleen,50594,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8466,CHEMBL622403,Blood,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8467,CHEMBL622404,Blood,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8468,CHEMBL622405,Brain,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8469,CHEMBL622406,Brain,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8470,CHEMBL622407,Brain,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8471,CHEMBL622408,Heart,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8472,CHEMBL622409,Heart,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8473,CHEMBL622410,Heart,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8474,CHEMBL622411,Kidney,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8475,CHEMBL627864,Kidney,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8476,CHEMBL627865,Kidney,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8477,CHEMBL627866,Liver,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8478,CHEMBL627751,Liver,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8479,CHEMBL627752,Spleen,50594,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8480,CHEMBL627753,Spleen,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8481,CHEMBL627754,Spleen,50594,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8482,CHEMBL627755,,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8483,CHEMBL627756,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8484,CHEMBL627757,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8485,CHEMBL627758,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8486,CHEMBL627759,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8487,CHEMBL627760,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8488,CHEMBL627761,Brain,50594,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8489,CHEMBL876811,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8490,CHEMBL627762,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8491,CHEMBL627763,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8492,CHEMBL627764,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8493,CHEMBL627765,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8494,CHEMBL627766,Heart,50594,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
8495,CHEMBL627767,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8496,CHEMBL627768,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8497,CHEMBL628422,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8498,CHEMBL628423,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8499,CHEMBL628424,,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8500,CHEMBL628425,,50597,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8501,CHEMBL628426,,50597,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8502,CHEMBL628427,,50597,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8503,CHEMBL626938,,50597,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8504,CHEMBL626939,,50597,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8505,CHEMBL626940,,50597,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8506,CHEMBL626941,,50597,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8507,CHEMBL626942,,50597,,Plasma clearance was reported in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8508,CHEMBL876812,,50597,,Plasma clearance after intravenous administration (1 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8509,CHEMBL626943,,50597,,Plasma clearance of compound in rats was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8510,CHEMBL626944,,50597,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8511,CHEMBL626945,,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8512,CHEMBL626946,,50597,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8513,CHEMBL626856,,50597,,Plasma clearance rate in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8514,CHEMBL626857,,50597,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8515,CHEMBL626858,Plasma,50597,,The compound was evaluated for plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8516,CHEMBL627018,Plasma,50597,,Total plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8517,CHEMBL625331,Blood,50597,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8518,CHEMBL625332,Blood,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8519,CHEMBL877590,,50597,,C max was determined at 10 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8520,CHEMBL625333,,50597,,C max was determined at 3 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8521,CHEMBL625334,,50597,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8522,CHEMBL625335,,50597,,Cmax after single intravenous bolus of 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8523,CHEMBL625336,,50597,,Cmax of compound at 5 mg/kg after po administration was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8524,CHEMBL625337,,50597,,Cmax 24 hr after 10 mg/kg oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8525,CHEMBL625338,,50597,,Cmax 24 hr after 2 mg/kg oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8526,CHEMBL625339,Plasma,50597,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8527,CHEMBL625340,,50597,,Cmax in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8528,CHEMBL625341,,50597,,Cmax in rat after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8529,CHEMBL622687,,50597,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8530,CHEMBL622688,Plasma,50597,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8531,CHEMBL622689,Blood,50597,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8532,CHEMBL620295,Blood,50597,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8533,CHEMBL620296,,50597,,Cmax after 10 mg/kg oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8534,CHEMBL620297,,50597,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8535,CHEMBL620298,,50597,,Cmax after IV dosing at 1 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8536,CHEMBL620299,,50597,,Cmax after oral administration at 20 mpk in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8537,CHEMBL620300,,50597,,Cmax after oral administration at 20 mpk in rats; Not performed.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8538,CHEMBL620301,,50597,,Cmax after oral administration at 20 mpk in rats d; Not performed.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8539,CHEMBL620302,,50597,,Cmax after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8540,CHEMBL620303,,50597,,Cmax after oral administration at a dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8541,CHEMBL620304,,50597,,Cmax after oral administration at a dose of 4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8542,CHEMBL620305,,50597,,Cmax in rats after 20 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8543,CHEMBL620306,,50597,,Cmax after peroral administration in rats at 2.4 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8544,CHEMBL620307,,50597,,Cmax at the dose of 2 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8545,CHEMBL620308,,50597,,Cmax at the dose of 5 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8546,CHEMBL620309,,50597,,Cmax by administering at 20 mg/kg p.o. in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8547,CHEMBL620310,,50597,,Cmax in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8548,CHEMBL620311,,50597,,Cmax in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8549,CHEMBL620312,,50597,,Cmax in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8550,CHEMBL620313,,50597,,Cmax in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8551,CHEMBL620314,,50597,,Cmax in rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8552,CHEMBL620315,,50597,,Cmax in rat at the dose of 1 mg/kg i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8553,CHEMBL620316,,50597,,Cmax in rat by po administration at a dose of 40 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8554,CHEMBL620317,,50597,,Cmax in rat p.o. at 20 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8555,CHEMBL620318,,50597,,Cmax in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8556,CHEMBL620319,,50597,,Cmax in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8557,CHEMBL620320,,50597,,Cmax was evaluated after 20 uM/kg of peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8558,CHEMBL620321,,50597,,Cmax was measured in rats after peroral administration at 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8559,CHEMBL620322,,50597,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8560,CHEMBL620323,,50597,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8561,CHEMBL620324,Frontal cortex,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1870.0,
8562,CHEMBL620325,Frontal cortex,50597,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1870.0,
8563,CHEMBL620326,Hippocampus,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8564,CHEMBL620327,Hippocampus,50597,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8565,CHEMBL620328,,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8566,CHEMBL620329,,50597,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8567,CHEMBL620330,Midbrain,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1891.0,
8568,CHEMBL875286,Midbrain,50597,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1891.0,
8569,CHEMBL620331,,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8570,CHEMBL620332,,50597,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8571,CHEMBL620333,Striatum,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8572,CHEMBL620334,Striatum,50597,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8573,CHEMBL621015,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8574,CHEMBL621016,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8575,CHEMBL621191,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8576,CHEMBL621192,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8577,CHEMBL621193,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8578,CHEMBL621194,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8579,CHEMBL624204,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8580,CHEMBL624205,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8581,CHEMBL624206,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8582,CHEMBL624207,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8583,CHEMBL624208,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8584,CHEMBL624209,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8585,CHEMBL624210,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8586,CHEMBL624211,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8587,CHEMBL624212,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8588,CHEMBL624213,Blood,50597,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8589,CHEMBL876611,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8590,CHEMBL624214,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8591,CHEMBL624215,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8592,CHEMBL624216,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8593,CHEMBL624217,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8594,CHEMBL624218,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8595,CHEMBL624219,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8596,CHEMBL624220,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8597,CHEMBL624221,Blood,50597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8598,CHEMBL624222,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8599,CHEMBL624223,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8600,CHEMBL624224,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8601,CHEMBL624225,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8602,CHEMBL622420,,50597,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8603,CHEMBL622421,,50597,,Volume of steady state distribution after i.v. administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8604,CHEMBL622422,,50597,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8605,CHEMBL622423,,50597,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8606,CHEMBL622424,,50597,,Vss was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8607,CHEMBL622425,,50597,,Vss in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8608,CHEMBL876612,,50597,,Vss was evaluated after 10 uM/kg of intra arterial administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8609,CHEMBL622426,,50597,,volume of distribution at steady state was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8610,CHEMBL622427,,50597,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8611,CHEMBL622428,,50597,,Pharmacokinetic (PK) parameter Vz in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8612,CHEMBL622429,,50597,,Volume distribution in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8613,CHEMBL622430,,50597,,Volume of distribution in rat; No data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8614,CHEMBL622431,,50597,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8615,CHEMBL622432,Ileum,50597,,% absorption predicted from in vitro rat ileum transport studies,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2116.0,
8616,CHEMBL622433,,50597,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8617,CHEMBL622434,,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8618,CHEMBL622435,,50597,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8619,CHEMBL618748,,50597,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8620,CHEMBL618749,,50597,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8621,CHEMBL618750,,50597,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8622,CHEMBL618751,,50597,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8623,CHEMBL618752,,50597,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8624,CHEMBL618753,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8625,CHEMBL618754,Plasma,50597,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8626,CHEMBL618755,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8627,CHEMBL618756,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8628,CHEMBL618757,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8629,CHEMBL618758,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8630,CHEMBL621088,,50597,,Oral bioavailability in rat (dose 30 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8631,CHEMBL621089,,50597,,Pharmacokinetic property (cLogP) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8632,CHEMBL621090,Blood,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,178.0,
8633,CHEMBL621091,Blood,50597,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,178.0,
8634,CHEMBL876731,,50597,,Clearance in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8635,CHEMBL621092,,50597,,Compound was evaluated for its clearance when administered intravenously in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8636,CHEMBL621093,,50597,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8637,CHEMBL621094,,50597,,Blood: Brain distribution ratio is determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8638,CHEMBL621095,,50597,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8639,CHEMBL621096,,50597,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8640,CHEMBL621097,Kidney,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8641,CHEMBL621098,,50597,,Percent dose excreted in 0-48 hours administered ip to male rat,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
8642,CHEMBL621099,Cerebellum,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8643,CHEMBL621100,Cerebellum,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8644,CHEMBL621101,Cerebellum,50597,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8645,CHEMBL621102,Cerebellum,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8646,CHEMBL876732,Cerebellum,50597,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
8647,CHEMBL621103,,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8648,CHEMBL621104,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8649,CHEMBL621105,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8650,CHEMBL621106,,50597,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8651,CHEMBL621107,,50597,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8652,CHEMBL621108,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8653,CHEMBL621109,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8654,CHEMBL621110,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8655,CHEMBL621111,Kidney,50594,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
8656,CHEMBL622541,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8657,CHEMBL622542,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8658,CHEMBL622543,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8659,CHEMBL624412,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8660,CHEMBL624413,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8661,CHEMBL624414,Liver,50594,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
8662,CHEMBL624415,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8663,CHEMBL624416,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8664,CHEMBL624417,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8665,CHEMBL624418,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8666,CHEMBL624419,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8667,CHEMBL624420,Lung,50594,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
8668,CHEMBL624421,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8669,CHEMBL624422,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8670,CHEMBL624423,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8671,CHEMBL625123,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8672,CHEMBL625124,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8673,CHEMBL625125,Muscle tissue,50594,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
8674,CHEMBL625126,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8675,CHEMBL626947,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8676,CHEMBL626948,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8677,CHEMBL626949,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8678,CHEMBL626950,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8679,CHEMBL626951,Zone of skin,50594,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
8680,CHEMBL626952,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8681,CHEMBL626953,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8682,CHEMBL626954,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8683,CHEMBL626955,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8684,CHEMBL626956,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8685,CHEMBL626957,Spleen,50594,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
8686,CHEMBL626958,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8687,CHEMBL626959,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8688,CHEMBL626960,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8689,CHEMBL626961,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8690,CHEMBL627589,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8691,CHEMBL627590,Blood,50594,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8692,CHEMBL627591,,50594,,Time taken for EC90 was determined when tested in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8693,CHEMBL627592,,50594,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8694,CHEMBL627593,,50594,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8695,CHEMBL627594,,50594,,Half life in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8696,CHEMBL876813,,50594,,Half life period in mouse after 10 mg/Kg dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8697,CHEMBL627595,,50594,,Half life period in mouse after 10 mg/kg dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8698,CHEMBL627596,,50594,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8699,CHEMBL627597,,50597,,Cmax value at 5 mg/kg po was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8700,CHEMBL627598,,50597,,Cmax value evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8701,CHEMBL627599,Brain,50597,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8702,CHEMBL627600,,50597,,Cmax value after administration of 20 mg/Kg oral dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8703,CHEMBL627601,,50597,,Cmax value at 1 mg/kg po in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8704,CHEMBL627776,,50597,,Cmax value at 5 mg/kg po in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8705,CHEMBL627777,,50597,,Cmax value at a dose of 10 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8706,CHEMBL627778,,50597,,Cmax value at a dose of 100 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8707,CHEMBL627779,,50597,,Cmax value at a dose of 50 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8708,CHEMBL876814,,50597,,Cmax value in rats at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8709,CHEMBL627780,,50597,,Cmax value was evaluated in rats at a dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8710,CHEMBL627781,,50597,,Cmax value was determined after peroral administration of 20 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8711,CHEMBL627782,,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8712,CHEMBL627783,Plasma,50597,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8713,CHEMBL627784,Plasma,50597,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8714,CHEMBL627785,,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8715,CHEMBL627786,,50597,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8716,CHEMBL627787,Plasma,50597,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8717,CHEMBL627788,Plasma,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8718,CHEMBL626579,Plasma,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8719,CHEMBL626580,Plasma,50597,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8720,CHEMBL876815,,50597,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8721,CHEMBL626581,Plasma,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8722,CHEMBL626582,Plasma,50597,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8723,CHEMBL626583,,50597,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8724,CHEMBL626205,,50597,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8725,CHEMBL626206,,50597,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8726,CHEMBL626207,,50597,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8727,CHEMBL623882,,50597,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8728,CHEMBL623883,,50597,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8729,CHEMBL623884,,50597,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8730,CHEMBL623885,Plasma,50597,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8731,CHEMBL623886,Plasma,50597,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8732,CHEMBL623887,,50597,,Maximal concentration in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8733,CHEMBL623888,,50597,,Maximal concentration after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8734,CHEMBL623889,Plasma,50597,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8735,CHEMBL623890,Plasma,50597,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8736,CHEMBL623891,Plasma,50597,,Cmax in rat plasma after oral dose (50 mg/Kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8737,CHEMBL623892,Plasma,50597,,Maximal plasma concentration was determined.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8738,CHEMBL623893,Plasma,50597,,Maximal plasma drug concentration was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8739,CHEMBL877616,,50597,,Maximal concentration in rats after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8740,CHEMBL623894,,50597,,Maximum concentration in rat after 2 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8741,CHEMBL623895,Plasma,50597,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8742,CHEMBL623896,,50597,,Maximum concentration of compound in rat was evaluated.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8743,CHEMBL623897,,50597,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8744,CHEMBL623898,,50597,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8745,CHEMBL623899,,50597,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8746,CHEMBL623900,,50597,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8747,CHEMBL623901,,50597,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8748,CHEMBL623902,,50597,,Maximum concentration was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8749,CHEMBL623903,Cerebrospinal fluid,50597,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1359.0,
8750,CHEMBL623904,Plasma,50597,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8751,CHEMBL877617,Plasma,50597,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8752,CHEMBL623905,,50597,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8753,CHEMBL623906,,50597,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8754,CHEMBL623907,Plasma,50597,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8755,CHEMBL623908,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8756,CHEMBL623909,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8757,CHEMBL623910,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8758,CHEMBL623911,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8759,CHEMBL623912,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8760,CHEMBL624616,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8761,CHEMBL624617,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8762,CHEMBL624618,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8763,CHEMBL624619,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8764,CHEMBL624794,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8765,CHEMBL624795,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8766,CHEMBL623921,,50597,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8767,CHEMBL623922,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8768,CHEMBL623923,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8769,CHEMBL623924,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8770,CHEMBL623925,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8771,CHEMBL623926,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8772,CHEMBL623927,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8773,CHEMBL623928,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8774,CHEMBL623929,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8775,CHEMBL623930,,50597,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8776,CHEMBL623931,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8777,CHEMBL622165,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8778,CHEMBL621249,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8779,CHEMBL621250,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8780,CHEMBL621448,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8781,CHEMBL621449,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8782,CHEMBL621450,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8783,CHEMBL621451,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8784,CHEMBL621452,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8785,CHEMBL621453,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8786,CHEMBL621454,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8787,CHEMBL621455,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8788,CHEMBL621456,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8789,CHEMBL625145,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8790,CHEMBL875847,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8791,CHEMBL625146,Brain,50597,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8792,CHEMBL625147,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8793,CHEMBL625148,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8794,CHEMBL625149,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8795,CHEMBL625150,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8796,CHEMBL625151,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8797,CHEMBL625152,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8798,CHEMBL625153,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8799,CHEMBL625154,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8800,CHEMBL625155,Brain,50597,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8801,CHEMBL625156,,50597,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8802,CHEMBL624354,,50597,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8803,CHEMBL624355,Hippocampus,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8804,CHEMBL624356,Hippocampus,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8805,CHEMBL624357,Hippocampus,50597,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8806,CHEMBL624358,Hippocampus,50597,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
8807,CHEMBL624359,Striatum,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8808,CHEMBL624360,Striatum,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8809,CHEMBL624361,Striatum,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8810,CHEMBL624362,Striatum,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8811,CHEMBL624363,Striatum,50597,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
8812,CHEMBL624364,Blood,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8813,CHEMBL624365,Blood,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8814,CHEMBL624366,Blood,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8815,CHEMBL624367,Blood,50597,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8816,CHEMBL624368,Brain,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8817,CHEMBL624369,Brain,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8818,CHEMBL624370,Brain,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8819,CHEMBL625069,Brain,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8820,CHEMBL625070,Brain,50597,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8821,CHEMBL626051,Heart,50597,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8822,CHEMBL626052,Heart,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8823,CHEMBL626053,Heart,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8824,CHEMBL626054,Heart,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8825,CHEMBL626055,Heart,50597,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8826,CHEMBL626056,Kidney,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8827,CHEMBL626057,Kidney,50597,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8828,CHEMBL625193,Kidney,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8829,CHEMBL625194,Kidney,50597,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8830,CHEMBL625195,Liver,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8831,CHEMBL625196,Liver,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8832,CHEMBL625197,Liver,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8833,CHEMBL625198,Liver,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8834,CHEMBL627929,Liver,50597,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
8835,CHEMBL627074,Lung,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8836,CHEMBL627075,Lung,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8837,CHEMBL627076,Lung,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8838,CHEMBL627077,Lung,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8839,CHEMBL627078,Lung,50597,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
8840,CHEMBL627079,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8841,CHEMBL873824,,50594,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8842,CHEMBL627080,Plasma,50594,,Half life in mouse plasma was determined at dose 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
8843,CHEMBL627081,,50594,,Half life was determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8844,CHEMBL627082,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8845,CHEMBL627083,,50594,,Half-life in male mice after 1 mg/kg intravenous dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8847,CHEMBL627085,Plasma,50594,,Half life in mice plasma,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
8848,CHEMBL627086,,50594,,Half life in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8849,CHEMBL627087,Plasma,50594,,Half life in mouse plasma at dose 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
8850,CHEMBL627088,,50594,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8851,CHEMBL627089,,50594,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8852,CHEMBL627090,,50594,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8853,CHEMBL627091,,50594,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8854,CHEMBL627092,,50594,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8855,CHEMBL876785,,50594,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8856,CHEMBL627093,,50594,,Half-life by iv administration in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8857,CHEMBL627094,,50594,,Half-life by oral administration in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8858,CHEMBL627095,,50594,,Half-life in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8859,CHEMBL627096,Brain,50594,,Half-life using mouse brain homogenate,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8860,CHEMBL627097,,50594,,Half-life was measured in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8861,CHEMBL627098,,50594,,Half-life was measured in mouse after an iv dose of 1 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8862,CHEMBL627099,Blood,50594,,Half-life period was determined in mouse blood,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
8863,CHEMBL627100,Brain,50594,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
8864,CHEMBL627101,Plasma,50594,,Plasma half life in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
8865,CHEMBL627102,,50594,,Stability of the peptide in the presence of mouse serum,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8866,CHEMBL627103,,50594,,Terminal half life of compound was determined in mouse,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8867,CHEMBL627104,,50594,,Terminal half life was evaluated in mice after intravenous administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8868,CHEMBL627105,,50594,,Terminal half life was evaluated in mice after oral administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8869,CHEMBL876786,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8870,CHEMBL873825,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8871,CHEMBL627106,,50594,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8872,CHEMBL626336,,50594,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8873,CHEMBL877462,,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8874,CHEMBL626337,,50594,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8875,CHEMBL626338,,50594,,Half life after intraperitoneal administration of 100 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8876,CHEMBL626339,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8877,CHEMBL626340,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8878,CHEMBL625377,,50594,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8879,CHEMBL625378,,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8880,CHEMBL625379,,50594,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
8881,CHEMBL625380,,22224,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000251,,
8882,CHEMBL625381,,22224,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000251,,
8883,CHEMBL625382,,22224,,Stability to porcine renal DHP-I,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000019,,
8884,CHEMBL873828,,22224,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000218,,
8885,CHEMBL625383,,22224,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000218,,
8886,CHEMBL625384,,22224,,Half-life of the parent prodrug in porcine esterase solution,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000019,,
8887,CHEMBL625385,,22224,,"First order rate constant, k was determined in in pig liver Esterase",U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000019,,
8888,CHEMBL625386,Liver,22224,,Half life of the in pig liver Esterase,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8889,CHEMBL623571,Liver,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8890,CHEMBL623572,Liver,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8891,CHEMBL623573,Liver,22224,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8892,CHEMBL623574,Liver,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8893,CHEMBL623575,Liver,22224,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8894,CHEMBL623749,Liver,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8895,CHEMBL623750,Liver,22224,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8896,CHEMBL623751,Liver,22224,,Half-life in vitro in pig liver,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8897,CHEMBL623752,Liver,22224,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,U,9823.0,,Autocuration,,0,,A,Sus scrofa,,1,BAO_0000221,2107.0,
8898,CHEMBL623753,Plasma,50597,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8899,CHEMBL623754,Plasma,50597,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8900,CHEMBL623755,Plasma,50597,,Maximum concentration in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8901,CHEMBL623756,,50597,,Maximum concentration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8902,CHEMBL623757,,50597,,Maximum concentration in rats at 1-2 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8903,CHEMBL623758,,50597,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8904,CHEMBL623759,Brain,50597,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
8905,CHEMBL623760,,50597,,Maximum concentration at the dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8906,CHEMBL623761,,50597,,Maximum concentration was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8907,CHEMBL623762,Plasma,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8908,CHEMBL877594,Plasma,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8909,CHEMBL623763,Plasma,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8910,CHEMBL623764,Plasma,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8911,CHEMBL623765,Plasma,50597,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8912,CHEMBL623766,Blood,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8913,CHEMBL623767,Blood,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8914,CHEMBL623768,Blood,50597,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
8915,CHEMBL623769,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8916,CHEMBL623770,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8917,CHEMBL623771,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8918,CHEMBL623772,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8919,CHEMBL623773,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8920,CHEMBL623774,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8921,CHEMBL623775,Plasma,50597,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8922,CHEMBL623776,,50597,,Cmax in rat (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
8923,CHEMBL622191,Plasma,50597,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8924,CHEMBL622192,Plasma,50597,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8925,CHEMBL622193,Plasma,50597,,Maximum plasma concentration determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8926,CHEMBL622194,Plasma,50597,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8927,CHEMBL622195,Plasma,50597,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8928,CHEMBL622196,Plasma,50597,,Maximum plasma concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8929,CHEMBL622197,Plasma,50597,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8930,CHEMBL622198,Plasma,50597,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8931,CHEMBL622199,Plasma,50597,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8932,CHEMBL622200,Plasma,50597,,Maximum plasma concentration of compound was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8933,CHEMBL622201,Plasma,50597,,Maximum plasma concentration after 20 mg/kg oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8934,CHEMBL623990,Plasma,50597,,Maximum plasma concentration after oral administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8935,CHEMBL623991,Plasma,50597,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8936,CHEMBL623992,Plasma,50597,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8937,CHEMBL623993,Plasma,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8938,CHEMBL623994,Plasma,50597,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8939,CHEMBL623995,Plasma,50597,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,1969.0,
8940,CHEMBL623996,Plasma,50597,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,1969.0,
8941,CHEMBL623997,Plasma,50597,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,1969.0,
8942,CHEMBL623998,Plasma,50597,,Maximum plasma concentration dosed orally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8943,CHEMBL623999,Plasma,50597,,Maximum plasma concentration dosed orally in rats after 6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8944,CHEMBL624000,Plasma,50597,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8945,CHEMBL624001,Plasma,50597,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8946,CHEMBL624002,Plasma,50597,,Maximum plasma concentration in rat after po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8947,CHEMBL624003,Plasma,50597,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8948,CHEMBL624004,Plasma,50597,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
8949,CHEMBL624005,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8950,CHEMBL624006,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8951,CHEMBL624007,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8952,CHEMBL624008,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8953,CHEMBL624009,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8954,CHEMBL874387,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8955,CHEMBL624010,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8956,CHEMBL624011,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8957,CHEMBL624012,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8958,CHEMBL624013,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8959,CHEMBL624736,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8960,CHEMBL624737,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8961,CHEMBL624738,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8962,CHEMBL624739,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8963,CHEMBL624740,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8964,CHEMBL624896,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8965,CHEMBL624897,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8966,CHEMBL624108,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8967,CHEMBL624109,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8968,CHEMBL624110,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8969,CHEMBL624111,Heart,50597,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8970,CHEMBL624112,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8971,CHEMBL624113,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8972,CHEMBL619709,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8973,CHEMBL619710,Heart,50597,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
8974,CHEMBL619711,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8975,CHEMBL619712,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8976,CHEMBL619713,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8977,CHEMBL619714,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8978,CHEMBL619715,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8979,CHEMBL619716,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8980,CHEMBL619717,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8981,CHEMBL619718,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8982,CHEMBL619719,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8983,CHEMBL875329,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8984,CHEMBL619720,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8985,CHEMBL619721,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8986,CHEMBL619722,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8987,CHEMBL619723,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8988,CHEMBL619724,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8989,CHEMBL619725,Kidney,50597,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8990,CHEMBL619726,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8991,CHEMBL619727,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8992,CHEMBL619728,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8993,CHEMBL619729,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
8994,CHEMBL619730,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8995,CHEMBL619731,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8996,CHEMBL619732,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8997,CHEMBL619733,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8998,CHEMBL619734,Muscle tissue,50597,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
8999,CHEMBL619735,Zone of skin,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9000,CHEMBL875330,Zone of skin,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9001,CHEMBL628465,Zone of skin,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9002,CHEMBL628466,Zone of skin,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9003,CHEMBL628467,Zone of skin,50597,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9004,CHEMBL628468,Spleen,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9005,CHEMBL628469,Spleen,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9006,CHEMBL628470,Spleen,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9007,CHEMBL628471,Spleen,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9008,CHEMBL628472,Spleen,50597,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9009,CHEMBL625191,Thyroid gland,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9010,CHEMBL625192,Thyroid gland,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9011,CHEMBL875337,Thyroid gland,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9012,CHEMBL626341,Thyroid gland,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9013,CHEMBL626342,Thyroid gland,50597,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9014,CHEMBL621943,Liver,50597,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9015,CHEMBL621944,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9016,CHEMBL621945,,50597,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9017,CHEMBL621946,,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9018,CHEMBL621947,,50597,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9019,CHEMBL621948,,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9020,CHEMBL621949,,50597,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9021,CHEMBL621950,,50597,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9022,CHEMBL621951,,50597,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9023,CHEMBL621952,Blood,50597,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9024,CHEMBL621953,Liver,50597,,Stability (%) in rat liver microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9025,CHEMBL621954,,50597,,Area under curve was calculated after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9026,CHEMBL621955,,50597,,Area under the curve was calculated after iv administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9027,CHEMBL621956,,50597,,Area under the curve was calculated in rat after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9028,CHEMBL621957,,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9029,CHEMBL621958,,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9030,CHEMBL621959,,50597,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9031,CHEMBL621960,,50597,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9032,CHEMBL621961,,50597,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9033,CHEMBL621962,,50597,,p value of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9034,CHEMBL876787,,50597,,p value of the compound,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
9035,CHEMBL621963,,50597,,p value of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9036,CHEMBL622637,Stomach,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9037,CHEMBL622638,Stomach,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9038,CHEMBL626561,Stomach,50597,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9039,CHEMBL626562,,22224,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),U,9986.0,,Autocuration,,0,,F,Oryctolagus cuniculus,,1,BAO_0000019,,
9040,CHEMBL626563,,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9041,CHEMBL626564,,22224,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9042,CHEMBL626565,,22224,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9043,CHEMBL626566,,22224,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9044,CHEMBL626567,,22224,,Clearance rate in rabbits,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9045,CHEMBL626568,,22224,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9046,CHEMBL626569,,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9047,CHEMBL626570,,22224,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9048,CHEMBL626571,,22224,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9049,CHEMBL626572,,22224,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9050,CHEMBL626573,Plasma,22224,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
9051,CHEMBL626574,Liver,22224,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000251,2107.0,
9052,CHEMBL626575,Liver,22224,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000251,2107.0,
9053,CHEMBL626576,,22224,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9054,CHEMBL626577,,22224,,Dose at which bioavailability of perorally administered compound was tested in rabbit,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9055,CHEMBL626578,,22224,,The compound was tested for its bioavailability in rabbit (by oral dosage).,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9056,CHEMBL625263,,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9057,CHEMBL625264,,22224,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9058,CHEMBL625265,,22224,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9059,CHEMBL625266,,22224,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000251,,
9060,CHEMBL876796,,22224,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000251,,
9061,CHEMBL625267,,22224,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9062,CHEMBL625268,Plasma,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
9063,CHEMBL625269,Plasma,22224,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
9064,CHEMBL624689,Plasma,22224,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
9065,CHEMBL624690,,22224,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9066,CHEMBL624691,Urine,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
9067,CHEMBL624692,Urine,22224,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
9068,CHEMBL624693,,22224,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9069,CHEMBL624694,,22224,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9070,CHEMBL877596,,22224,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000221,,
9071,CHEMBL624695,,22224,,Time within which only 10% of the drug was degraded,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000019,,
9072,CHEMBL624696,Liver,22224,,Half life period in rabbit liver homogenate,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000221,2107.0,
9073,CHEMBL624697,,22224,,Half life value in rabbits,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000019,,
9074,CHEMBL624698,Blood,22224,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,178.0,
9075,CHEMBL624699,Blood,22224,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,178.0,
9076,CHEMBL624700,,22224,,Half-life period in rabbits following intravenous administration at 2 mg/kg,U,9986.0,,Autocuration,,0,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
9077,CHEMBL622903,Plasma,50597,,AUC 0-8 hr value in rats at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9078,CHEMBL622904,Plasma,50597,,AUC after administration at 2000 mg/kg/day in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9079,CHEMBL622905,Plasma,50597,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9080,CHEMBL622906,Plasma,50597,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9081,CHEMBL622907,Plasma,50597,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9082,CHEMBL622908,Plasma,50597,,AUC in rat after oral administration at 10.5 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9083,CHEMBL622909,Plasma,50597,,AUC in rat after oral administration at 11.2 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9084,CHEMBL622910,Plasma,50597,,AUC in rat after oral administration at 9.7 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9085,CHEMBL622911,Brain,50597,,AUC in rat brain after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9086,CHEMBL622912,Plasma,50597,,AUC in rat p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9087,CHEMBL622913,Plasma,50597,,AUC in rat p.o. at 20 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9088,CHEMBL622914,Plasma,50597,,AUC in rat plasma after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9089,CHEMBL622915,Plasma,50597,,AUC in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9090,CHEMBL622916,Plasma,50597,,AUC value after IV dose at a dose of 5 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9091,CHEMBL622917,Plasma,50597,,AUC value after oral dose at a dose of 10 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9092,CHEMBL622918,Plasma,50597,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9093,CHEMBL622919,Plasma,50597,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9094,CHEMBL622920,Plasma,50597,,Maximum plasma concentration was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9095,CHEMBL622921,Plasma,50597,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9096,CHEMBL622922,Plasma,50597,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9097,CHEMBL622923,Plasma,50597,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9098,CHEMBL877604,Plasma,50597,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9099,CHEMBL622924,Plasma,50597,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9100,CHEMBL622925,Plasma,50597,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9101,CHEMBL622926,Plasma,50597,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9102,CHEMBL623625,Plasma,50597,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9103,CHEMBL623626,Plasma,50597,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9104,CHEMBL623627,Plasma,50597,,Maximum plasma drug concentration was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9105,CHEMBL623628,,50597,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9106,CHEMBL623629,Plasma,50597,,Mean peak plasma concentration was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9107,CHEMBL623630,Plasma,50597,,Mean peak plasma concentration was observed after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9108,CHEMBL623804,,50597,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9109,CHEMBL623805,,50597,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9110,CHEMBL623806,Plasma,50597,,Peak oral plasma concentration was determined in rats by oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9111,CHEMBL623807,Plasma,50597,,Peak plasma concentration (Cmax) was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9112,CHEMBL623808,Plasma,50597,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9113,CHEMBL623809,Plasma,50597,,Peak plasma concentration (Cmax) in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9114,CHEMBL623810,Plasma,50597,,Peak plasma concentration at 1 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9115,CHEMBL623811,Plasma,50597,,Peak plasma concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9116,CHEMBL623812,Plasma,50597,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9117,CHEMBL877605,,50597,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9118,CHEMBL623813,,50597,,Pharmacokinetic property (Cmax) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9119,CHEMBL623814,,50597,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9120,CHEMBL623815,,50597,,Cmax in rat after 3mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9121,CHEMBL623816,,50597,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,N,10116.0,,Intermediate,Sprague-Dawley,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9122,CHEMBL623145,,50597,,Cmax in rats after 20 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9123,CHEMBL623146,Plasma,50597,,Cmax in rat plasma after 30mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9124,CHEMBL623147,Plasma,50597,,Plasma concentration after oral administration of 100 mg/kg to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9125,CHEMBL623042,Brain,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9126,CHEMBL623043,,50597,,Tested for the Cmax in rat at 10 mg/kg per orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9127,CHEMBL623044,,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9128,CHEMBL623045,,50597,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9129,CHEMBL623046,,50597,,Bioavailability as oral Cmax in rats at 30 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9130,CHEMBL623226,,50597,,Bioavailability as oral Cmax in rats at 6hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9131,CHEMBL623227,,50597,,The maximum concentration of compound was measured at the dose of 100 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9132,CHEMBL623228,,50597,,The maximum concentration of compound was measured at the dose of 300 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9133,CHEMBL623229,,50597,,The maximum concentration of compound was measured at the dose of 30 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9134,CHEMBL623230,Plasma,50597,,The maximum plasma levels for the compounds were determined by LC-MS.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9135,CHEMBL623231,Plasma,50597,,mean peak plasma concentration was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9136,CHEMBL623232,Plasma,50597,,mean peak plasma concentration was observed after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9137,CHEMBL623233,,50597,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9138,CHEMBL623234,,50597,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9139,CHEMBL623235,,50597,,Concentration in plasma (portal) following oral dose in rats at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9140,CHEMBL623236,,50597,,Concentration in plasma (portal) following oral dose in rats at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9141,CHEMBL623237,,50597,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9142,CHEMBL623238,,50597,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9143,CHEMBL623239,,50597,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9144,CHEMBL623240,Plasma,22224,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9145,CHEMBL623241,Hypothalamus,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
9146,CHEMBL623242,Hypothalamus,50597,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
9147,CHEMBL874394,,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9148,CHEMBL623243,,50597,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9149,CHEMBL623244,,50597,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9150,CHEMBL623245,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9151,CHEMBL623246,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9152,CHEMBL623247,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9153,CHEMBL623248,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9154,CHEMBL623249,Kidney,50597,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9155,CHEMBL625072,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9156,CHEMBL625073,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9157,CHEMBL625074,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9158,CHEMBL625075,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9159,CHEMBL625076,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9160,CHEMBL625077,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9161,CHEMBL625078,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9162,CHEMBL874395,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9163,CHEMBL625079,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9164,CHEMBL625080,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9165,CHEMBL625081,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9166,CHEMBL625082,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9167,CHEMBL625083,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9168,CHEMBL625084,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9169,CHEMBL625085,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9170,CHEMBL625086,Liver,50597,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9171,CHEMBL625087,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9172,CHEMBL625088,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9173,CHEMBL622205,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9174,CHEMBL622206,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9175,CHEMBL622207,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9176,CHEMBL622366,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9177,CHEMBL622367,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9178,CHEMBL875331,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9179,CHEMBL622368,Liver,50597,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9180,CHEMBL622369,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9181,CHEMBL622370,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9182,CHEMBL622371,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9183,CHEMBL622372,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9184,CHEMBL622373,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9185,CHEMBL622374,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9186,CHEMBL622375,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9187,CHEMBL622376,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9188,CHEMBL622377,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9189,CHEMBL622378,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9190,CHEMBL622379,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9191,CHEMBL622380,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9192,CHEMBL622381,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9193,CHEMBL622382,Lung,50597,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9194,CHEMBL622383,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9195,CHEMBL875332,Stomach,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9196,CHEMBL622384,Stomach,50597,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9197,CHEMBL622385,Stomach,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9198,CHEMBL622386,Stomach,50597,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9199,CHEMBL622387,,50597,,The compound was tested for the plasma binding in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9200,CHEMBL622388,,50597,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9201,CHEMBL622389,,50597,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9202,CHEMBL622390,,50597,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9203,CHEMBL622391,,50597,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9204,CHEMBL622392,,50597,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9205,CHEMBL622393,,50597,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9206,CHEMBL622394,,50597,,Plasma level at 2 hr after administration of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9207,CHEMBL622395,,50597,,plasma level at 2 hr after administration of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9208,CHEMBL622396,Serum,50597,,Stability in rat serum measured as % recovery at 1 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9209,CHEMBL624894,Serum,50597,,Stability in rat serum measured as % recovery at 10 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9210,CHEMBL624895,Serum,50597,,Stability in rat serum measured as % recovery at 10 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9211,CHEMBL624058,Serum,50597,,Stability in rat serum measured as % recovery at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9212,CHEMBL624059,Serum,50597,,Stability in rat serum measured as % recovery at 3 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9213,CHEMBL624060,Serum,50597,,Stability in rat serum measured as % recovery at 3 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9214,CHEMBL624061,Serum,50597,,Stability in rat serum measured as % recovery at 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9215,CHEMBL624062,Serum,50597,,Stability in rat serum measured as % recovery at 5 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9216,CHEMBL624063,,50597,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9217,CHEMBL624064,,50597,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9218,CHEMBL624065,Plasma,50597,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9219,CHEMBL624066,Plasma,50597,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9220,CHEMBL877490,,50597,,Half life tested in mature male rat at a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9221,CHEMBL874442,,50597,,Half life after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9222,CHEMBL626890,,50597,,Half life period after administration (30 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9223,CHEMBL626891,,50597,,Half life period in rat after 5 mg/Kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9224,CHEMBL626892,,50597,,Half life period in rat after 5 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9225,CHEMBL626893,,50597,,Half life period was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9226,CHEMBL626894,,50597,,Half life period was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9227,CHEMBL626895,,50597,,Half life period was evaluated in rat; 0.5-1.0,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9228,CHEMBL626896,,50597,,Half life period was evaluated in rat; 5.9-7.5,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9229,CHEMBL626897,Plasma,50597,,Half-life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9230,CHEMBL626898,,50597,,Half-life time in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9231,CHEMBL626899,,50597,,Terminal half-life after iv administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9232,CHEMBL626900,,50597,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9233,CHEMBL626901,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9234,CHEMBL626902,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9235,CHEMBL626903,,50597,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9236,CHEMBL874443,,50597,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9237,CHEMBL626904,,50597,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9238,CHEMBL626905,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9239,CHEMBL873830,Plasma,50597,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9240,CHEMBL626906,,50597,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9241,CHEMBL631076,Plasma,50597,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9242,CHEMBL631077,Plasma,50597,,Biological half-life was measured in plasma of rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9243,CHEMBL631078,,50597,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9244,CHEMBL631079,,50597,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9245,CHEMBL631080,,50597,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9246,CHEMBL631081,,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9247,CHEMBL631239,,50597,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9248,CHEMBL631240,Plasma,50597,,Compound was evaluated for plasma half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9249,CHEMBL631241,Plasma,50597,,AUC value at a dose of 5 mg/kg (p.o.) in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9250,CHEMBL631242,Plasma,50597,,AUC value after administration of 20 mg/Kg oral dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9251,CHEMBL631243,Plasma,50597,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9252,CHEMBL874444,Plasma,50597,,AUC0-96 after administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9253,CHEMBL631244,Plasma,50597,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9254,CHEMBL631245,,50597,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9255,CHEMBL627162,,50597,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9256,CHEMBL627163,,50597,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9257,CHEMBL627164,,50597,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9258,CHEMBL627165,Kidney,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9259,CHEMBL627166,,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9260,CHEMBL627167,,50597,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9261,CHEMBL627822,,50597,,Area under curve (AUC) at a dose of 30 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9262,CHEMBL627823,,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9263,CHEMBL627824,,50597,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9264,CHEMBL627825,,50597,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9265,CHEMBL627826,,50597,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9266,CHEMBL627827,,50597,,Area under curve (Pharmacokinetic property) was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9267,CHEMBL627828,,50597,,Area under curve (Pharmacokinetic property) of the compound; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9268,CHEMBL627829,,50597,,Area under curve after intravenous administration (1 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9269,CHEMBL627830,,50597,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9270,CHEMBL627831,,50597,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9271,CHEMBL627832,,50597,,Area under curve in male SD rats was observed after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9272,CHEMBL627833,,50597,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9273,CHEMBL627834,,50597,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9274,CHEMBL628004,,50597,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9275,CHEMBL628005,,50597,,Area under curve at 5 mg/kg po was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9276,CHEMBL628006,,50597,,Area under curve in Rat at a oral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9277,CHEMBL628007,,50597,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9278,CHEMBL625676,,50597,,Area under curve was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9279,CHEMBL631309,,50597,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9280,CHEMBL631310,,50597,,Area under curve after intravenous administration at 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9281,CHEMBL631311,,50597,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9282,CHEMBL631312,,50597,,Area under curve at 4 hr in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9283,CHEMBL631313,,50597,,Area under curve at a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9284,CHEMBL631314,,50597,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9285,CHEMBL631315,,50597,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9286,CHEMBL631316,,50597,,Area under curve for a 2-mpk po dose in SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9287,CHEMBL631317,,50597,,Area under curve in SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9288,CHEMBL874471,,50597,,Area under curve in rat after oral administration at 13 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9289,CHEMBL631318,,50597,,Area under curve in rat by po administration at 0-24 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9290,CHEMBL631319,Plasma,50597,,Area under curve in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9291,CHEMBL631320,,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9292,CHEMBL631321,,50597,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9293,CHEMBL631322,,50597,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9294,CHEMBL631323,,50597,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9295,CHEMBL631324,,50597,,Area under curve value in rat at a dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9296,CHEMBL631325,,50597,,Area under curve was determined after oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9297,CHEMBL631326,,50597,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9298,CHEMBL631327,,50597,,Area under curve was determined after peroral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9299,CHEMBL631328,,50597,,Area under curve was determined at a dose 30 mpk administered orally.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9300,CHEMBL631329,,50597,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9301,CHEMBL627217,,50597,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9302,CHEMBL626352,,50597,,Area under curve was determined in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9303,CHEMBL626353,,50597,,Area under curve was determined in rat after PO administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9304,CHEMBL626354,,50597,,Area under curve was determined in rat after a 3 mg/kg of oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9305,CHEMBL626355,,50597,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9306,CHEMBL626356,,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9307,CHEMBL626357,,50597,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9308,CHEMBL626358,,50597,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9309,CHEMBL626359,,50597,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9310,CHEMBL626360,Plasma,50597,,Peak plasma concentration in rat at a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9311,CHEMBL626361,,50597,,Plasma concentration at 2 hr in rats was evaluated.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9312,CHEMBL626362,,50597,,Plasma concentration at 2 hr in rats was evaluated; Not available,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9313,CHEMBL626363,,50597,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9314,CHEMBL626970,,50597,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9315,CHEMBL626971,,50597,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9316,CHEMBL626972,Plasma,50597,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9317,CHEMBL626973,Plasma,50597,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9318,CHEMBL626974,Plasma,50597,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9319,CHEMBL874592,Plasma,50597,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9320,CHEMBL626975,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9321,CHEMBL626976,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9322,CHEMBL626977,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9323,CHEMBL626978,,50597,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9324,CHEMBL626979,,50597,,PK study was carried to determine the relative absorption ranking in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9325,CHEMBL626980,Plasma,50597,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9326,CHEMBL626981,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9327,CHEMBL626982,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9328,CHEMBL626983,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9329,CHEMBL622522,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9330,CHEMBL622523,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9331,CHEMBL622524,Blood,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9332,CHEMBL622525,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9333,CHEMBL622526,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9334,CHEMBL619849,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9335,CHEMBL619850,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9336,CHEMBL623864,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9337,CHEMBL623865,Brain,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9338,CHEMBL623866,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9339,CHEMBL623867,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9340,CHEMBL877615,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9341,CHEMBL623868,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9342,CHEMBL623869,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9343,CHEMBL623870,Heart,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9344,CHEMBL623871,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9345,CHEMBL623872,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9346,CHEMBL622129,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9347,CHEMBL622130,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9348,CHEMBL622131,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9349,CHEMBL622132,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9350,CHEMBL622133,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9351,CHEMBL622134,Lung,50597,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9352,CHEMBL622135,Lung,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9353,CHEMBL622136,Lung,50597,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9354,CHEMBL622137,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9355,CHEMBL622138,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9356,CHEMBL623017,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9357,CHEMBL623018,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9358,CHEMBL623019,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9359,CHEMBL623020,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9360,CHEMBL623021,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9361,CHEMBL623022,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9362,CHEMBL623023,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9363,CHEMBL623024,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9364,CHEMBL623025,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9365,CHEMBL620545,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9366,CHEMBL620546,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9367,CHEMBL620547,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9368,CHEMBL620548,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9369,CHEMBL620549,Muscle tissue,50597,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9370,CHEMBL620550,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9371,CHEMBL620551,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9372,CHEMBL620552,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9373,CHEMBL620553,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9374,CHEMBL620554,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9375,CHEMBL875845,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9376,CHEMBL620555,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9377,CHEMBL620556,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9378,CHEMBL620557,Muscle tissue,50597,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9379,CHEMBL620558,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9380,CHEMBL620559,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9381,CHEMBL622939,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9382,CHEMBL622940,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9383,CHEMBL622941,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9384,CHEMBL622942,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9385,CHEMBL622943,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9386,CHEMBL622944,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9387,CHEMBL622945,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9388,CHEMBL622946,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9389,CHEMBL622947,,50597,,Compound was evaluated for terminal half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9390,CHEMBL622948,Plasma,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9391,CHEMBL622949,Plasma,50597,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9392,CHEMBL622950,,50597,,Compound was tested for its half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9393,CHEMBL622951,Plasma,22224,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,U,9544.0,,Intermediate,,0,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
9394,CHEMBL622952,Plasma,22224,,Compound was tested for its plasma half life in Sprague Dawley rats,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000366,1969.0,
9395,CHEMBL622953,Plasma,22224,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000366,1969.0,
9396,CHEMBL873818,Plasma,50597,,Compound was tested for plasma half-life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9397,CHEMBL622954,,50597,,Elimination half life after i.v. administration of compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9398,CHEMBL622955,,50597,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9399,CHEMBL875229,,50597,,Elimination half-life after IV dosing at 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9400,CHEMBL622956,,50597,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9401,CHEMBL622957,,50597,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9402,CHEMBL622958,Brain,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9403,CHEMBL622959,Plasma,50597,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9404,CHEMBL622960,Brain,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9405,CHEMBL622961,Plasma,50597,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9406,CHEMBL622962,,50597,,Evaluated for the half life in rat (in vivo),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9407,CHEMBL622963,,50597,,Hafl life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9408,CHEMBL622964,,50597,,Hafl life rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9409,CHEMBL622965,,50597,,Hafl life rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9410,CHEMBL622966,,50597,,Hafl life rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9411,CHEMBL622967,,50597,,Hafl life rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9412,CHEMBL622968,Kidney,50597,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9413,CHEMBL622969,Liver,50597,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9414,CHEMBL875327,Lung,50597,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9415,CHEMBL628638,,50597,,Half life in rat after 1 mg/kg i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9416,CHEMBL628639,,50597,,Half life in rat after 2 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9417,CHEMBL625840,,50597,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9418,CHEMBL625841,,50597,,Half life of 10 mg/kg oral dose determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9419,CHEMBL625842,,50597,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9420,CHEMBL625843,,50597,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9421,CHEMBL625844,,50597,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9422,CHEMBL873822,,50597,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9423,CHEMBL625845,,50597,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9424,CHEMBL627059,,50597,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9425,CHEMBL627060,,50597,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9426,CHEMBL627061,,50597,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9427,CHEMBL627709,,50597,,Half life of compound at 5 mg/kg after po administration was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9428,CHEMBL627710,,50597,,Half life of compound determined after intravenous administration to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9429,CHEMBL627711,,50597,,Half life of compound was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9430,CHEMBL627712,Plasma,50597,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9431,CHEMBL627713,,50597,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9432,CHEMBL627714,,50597,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9433,CHEMBL627889,,22224,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,U,9541.0,,Intermediate,,0,,A,Macaca fascicularis,,1,BAO_0000218,,
9434,CHEMBL627890,,22224,,Half life determined in rat by intravenous administration,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
9435,CHEMBL627891,,50597,,Half life determined in rats after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9436,CHEMBL627892,Plasma,50597,,Half life in rat plasma after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9437,CHEMBL627893,Plasma,50597,,Half life in rat plasma after administration of 2 mg/kg iv,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9438,CHEMBL627894,Plasma,50597,,Half life in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9439,CHEMBL627895,Plasma,50597,,Half life in rat plasma was determined; NA means not applicable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9440,CHEMBL627896,,50597,,Half life in rat was tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9441,CHEMBL627897,Plasma,50597,,Half life measured in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9442,CHEMBL627898,,50597,,Half life recorded in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9443,CHEMBL627899,,50597,,Half life was calculated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9444,CHEMBL873823,,50597,,Half life was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9445,CHEMBL627900,,50597,,Half life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9446,CHEMBL627901,,50597,,Half life after 10 mg/kg oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9447,CHEMBL627902,,50597,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9448,CHEMBL627903,,50597,,Half life after administering orally a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9449,CHEMBL627904,,50597,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9450,CHEMBL627905,,50597,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9451,CHEMBL627906,,50597,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9452,CHEMBL627907,,50597,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9453,CHEMBL876783,,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9454,CHEMBL627908,,50597,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9455,CHEMBL627909,,50597,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9456,CHEMBL627910,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9457,CHEMBL627911,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9458,CHEMBL627912,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9459,CHEMBL627913,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9460,CHEMBL627914,,50597,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9461,CHEMBL627915,,50597,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9462,CHEMBL627916,,50597,,Area under the curve was evaluated after 20 uM/kg of peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9463,CHEMBL627917,,50597,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9464,CHEMBL627918,,50597,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9465,CHEMBL627919,,50597,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9466,CHEMBL627920,,50597,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9467,CHEMBL627921,,50597,,Area under the curve was evaluated at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9468,CHEMBL627922,,50597,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9469,CHEMBL876784,,50597,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9470,CHEMBL627923,,50597,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9471,CHEMBL626208,,50597,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9472,CHEMBL626209,,50597,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9473,CHEMBL626210,,50597,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9474,CHEMBL627994,Plasma,50597,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9475,CHEMBL627995,,50597,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9476,CHEMBL627996,,50597,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9477,CHEMBL627997,,50597,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9478,CHEMBL627998,,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9479,CHEMBL628640,,50597,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9480,CHEMBL628641,,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9481,CHEMBL628642,,50597,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9482,CHEMBL628643,,50597,,Compound was evaluated for area under the curve expressed as (h*ug/ml),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9483,CHEMBL628644,,50597,,Compound was tested for area under curve in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9484,CHEMBL628645,,50597,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9485,CHEMBL628646,,50597,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9486,CHEMBL628647,,50597,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9487,CHEMBL628648,,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9488,CHEMBL625358,,50597,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9489,CHEMBL625359,,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9490,CHEMBL625360,,50597,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9491,CHEMBL625361,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9492,CHEMBL625362,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9493,CHEMBL625363,,50597,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9494,CHEMBL625364,,50597,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9495,CHEMBL625365,,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9496,CHEMBL625366,,50597,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9497,CHEMBL625367,,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9498,CHEMBL625368,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9499,CHEMBL625369,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9500,CHEMBL625370,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9501,CHEMBL625371,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9502,CHEMBL625372,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9503,CHEMBL625373,Kidney,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9504,CHEMBL625374,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9505,CHEMBL877593,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9506,CHEMBL625375,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9507,CHEMBL625376,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9508,CHEMBL621973,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9509,CHEMBL621974,Liver,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9510,CHEMBL621975,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9511,CHEMBL622166,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9512,CHEMBL622167,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9513,CHEMBL622168,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9514,CHEMBL622169,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9515,CHEMBL622170,Lung,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9516,CHEMBL622171,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9517,CHEMBL622172,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9518,CHEMBL622173,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9519,CHEMBL622174,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9520,CHEMBL622175,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9521,CHEMBL622176,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9522,CHEMBL622177,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9523,CHEMBL622178,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9524,CHEMBL622179,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9525,CHEMBL622180,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9526,CHEMBL622181,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9527,CHEMBL622182,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9528,CHEMBL622183,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9529,CHEMBL622184,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9530,CHEMBL622185,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9531,CHEMBL622186,,50597,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9532,CHEMBL622187,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9533,CHEMBL625002,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9534,CHEMBL622090,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9535,CHEMBL622091,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9536,CHEMBL622092,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9537,CHEMBL622093,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9538,CHEMBL622094,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9539,CHEMBL622095,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9540,CHEMBL622264,,50597,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9541,CHEMBL622265,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9542,CHEMBL622266,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9543,CHEMBL622267,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9544,CHEMBL622268,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9545,CHEMBL622269,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9546,CHEMBL625071,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9547,CHEMBL621621,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9548,CHEMBL621622,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9549,CHEMBL621623,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9550,CHEMBL621624,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9551,CHEMBL621625,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9552,CHEMBL621626,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9553,CHEMBL621627,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9554,CHEMBL621628,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9555,CHEMBL875328,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9556,CHEMBL621629,Spleen,50597,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9557,CHEMBL621630,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9558,CHEMBL621631,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9559,CHEMBL621632,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9560,CHEMBL621633,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9561,CHEMBL621634,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9562,CHEMBL621635,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9563,CHEMBL621636,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9564,CHEMBL621637,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9565,CHEMBL621638,Spleen,50597,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9566,CHEMBL618883,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9567,CHEMBL618884,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9568,CHEMBL628627,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9569,CHEMBL628628,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9570,CHEMBL628629,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9571,CHEMBL628630,,50597,,Half life after administering orally a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9572,CHEMBL628631,,50597,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9573,CHEMBL628632,,50597,,Half life after administering intravenously a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9574,CHEMBL628633,,50597,,Half life after oral dosing in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9575,CHEMBL628634,,50597,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9576,CHEMBL627789,,50597,,Half life by intravenous administration of 3.4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9577,CHEMBL627790,,50597,,Half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9578,CHEMBL627791,,50597,,Half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9579,CHEMBL627792,,50597,,Half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9580,CHEMBL627793,,50597,,Half life in rat after intravenous administration of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9581,CHEMBL627794,Plasma,50597,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9582,CHEMBL627795,,50597,,Half life in rat after po administration of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9583,CHEMBL627796,,50597,,Half life in rat after po administration of the compound; ND means Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9584,CHEMBL875335,Plasma,50597,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9585,CHEMBL627797,Plasma,50597,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9586,CHEMBL627798,,50597,,Half life in rat i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9587,CHEMBL627799,,50597,,Half life in rat i.v. at 2 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9588,CHEMBL627800,,50597,,Half life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9589,CHEMBL627801,,50597,,Half life in rats after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9590,CHEMBL627802,,50597,,Half life in rats at the dose of 1.0 mpk by i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9591,CHEMBL627803,,50597,,Half life in rat,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9592,CHEMBL873820,,50597,,Half life was evaluated after intravenous administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9593,CHEMBL627804,,50597,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9594,CHEMBL627805,,50597,,Half life was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9595,CHEMBL627806,,50597,,Half life was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9596,CHEMBL627107,,50597,,Half life was evaluated in rat; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9597,CHEMBL627108,,50597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9598,CHEMBL627109,,50597,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9599,CHEMBL627110,Blood,50597,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9600,CHEMBL627111,,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,9443.0,,Intermediate,,0,,A,Primates,,1,BAO_0000218,,
9601,CHEMBL627112,,22224,,Half life was measured in monkey at dose of 10 mg/kg by po administration,U,9443.0,,Intermediate,,0,,A,Primates,,1,BAO_0000218,,
9602,CHEMBL627113,,22224,,Half life was measured in rat at dose of 30 mg/kg by iv administration,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
9603,CHEMBL627114,,22224,,Half life was measured in rat at dose of 30 mg/kg by po administration,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
9604,CHEMBL627115,,50597,,Half life (t1/2) was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9605,CHEMBL627116,,50597,,Half life period at a dose of 10 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9606,CHEMBL627117,,50597,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9607,CHEMBL627118,,50597,,Half life period was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9608,CHEMBL627119,,50597,,Half life period after intravenous administration at 20 mpk in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9609,CHEMBL627120,,50597,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9610,CHEMBL626922,,50597,,Half life period after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9611,CHEMBL626923,,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9612,CHEMBL626924,,50597,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9613,CHEMBL626925,Plasma,50597,,Half life period in 80% rat plasma at 37 degree Centigrade,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9614,CHEMBL626926,,50597,,Half life period in SD rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9615,CHEMBL626927,Plasma,50597,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9616,CHEMBL626928,Plasma,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9617,CHEMBL626929,Plasma,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9618,CHEMBL626930,Plasma,50597,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9619,CHEMBL626931,,50597,,Half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9620,CHEMBL626932,,50597,,Half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9621,CHEMBL626933,,50597,,Half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9622,CHEMBL873826,,50597,,Half life period in rat after oral administration at 10.5 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9623,CHEMBL626934,,50597,,Half life period in rat after oral administration at 11.2 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9624,CHEMBL626935,,50597,,Half life period in rat after oral administration at 13 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9625,CHEMBL626936,,50597,,Half life period in rat after oral administration at 9.7 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9626,CHEMBL626937,,50597,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9627,CHEMBL625906,,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9628,CHEMBL625907,,50597,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9629,CHEMBL625908,,50597,,PK study was carried to determine AUC (area under curve) value in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9630,CHEMBL625909,,50597,,Pharmacokinetic parameter AUC after intravenous administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9631,CHEMBL625910,,50597,,Pharmacokinetic parameter AUC after oral administration to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9632,CHEMBL625911,,50597,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9633,CHEMBL625912,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9634,CHEMBL626538,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9635,CHEMBL876794,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9636,CHEMBL626539,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9637,CHEMBL626540,,50597,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9638,CHEMBL626541,,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9639,CHEMBL626542,,50597,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9640,CHEMBL626543,,50597,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9641,CHEMBL626544,,50597,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9642,CHEMBL626545,,50597,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9643,CHEMBL626546,,50597,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9644,CHEMBL626547,,50597,,Pharmacokinetic parameter area under curve was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9645,CHEMBL626548,,50597,,Pharmacokinetic property (AUC) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9646,CHEMBL626549,,50597,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9647,CHEMBL626550,,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9648,CHEMBL626551,,50597,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9649,CHEMBL623777,,50597,,Pharmacokinetic property was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9650,CHEMBL623778,,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9651,CHEMBL623779,,50597,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9652,CHEMBL623780,Plasma,50597,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9653,CHEMBL622015,Plasma,50597,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9654,CHEMBL622016,Plasma,50597,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9655,CHEMBL622017,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9656,CHEMBL622018,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9657,CHEMBL622019,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9658,CHEMBL622020,,50597,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9659,CHEMBL622021,,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9660,CHEMBL622022,,50597,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9661,CHEMBL622023,,50597,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9662,CHEMBL622024,,50597,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9663,CHEMBL622693,,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9664,CHEMBL622694,,50597,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9665,CHEMBL622695,,50597,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9666,CHEMBL622696,,50597,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9667,CHEMBL622697,,50597,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9668,CHEMBL622874,,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9669,CHEMBL622875,,50597,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9670,CHEMBL622876,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9671,CHEMBL622877,,50597,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9672,CHEMBL622878,,50597,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9673,CHEMBL622879,Plasma,50597,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9674,CHEMBL877602,,50597,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9675,CHEMBL622880,,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9676,CHEMBL622881,,50597,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9677,CHEMBL622882,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9678,CHEMBL622883,,50597,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9679,CHEMBL622884,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9680,CHEMBL622885,Thyroid gland,50597,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9681,CHEMBL622886,,50597,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9682,CHEMBL622887,,50597,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9683,CHEMBL622888,Urine,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9684,CHEMBL622889,Blood,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9685,CHEMBL622890,Blood,50597,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9686,CHEMBL622891,Blood,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9687,CHEMBL877603,Blood,50597,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9688,CHEMBL622892,Brain,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9689,CHEMBL622893,Brain,50597,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9690,CHEMBL622894,Brain,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9691,CHEMBL622895,Brain,50597,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9692,CHEMBL622896,Brain,50597,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9693,CHEMBL622897,Heart,50597,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9694,CHEMBL622898,Heart,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9695,CHEMBL622899,Heart,50597,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9696,CHEMBL622900,Kidney,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9697,CHEMBL624114,Kidney,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9698,CHEMBL624115,Kidney,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9699,CHEMBL624116,Kidney,50597,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9700,CHEMBL624117,Liver,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9701,CHEMBL624118,Liver,50597,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9702,CHEMBL624119,Liver,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9703,CHEMBL624120,Liver,50597,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9704,CHEMBL624121,Lung,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9705,CHEMBL624122,Lung,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9706,CHEMBL624123,Lung,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9707,CHEMBL624124,Lung,50597,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9708,CHEMBL624125,Muscle tissue,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9709,CHEMBL624126,Muscle tissue,50597,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9710,CHEMBL624127,Muscle tissue,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9711,CHEMBL624128,Muscle tissue,50597,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9712,CHEMBL624129,Zone of skin,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9713,CHEMBL624130,Zone of skin,50597,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9714,CHEMBL622340,Zone of skin,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9715,CHEMBL622341,Zone of skin,50597,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
9716,CHEMBL622342,Intestine,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
9717,CHEMBL622343,Intestine,50597,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
9718,CHEMBL622344,Intestine,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
9719,CHEMBL622345,Intestine,50597,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
9720,CHEMBL622346,Spleen,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9721,CHEMBL622347,Spleen,50597,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9722,CHEMBL622348,Spleen,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9723,CHEMBL622349,Spleen,50597,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9724,CHEMBL622350,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9725,CHEMBL622351,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9726,CHEMBL622352,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9727,CHEMBL622353,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9728,CHEMBL622354,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9729,CHEMBL622355,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9730,CHEMBL622356,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9731,CHEMBL622357,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9732,CHEMBL622358,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9733,CHEMBL622359,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9734,CHEMBL874393,,50597,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9735,CHEMBL622872,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9736,CHEMBL622873,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9737,CHEMBL623047,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9738,CHEMBL623048,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9739,CHEMBL623049,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9740,CHEMBL623050,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9741,CHEMBL623051,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9742,CHEMBL623052,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9743,CHEMBL626343,,50597,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9744,CHEMBL626344,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9745,CHEMBL626345,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9746,CHEMBL626346,,50597,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9747,CHEMBL626347,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9748,CHEMBL626348,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9749,CHEMBL626349,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9750,CHEMBL626350,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
9751,CHEMBL626351,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9752,CHEMBL627650,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9753,CHEMBL627651,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
9754,CHEMBL627652,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9755,CHEMBL627653,,50597,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9756,CHEMBL627654,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9757,CHEMBL627835,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9758,CHEMBL627836,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9759,CHEMBL627837,,50597,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9760,CHEMBL627838,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9761,CHEMBL875338,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9762,CHEMBL627839,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9763,CHEMBL627840,,50597,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9764,CHEMBL627841,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9765,CHEMBL627842,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9766,CHEMBL627843,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9767,CHEMBL627844,,50597,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9768,CHEMBL627845,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9769,CHEMBL627846,,50597,,Half life period in rat by iv administration at a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9770,CHEMBL627847,Plasma,50597,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9771,CHEMBL873821,Plasma,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9772,CHEMBL626079,Plasma,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9773,CHEMBL626080,Plasma,50597,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9774,CHEMBL626081,Plasma,50597,,Half life period was evaluated in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9775,CHEMBL875344,Plasma,50597,,Half life period was evaluated in rat plasma; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9776,CHEMBL626082,,50597,,Half life period was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9777,CHEMBL626250,,50597,,"Half life period was evaluated in rats, iv",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9778,CHEMBL626251,,50597,,Half life period after intravenous administration at 5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9779,CHEMBL626252,,50597,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9780,CHEMBL626253,,50597,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9781,CHEMBL626254,Plasma,50597,,Half life stability of compound was evaluated in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9782,CHEMBL626255,,50597,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9783,CHEMBL626256,,50597,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9784,CHEMBL626257,,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9785,CHEMBL626258,,50597,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9786,CHEMBL626259,,50597,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9787,CHEMBL626260,,50597,,Half in rat i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9788,CHEMBL875345,,50597,,Half period in rat after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9789,CHEMBL626261,,50597,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9790,CHEMBL626262,Liver,50597,,Half-life measured in in vitro Cathepsin B assay in rat liver,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9791,CHEMBL626263,,50597,,Half-life of compound was determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9792,CHEMBL625270,,50597,,Half-life at 10 mg/kg in rat upon intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9793,CHEMBL625271,,50597,,Half-life determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9794,CHEMBL625272,,50597,,Half-life determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9795,CHEMBL625273,Brain,50597,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9796,CHEMBL625274,Plasma,50597,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9797,CHEMBL625275,,50597,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9798,CHEMBL625276,Plasma,50597,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9799,CHEMBL625277,Plasma,50597,,Half-life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9800,CHEMBL625278,Plasma,50597,,Half-life in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9801,CHEMBL625279,Plasma,50597,,Half-life in rat plasma; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9802,CHEMBL625280,Serum,50597,,Half-life in rat serum,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9803,CHEMBL876797,Serum,50597,,Half-life in rat serum; na is not available,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
9804,CHEMBL625281,,50597,,Half-life was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9805,CHEMBL873827,Plasma,50597,,Half-life was calculated in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9806,CHEMBL625282,,50597,,Half-life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9807,CHEMBL625283,,50597,,Half-life was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9808,CHEMBL625284,,50597,,Half-life after administration of 20 mg/Kg oral dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9809,CHEMBL625285,,50597,,Half-life after administration of 3.2 mg/kg intravenously in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9810,CHEMBL625286,,50597,,Half-life after intravenous administration in female rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9811,CHEMBL625287,,50597,,Half-life after intravenous administration in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9812,CHEMBL625288,,50597,,Half-life after intravenous dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9813,CHEMBL625289,Liver,50597,,Half-life in a rat liver homogenate preparation,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9814,CHEMBL625290,Plasma,50597,,Half-life in plasma of rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9815,CHEMBL876798,Plasma,50597,,Half-life in plasma of rat at dose of 3-10 mgkg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9816,CHEMBL625291,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9817,CHEMBL625292,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9818,CHEMBL625293,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9819,CHEMBL622832,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9820,CHEMBL622833,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9821,CHEMBL622834,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9822,CHEMBL622835,,50597,,Half-life in rat after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9823,CHEMBL622836,,50597,,Half-life in rat after po administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9824,CHEMBL622837,,50597,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9825,CHEMBL622838,,50597,,Half-life in rat at 3 mg/kg dose administered intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9826,CHEMBL622839,Brain,50597,,Half-life in rat brain homogenate,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9827,CHEMBL622840,Plasma,50597,,Half-life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9828,CHEMBL622841,,50597,,Half-life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9829,CHEMBL622842,,50597,,Half-life in Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9830,CHEMBL622843,Plasma,50597,,Half-life in vitro in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9831,CHEMBL622844,Plasma,50597,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9832,CHEMBL622845,,50597,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9833,CHEMBL622846,,50597,,The area under the curve of compound was measured at the dose of 100 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9834,CHEMBL622847,,50597,,The area under the curve of compound was measured at the dose of 300 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9835,CHEMBL622848,,50597,,The area under the curve of compound was measured at the dose of 30 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9836,CHEMBL622849,,50597,,Bioavailability as oral AUC in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9837,CHEMBL622850,Plasma,50597,,The plasma concentration versus time curve (AUC) was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9838,CHEMBL876807,,50597,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9839,CHEMBL622851,,50597,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9840,CHEMBL622852,,50597,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9841,CHEMBL622853,,50597,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9842,CHEMBL622854,,50597,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9843,CHEMBL622855,,50597,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9844,CHEMBL622856,Plasma,50597,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9845,CHEMBL622857,Plasma,50597,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9846,CHEMBL622858,Plasma,50597,,AUC in rat after po administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9847,CHEMBL622859,Plasma,50597,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9848,CHEMBL622860,,50597,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9849,CHEMBL622861,,50597,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9850,CHEMBL622862,,50597,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9851,CHEMBL622863,,50597,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9852,CHEMBL623817,,50597,,Area under curve value 6 hr after po administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9853,CHEMBL623818,,50597,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9854,CHEMBL623819,,50597,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9855,CHEMBL623820,,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9856,CHEMBL623821,,50597,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9857,CHEMBL623822,Plasma,50597,,AUC normalized for dose (AUCN) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9858,CHEMBL623823,,50597,,Area under curve in rat after p.o. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9859,CHEMBL623824,,50597,,Area under curve in rat after p.o. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9860,CHEMBL623825,,50597,,Area under curve in rat after p.o. administration; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9861,CHEMBL622070,,50597,,Area under curve in rat after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9862,CHEMBL622071,,50597,,Area under curve (carotid artery) value of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9863,CHEMBL622072,,50597,,Bioavailability expressed as the area under curve of rat carotid artery,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9864,CHEMBL622073,,50597,,Area under curve in male SD rats was observed after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9865,CHEMBL622074,,50597,,Area under curve of the compound was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9866,CHEMBL622075,,50597,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9867,CHEMBL622076,Plasma,50597,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9868,CHEMBL622077,Plasma,50597,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9869,CHEMBL622078,,50597,,Area under curve (portal vein) value of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9870,CHEMBL622079,,50597,,Bioavailability expressed as the area under curve of rat portal vein,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9871,CHEMBL622080,Plasma,50597,,Area Under plasma concentration time curve in rat upon peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9872,CHEMBL877612,,50597,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9873,CHEMBL622081,,50597,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9874,CHEMBL622082,,50597,,Compound was evaluated for oral bioavailability in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9875,CHEMBL622083,,50597,,Compound was evaluated for oral bioavailability in rats after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9876,CHEMBL622084,,50597,,Compound was evaluated for oral bioavailability in rats; 30-80,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9877,CHEMBL622085,,50597,,Compound was evaluated for oral bioavailability in rats; 50-60,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9878,CHEMBL622086,,50597,,Compound was evaluated for oral bioavailability in rats; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9879,CHEMBL622087,,50597,,Compound was evaluated for oral bioavailability in rats; peptide,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9880,CHEMBL622088,Blood,50597,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9881,CHEMBL622089,Blood,50597,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9882,CHEMBL623685,Blood,50597,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9883,CHEMBL623686,Blood,50597,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9884,CHEMBL623687,Stomach,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9885,CHEMBL623688,Stomach,50597,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9886,CHEMBL623689,Stomach,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9887,CHEMBL622485,Stomach,50597,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,945.0,
9888,CHEMBL622486,Thyroid gland,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9889,CHEMBL877613,Thyroid gland,50597,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9890,CHEMBL622487,Thyroid gland,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9891,CHEMBL622488,Thyroid gland,50597,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
9892,CHEMBL622489,Heart,50597,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9893,CHEMBL622490,Urine,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9894,CHEMBL622491,Urine,50597,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9895,CHEMBL622492,Liver,50597,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9896,CHEMBL622493,Urine,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9897,CHEMBL622494,Urine,50597,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9898,CHEMBL622495,Muscle tissue,50597,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9899,CHEMBL622496,,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9900,CHEMBL622497,Urine,50597,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9901,CHEMBL622498,,50597,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9902,CHEMBL624918,Urine,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9903,CHEMBL624919,Urine,50597,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9904,CHEMBL624920,Blood,50597,,Biodistribution of compound in rat blood after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9905,CHEMBL624921,Blood,50597,,Biodistribution of compound in rat blood after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
9906,CHEMBL624922,Brain,50597,,Biodistribution of compound in rat brain after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
9907,CHEMBL624923,Heart,50597,,Biodistribution of compound in rat heart after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9908,CHEMBL624924,Heart,50597,,Biodistribution of compound in rat heart after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9909,CHEMBL624925,Kidney,50597,,Biodistribution of compound in rat kidney after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9910,CHEMBL624926,Kidney,50597,,Biodistribution of compound in rat kidney after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9911,CHEMBL624927,Liver,50597,,Biodistribution of compound in rat liver after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9912,CHEMBL874402,Liver,50597,,Biodistribution of compound in rat liver after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9913,CHEMBL624928,Lung,50597,,Biodistribution of compound in rat lung after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9914,CHEMBL624929,Lung,50597,,Biodistribution of compound in rat lung after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
9915,CHEMBL624930,Muscle tissue,50597,,Biodistribution of compound in rat muscle after 5 min of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9916,CHEMBL624931,Muscle tissue,50597,,Biodistribution of compound in rat muscle after 5 min of administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9917,CHEMBL624932,Heart,50597,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9918,CHEMBL624933,Heart,50597,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
9919,CHEMBL624934,Liver,50597,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9920,CHEMBL624935,Liver,50597,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9921,CHEMBL624936,,50597,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9922,CHEMBL624937,,50597,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9923,CHEMBL624938,Spleen,50597,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9924,CHEMBL624939,Spleen,50597,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
9925,CHEMBL624940,,50597,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9926,CHEMBL874403,,50597,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9927,CHEMBL624941,,50597,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9928,CHEMBL624942,Urine,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9929,CHEMBL624943,Urine,50597,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
9930,CHEMBL624944,,50597,,% Bioavailability after 1 day of the drug administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9931,CHEMBL624945,,50597,,% Bioavailability after 4 day of the drug administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9932,CHEMBL624946,,50597,,Absolute bioavailability was evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9933,CHEMBL624947,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9934,CHEMBL624948,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9935,CHEMBL624949,,50597,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9936,CHEMBL622025,Kidney,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9937,CHEMBL622026,Kidney,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9938,CHEMBL622027,Kidney,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9939,CHEMBL622028,Kidney,50597,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
9940,CHEMBL622029,Liver,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9941,CHEMBL622208,Liver,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9942,CHEMBL622209,Liver,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9943,CHEMBL622210,Liver,50597,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
9944,CHEMBL622211,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9945,CHEMBL622212,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9946,CHEMBL622213,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9947,CHEMBL874404,,50597,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9948,CHEMBL620452,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9949,CHEMBL620453,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9950,CHEMBL620454,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9951,CHEMBL624067,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9952,CHEMBL624068,,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9953,CHEMBL624069,Female gonad,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
9954,CHEMBL624070,Female gonad,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
9955,CHEMBL624071,Female gonad,50597,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
9956,CHEMBL624072,Uterus,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
9957,CHEMBL624073,Uterus,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
9958,CHEMBL624788,Uterus,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
9959,CHEMBL624789,Uterus,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
9960,CHEMBL624790,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9961,CHEMBL624791,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9962,CHEMBL624792,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9963,CHEMBL624793,,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9964,CHEMBL877491,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9965,CHEMBL624957,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9966,CHEMBL624958,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9967,CHEMBL624959,Muscle tissue,50597,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
9968,CHEMBL624960,,50597,,Dissociation constant was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9969,CHEMBL624961,,50597,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9970,CHEMBL624962,,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9971,CHEMBL624963,,50597,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9972,CHEMBL624964,,50597,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9973,CHEMBL624965,,50597,,LogP value was evaluated in the in situ rat gut perfusion assay,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9974,CHEMBL624966,,50597,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9975,CHEMBL624967,,50597,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9976,CHEMBL624968,,50597,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9977,CHEMBL624969,,50597,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9978,CHEMBL624970,,50597,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,N,10116.0,,Expert,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
9979,CHEMBL624971,,50597,,Half-life was evaluated after 10 uM/kg of intra arterial administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9980,CHEMBL624972,,50597,,Half-life was evaluated after 20 uM/kg of peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9981,CHEMBL624973,,50597,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9982,CHEMBL624974,Plasma,50597,,Half-life was evaluated in plasma of rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9983,CHEMBL624975,,50597,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9984,CHEMBL877492,,50597,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9985,CHEMBL624976,,50597,,Half-life was measured in rat after an iv dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9986,CHEMBL624977,,50597,,Half-life period of compound in rats after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9987,CHEMBL626848,Plasma,50597,,Half-life period of compound was measured in rat plasma.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9988,CHEMBL626849,Plasma,50597,,Half-life period of compound was measured in rat plasma; ND is not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9989,CHEMBL626850,Plasma,50597,,Half-life period of compound was measured in rat plasma; not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
9990,CHEMBL626851,,50597,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9991,CHEMBL626852,,50597,,Half-life period in rat by iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9992,CHEMBL626853,,50597,,Half-life period in rats following intravenous administration at 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9993,CHEMBL626854,,50597,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9994,CHEMBL627486,,50597,,Half-life period was determined for the compound in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9995,CHEMBL627487,,50597,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9996,CHEMBL627488,,50597,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9997,CHEMBL627489,,50597,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9998,CHEMBL627490,,50597,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
9999,CHEMBL873829,,50597,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10000,CHEMBL627655,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10001,CHEMBL625994,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10002,CHEMBL625995,,50597,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10003,CHEMBL625996,,50597,,Half-life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10004,CHEMBL625850,Plasma,50597,,In vitro half life in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10005,CHEMBL625851,Plasma,50597,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10006,CHEMBL625852,,50597,,In vitro half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10007,CHEMBL625853,,50597,,In vivo half life period after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10008,CHEMBL625854,,50597,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10009,CHEMBL874450,,50597,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10010,CHEMBL625855,,50597,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10011,CHEMBL625856,,50597,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10012,CHEMBL625857,,50597,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10013,CHEMBL873831,,50597,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10014,CHEMBL625858,,50597,,Longer half-life in rat (i.v.) at 0.5 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10015,CHEMBL625859,,50597,,Longer half-life in rat (p.o.) at 2.0 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10016,CHEMBL625860,,50597,,Pharmacokinetic property (half life) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10017,CHEMBL625861,,50597,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10018,CHEMBL625862,,50597,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10019,CHEMBL625863,,50597,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10020,CHEMBL625864,,50597,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10021,CHEMBL625865,,50597,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10022,CHEMBL625866,,50597,,Pharmacokinetic half time was determined intravenously in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10023,CHEMBL625867,Plasma,50597,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10024,CHEMBL625868,Plasma,50597,,Plasma half life of hydrolysis of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10025,CHEMBL625869,Plasma,50597,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10026,CHEMBL874451,Plasma,50597,,Plasma half life period was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10027,CHEMBL625870,Plasma,50597,,Plasma half-life in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10028,CHEMBL625871,Plasma,50597,,Plasma half-life in Sprague-Dawley rats; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10029,CHEMBL625872,Plasma,50597,,Plasma half-life in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10030,CHEMBL625873,Plasma,50597,,Plasma half-life in rats; <MQL,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10031,CHEMBL625874,Plasma,50597,,Plasma half-life period (0-8 h) was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10032,CHEMBL625875,Plasma,50597,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10033,CHEMBL625876,Plasma,50597,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10034,CHEMBL631258,Plasma,50597,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10035,CHEMBL631259,Plasma,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10036,CHEMBL631260,Plasma,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10037,CHEMBL631261,Blood,50597,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10038,CHEMBL631262,Blood,50597,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10039,CHEMBL631263,Blood,50597,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10040,CHEMBL631264,,50597,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10041,CHEMBL631265,,50597,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10042,CHEMBL631266,,50597,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10043,CHEMBL631267,,50597,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10044,CHEMBL631268,,50597,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10045,CHEMBL631269,,50597,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10046,CHEMBL631270,,50597,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10047,CHEMBL631271,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10048,CHEMBL631272,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10049,CHEMBL631273,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10050,CHEMBL631274,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10051,CHEMBL631275,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10052,CHEMBL626984,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10053,CHEMBL626985,Heart,50597,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10054,CHEMBL626986,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10055,CHEMBL626987,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10056,CHEMBL626988,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10057,CHEMBL626989,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10058,CHEMBL626990,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10059,CHEMBL626991,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10060,CHEMBL626992,Liver,50597,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10061,CHEMBL626993,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10062,CHEMBL874593,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10063,CHEMBL626994,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10064,CHEMBL626995,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10065,CHEMBL626190,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10066,CHEMBL626191,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10067,CHEMBL626364,Lung,50597,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10068,CHEMBL626365,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10069,CHEMBL626366,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10070,CHEMBL626367,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10071,CHEMBL626368,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10072,CHEMBL626369,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10073,CHEMBL626370,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10074,CHEMBL626371,,50597,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10075,CHEMBL626372,,50597,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10076,CHEMBL626373,,50597,,Bioavailability after a dose of 10 mg/kg p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10077,CHEMBL626374,,50597,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10078,CHEMBL626375,,50597,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10079,CHEMBL626376,,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10080,CHEMBL626377,,50597,,Bioavailability in rat po was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10081,CHEMBL626378,,50597,,Bioavailability of compound at 10 mg/kg in rat after oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10082,CHEMBL626379,,50597,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10083,CHEMBL626380,,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10084,CHEMBL626381,,50597,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10085,CHEMBL626382,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10086,CHEMBL626383,,50597,,Bioavailability in rat (Sprague-Dawley) (female),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10087,CHEMBL874652,,50597,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10088,CHEMBL626384,,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10089,CHEMBL626385,,50597,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10090,CHEMBL626386,,50597,,Bioavailability in rat at an oral dose of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10091,CHEMBL626387,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10092,CHEMBL626388,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10093,CHEMBL626389,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10094,CHEMBL626390,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10095,CHEMBL626391,,50597,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10096,CHEMBL626392,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10097,CHEMBL626393,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10098,CHEMBL623026,,50597,,Bioavailability was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10099,CHEMBL623027,,50597,,Bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10100,CHEMBL623028,,50597,,Bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10101,CHEMBL623029,,50597,,Bioavailability in rat after 1 day dosing,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10102,CHEMBL623030,,50597,,Bioavailability in rat after 4 day dosing,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10103,CHEMBL623031,,50597,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10104,CHEMBL623032,,50597,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10105,CHEMBL623033,,50597,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10106,CHEMBL623034,,50597,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10107,CHEMBL623035,,50597,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10108,CHEMBL623036,,50597,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10109,CHEMBL623037,,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10110,CHEMBL623038,,50597,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10111,CHEMBL874385,Plasma,50597,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10112,CHEMBL623039,,50597,,Bioavailability in rat (Fisher) (fasted),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10113,CHEMBL623040,,22224,,Bioavailability in monkey after po administration of 10 mg/kg dose,U,9443.0,,Intermediate,,0,,A,Primates,,1,BAO_0000218,,
10114,CHEMBL623041,,22224,,Oral bioavailability in monkey (dose 10 mg/kg),U,9443.0,,Intermediate,,0,,A,Primates,,1,BAO_0000218,,
10115,CHEMBL623741,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10116,CHEMBL623742,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10117,CHEMBL623743,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10118,CHEMBL623744,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10119,CHEMBL623745,,50597,,Bioavailability in rat (dose 2.0 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10120,CHEMBL623746,,50597,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10121,CHEMBL623747,,50597,,Oral bioavailability in rat (dose 5 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10122,CHEMBL623748,,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
10123,CHEMBL623916,,22224,,Bioavailability in rat after po administration of 30 mg/kg dose,U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
10124,CHEMBL623917,,50597,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10125,CHEMBL623918,,50597,,Bioavailability in rat (dose 2 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10126,CHEMBL874386,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10127,CHEMBL623919,Plasma,50597,,Bioavailability in rat; Only traces detected in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10128,CHEMBL623920,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10129,CHEMBL623148,,50597,,Bioavailability upon oral administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10130,CHEMBL623149,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10131,CHEMBL623150,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10132,CHEMBL623151,,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10133,CHEMBL623152,,50597,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10134,CHEMBL623153,,50597,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,N,10116.0,,Expert,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10135,CHEMBL623154,,50597,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,N,10116.0,,Expert,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10136,CHEMBL623155,,50597,,In vitro and metabolic stability was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10137,CHEMBL623156,,50597,,In vitro metabolic stability in rat hepatocytes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10138,CHEMBL623157,,50597,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10139,CHEMBL623158,Liver,50597,,Metabolic rate for compound was observed in rat hepatocytes,N,10116.0,Hepatocyte,Intermediate,,1,,A,Rattus norvegicus,401.0,1,BAO_0000218,2107.0,
10140,CHEMBL623159,,50597,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10141,CHEMBL874390,,50597,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10142,CHEMBL623160,,50597,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10143,CHEMBL623161,,50597,,Metabolism of compound in rat S9 microsomes; Trace,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10144,CHEMBL623162,,50597,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10145,CHEMBL623163,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10146,CHEMBL623164,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10147,CHEMBL623165,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10148,CHEMBL623166,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10149,CHEMBL624983,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10150,CHEMBL624984,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10151,CHEMBL624985,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10152,CHEMBL622970,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10153,CHEMBL622971,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10154,CHEMBL622972,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10155,CHEMBL622973,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10156,CHEMBL622974,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10157,CHEMBL622975,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10158,CHEMBL622976,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10159,CHEMBL622977,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10160,CHEMBL624351,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10161,CHEMBL624352,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10162,CHEMBL624353,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10163,CHEMBL622397,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10164,CHEMBL622398,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10165,CHEMBL622399,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10166,CHEMBL622400,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10167,CHEMBL628428,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10168,CHEMBL628590,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10169,CHEMBL628591,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10170,CHEMBL628592,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10171,CHEMBL628593,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10172,CHEMBL875333,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10173,CHEMBL628594,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10174,CHEMBL628595,Plasma,50597,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10175,CHEMBL628596,Plasma,50597,,Stability in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10176,CHEMBL628597,Plasma,50597,,Stability in rat plasma was determined; ND= no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10177,CHEMBL628598,Plasma,50597,,Tested for plasma half life period in rat (0-8 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10178,CHEMBL628599,Plasma,50597,,Tested for plasma half life period in rat (0-8 hr); Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10179,CHEMBL628600,,50597,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10180,CHEMBL628601,,50597,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10181,CHEMBL628602,,50597,,Tested for the half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10182,CHEMBL628603,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10183,CHEMBL628604,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10184,CHEMBL628605,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10185,CHEMBL628606,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10186,CHEMBL628607,,50597,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10187,CHEMBL628608,,50597,,The biological half life the compound was measured at the dose of 100 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10188,CHEMBL628609,,50597,,The biological half life the compound was measured at the dose of 30 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10189,CHEMBL628610,Plasma,50597,,The compound was evaluated for plasma half life period in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10190,CHEMBL873819,,50597,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10191,CHEMBL628611,,50597,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10192,CHEMBL628612,,50597,,The pharmacokinetic parameter half-life period in vivo in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10193,CHEMBL628613,,50597,,"The pharmacokinetic property, Half-life was determined",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10194,CHEMBL628614,,50597,,"The pharmacokinetic property, Half-life in rat in vivo",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10195,CHEMBL628615,,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10196,CHEMBL628616,,50597,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10197,CHEMBL627924,Plasma,50597,,The plasma half life period in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10198,CHEMBL627925,Liver,50597,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10199,CHEMBL627926,,50597,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10200,CHEMBL627927,,50597,,t1/2 (apparent elimination)of the compound was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10201,CHEMBL627928,,50597,,t1/2 value in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10202,CHEMBL627539,,50597,,Half life in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10203,CHEMBL876790,Plasma,50597,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10204,CHEMBL858186,,50597,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10205,CHEMBL627540,,50597,,Half-life period in fasted rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10206,CHEMBL627541,,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10207,CHEMBL627715,,50597,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10208,CHEMBL627716,,50597,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10209,CHEMBL627717,,50597,,Maximum time required to achieve Cmax was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10210,CHEMBL627718,,50597,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10211,CHEMBL627719,,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10212,CHEMBL627720,,50597,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10213,CHEMBL627721,,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10214,CHEMBL627722,,50597,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10215,CHEMBL627723,,50597,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10216,CHEMBL626058,,50597,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10217,CHEMBL626059,,50597,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10218,CHEMBL626060,,50597,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10219,CHEMBL626061,Plasma,50597,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10220,CHEMBL876791,,50597,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10221,CHEMBL626062,,50597,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10222,CHEMBL626063,,50597,,Tmax at the dose of 2 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10223,CHEMBL626064,,50597,,Tmax at the dose of 5 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10224,CHEMBL626065,Plasma,50597,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10225,CHEMBL626066,Plasma,50597,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10226,CHEMBL626067,,50597,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10227,CHEMBL626068,,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10228,CHEMBL626069,,50597,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10229,CHEMBL626070,,50597,,Percent total excretion of 3-methoxyacetaminophen glucuronide,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10230,CHEMBL626071,,50597,,Percent total excretion of N-methoxyacetaminophen glucuronide,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10231,CHEMBL626072,,50597,,Percent total excretion of N-methoxyacetaminophen sulfate,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10232,CHEMBL626073,,50597,,Percent total excretion of acetaminophen,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10233,CHEMBL626741,Thyroid gland,50597,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
10234,CHEMBL626742,,50597,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10235,CHEMBL626743,,50597,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10236,CHEMBL876792,,50597,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10237,CHEMBL626744,,50597,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10238,CHEMBL626745,,50597,,Compound was tested for antidiuretic activity in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10239,CHEMBL626746,Plasma,50597,,AUC in rat after 3mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10240,CHEMBL626747,,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10241,CHEMBL626748,,50597,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10242,CHEMBL626749,,50597,,Bioavailability administered orally at a dose of 10 mg/kg to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10243,CHEMBL626750,,50597,,Oral Bioavailability was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10244,CHEMBL626751,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10245,CHEMBL626913,,50597,,Oral bioavailability in rat; Not performed.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10246,CHEMBL626914,,50597,,Bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10247,CHEMBL626915,,50597,,Bioavailability was determined; ND denotes no data,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10248,CHEMBL626916,,50597,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10249,CHEMBL626917,,50597,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10250,CHEMBL626918,,50597,,Binding towards rat plasma protein at 10 uM,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10251,CHEMBL626919,,50597,,Binding towards rat plasma protein at 100 uM,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10252,CHEMBL626920,,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10253,CHEMBL621976,,50597,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10254,CHEMBL877599,,50597,,Bioavailability in rat after 5 mg/kg oral gavage,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10255,CHEMBL621977,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10256,CHEMBL621978,,50597,,Bioavailability in rat (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10257,CHEMBL621979,,50597,,Bioavailability in rat (dose 3 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10258,CHEMBL621980,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10259,CHEMBL621981,,50597,,Bioavailability of the compound in rats after administration of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10260,CHEMBL621982,,50597,,Bioavailability after administration of 10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10261,CHEMBL882953,,50597,,Bioavailability after administration of 2 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10262,CHEMBL621983,,50597,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10263,CHEMBL621984,,50597,,Bioavailability in dogs was determined; high,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10264,CHEMBL621985,,50597,,Bioavailability in monkey after intravenous administration at 1 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10265,CHEMBL621986,,50597,,Bioavailability in monkey after peroral administration at 10 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10266,CHEMBL621987,,50597,,Bioavailability in rat after intravenous administration at 1 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10267,CHEMBL877600,,50597,,Bioavailability in rat after intravenous administration at 2 mpk,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10268,CHEMBL621988,,50597,,Bioavailability in rat after peroral administration at 30 mpk,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10269,CHEMBL621989,,50597,,Bioavailability in rat after peroral administration at at 100 mpk,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10270,CHEMBL621990,,50597,,Bioavailability in rats was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10271,CHEMBL621991,,50597,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10272,CHEMBL621992,,50597,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10273,CHEMBL621993,,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10274,CHEMBL621994,,50597,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10275,CHEMBL621995,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10276,CHEMBL621996,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10277,CHEMBL621997,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10278,CHEMBL621998,,50597,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10279,CHEMBL621999,,50597,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10280,CHEMBL622000,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10281,CHEMBL622001,,50597,,Bioavailability was measured in rat after oral administration; 2-4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10282,CHEMBL622002,,50597,,Bioavailability was measured in rat after oral administration; 3-7,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10283,CHEMBL622003,,50597,,Bioavailability in rat (intraduodenal administration),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10284,CHEMBL877601,,50597,,Bioavailability in rat (intraduodenal administration),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10285,CHEMBL624871,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10286,CHEMBL622004,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10287,CHEMBL882954,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10288,CHEMBL622005,,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10289,CHEMBL622006,,50597,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10290,CHEMBL622007,,50597,,Bioavailability was measured in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10291,CHEMBL622008,,50597,,Bioavailability was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10292,CHEMBL622009,,50597,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10293,CHEMBL622010,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10294,CHEMBL622011,,50597,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10295,CHEMBL622012,,50597,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10296,CHEMBL622013,,50597,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10297,CHEMBL622014,,50597,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10298,CHEMBL624749,,50597,,Bioavailability was determined at 3 mg/kg po dose in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10299,CHEMBL624750,,50597,,Oral bioavailability in rat (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10300,CHEMBL624751,,50597,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10301,CHEMBL624752,,50597,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10302,CHEMBL624753,,50597,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10303,CHEMBL624754,,50597,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10304,CHEMBL624755,,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10305,CHEMBL624756,,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10306,CHEMBL624757,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10307,CHEMBL624758,,50597,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10308,CHEMBL622270,,50597,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10309,CHEMBL622271,,50597,,Bioavailability in rat (Sprague-Dawley),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10310,CHEMBL622272,,50597,,Bioavailability in rat at the dose of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10311,CHEMBL622273,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10312,CHEMBL622274,,50597,,Bioavailability in rat (cannulated) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10313,CHEMBL622275,,50597,,Bioavailability value of compound in rats was determined after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10314,CHEMBL622276,,50597,,Oral bioavailability in rat (dose 20 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10315,CHEMBL622277,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10316,CHEMBL622278,,50597,,Oral bioavailability in rat (dose 5 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10317,CHEMBL622279,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10318,CHEMBL622280,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10319,CHEMBL624083,,50597,,Compound was evaluated for oral bioavailability in rats; 15-27 %,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10320,CHEMBL624084,,50597,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10321,CHEMBL624085,,50597,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10322,CHEMBL624086,,50597,,Compound was tested for bioavailability in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10323,CHEMBL624087,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10324,CHEMBL624088,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10325,CHEMBL624089,,22224,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,U,9544.0,,Intermediate,,0,,A,Macaca mulatta,,1,BAO_0000218,,
10326,CHEMBL624090,,22224,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),U,10116.0,,Intermediate,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
10327,CHEMBL624091,,50597,,Evaluated for the bioavailability in rat (in vivo),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10328,CHEMBL624092,,50597,,F value of compound in rats was determined after peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10329,CHEMBL624093,,50597,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10330,CHEMBL624094,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10331,CHEMBL624095,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10332,CHEMBL624096,,50597,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10333,CHEMBL624097,,50597,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10334,CHEMBL624098,,50597,,Maximum fall in carotid flow in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10335,CHEMBL874392,,50597,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10336,CHEMBL624099,,50597,,Oral bioavailability in rat (dose 5 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10337,CHEMBL624100,,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10338,CHEMBL624101,,50597,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10339,CHEMBL624102,,50597,,Oral bioavailability in rat (male Wistar),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10340,CHEMBL624103,,50597,,Oral bioavailability after administration (30 mg/kg) in rat; good,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10341,CHEMBL624104,,50597,,Oral bioavailability at the dose of 2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10342,CHEMBL624105,,50597,,Oral bioavailability determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10343,CHEMBL624106,,50597,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10344,CHEMBL624107,,50597,,Oral bioavailability in rat (dose single 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10345,CHEMBL623943,,50597,,Oral bioavailability in rat (dose single 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10346,CHEMBL623944,,50597,,Oral bioavailability in rat (dose 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10347,CHEMBL623945,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10348,CHEMBL623946,,50597,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10349,CHEMBL623947,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10350,CHEMBL623948,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10351,CHEMBL623949,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10352,CHEMBL623950,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10353,CHEMBL874398,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10354,CHEMBL623951,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10355,CHEMBL623952,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10356,CHEMBL623953,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10357,CHEMBL623954,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10358,CHEMBL623955,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10359,CHEMBL623956,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10360,CHEMBL627807,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10361,CHEMBL627808,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10362,CHEMBL627809,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10363,CHEMBL627810,,50597,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10364,CHEMBL627811,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10365,CHEMBL627812,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10366,CHEMBL627813,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10367,CHEMBL627814,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10368,CHEMBL875336,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10369,CHEMBL627815,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10370,CHEMBL627816,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10371,CHEMBL627817,,50597,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10372,CHEMBL627818,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10373,CHEMBL627819,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10374,CHEMBL627820,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10375,CHEMBL627821,,50597,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10376,CHEMBL628464,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10377,CHEMBL626239,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10378,CHEMBL626240,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10379,CHEMBL626241,,50597,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10380,CHEMBL626242,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10381,CHEMBL626243,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10382,CHEMBL626244,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10383,CHEMBL626907,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10384,CHEMBL626908,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10385,CHEMBL626909,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10386,CHEMBL626910,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10387,CHEMBL875342,,50597,,Percent total excretion of acetaminophen cysteine conjugate,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10388,CHEMBL626911,,50597,,Percent total excretion of acetaminophen glucuronide,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10389,CHEMBL626912,,50597,,Percent total excretion of acetaminophen sulfate,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10390,CHEMBL627065,,50597,,Percent total excretion of acetaminophen-mercapturic acid,N,10116.0,,Intermediate,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
10391,CHEMBL627066,Urine,50597,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
10392,CHEMBL627067,,50597,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10393,CHEMBL627068,Muscle tissue,22224,,Biodistribution of compound in rat muscle after 5 min of administration,U,8656.0,,Autocuration,,0,,A,ratrat,,1,BAO_0000218,2385.0,
10394,CHEMBL627069,Muscle tissue,22224,,Biodistribution of compound in rat muscle after 5 min of administration.,U,8656.0,,Autocuration,,0,,A,ratrat,,1,BAO_0000218,2385.0,
10395,CHEMBL627070,,22224,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10396,CHEMBL627071,,22224,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10397,CHEMBL627072,,22224,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10398,CHEMBL627073,,22224,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10399,CHEMBL625387,,22224,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10400,CHEMBL625388,,22224,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,,
10401,CHEMBL625389,Plasma,22224,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,1969.0,
10402,CHEMBL875343,Plasma,22224,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),U,9940.0,,Autocuration,,0,,A,Ovis aries,,1,BAO_0000218,1969.0,
10403,CHEMBL876795,,50497,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),N,8570.0,,Intermediate,,1,,A,Serpentes,,1,BAO_0000218,,
10404,CHEMBL626552,,50497,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,N,8570.0,,Intermediate,,1,,A,Serpentes,,1,BAO_0000218,,
10405,CHEMBL626553,,50497,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,N,8570.0,,Intermediate,,1,,A,Serpentes,,1,BAO_0000218,,
10406,CHEMBL626554,Plasma,22224,,The human biological plasma half life of the compound,U,9606.0,,Autocuration,,0,,A,Homo sapiens,,1,BAO_0000366,1969.0,
10407,CHEMBL626555,Urine,50597,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
10408,CHEMBL626556,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10409,CHEMBL626557,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10410,CHEMBL626558,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10411,CHEMBL626559,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10412,CHEMBL626560,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10413,CHEMBL876803,,50597,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10414,CHEMBL627964,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10415,CHEMBL627965,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10416,CHEMBL627966,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10417,CHEMBL627967,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10418,CHEMBL627968,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10419,CHEMBL627969,,50597,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10420,CHEMBL627970,,50597,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10421,CHEMBL627971,Blood,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10422,CHEMBL627972,Blood,50597,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10423,CHEMBL856029,,180,,Dissociation constant against binding to human cyclophilin A,D,9606.0,,Expert,,9,,B,Homo sapiens,,1,BAO_0000357,,
10424,CHEMBL627973,,11591,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,H,9913.0,,Expert,,8,,B,Bos taurus,,1,BAO_0000019,,
10425,CHEMBL627974,,22224,,-Log C was determined by performing the electroshock minimum test,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10426,CHEMBL627975,,22224,,-Log C was determined by performing the foot shock test,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10427,CHEMBL627976,,22224,,-Log C was determined by performing the incl screen test,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10428,CHEMBL627977,,22224,,-Log C was determined by performing the maximum electroshock test,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10429,CHEMBL627978,,22224,,-Log C was determined by performing the pentylenetetrazole test,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10430,CHEMBL627979,,22224,,Tested for experimental arotinoid inhibitory dose,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10431,CHEMBL876804,,22224,,Negative log transformed activity,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10432,CHEMBL627980,,22224,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10433,CHEMBL627981,,50512,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
10434,CHEMBL627982,,50512,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
10435,CHEMBL627983,,50512,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
10436,CHEMBL627984,Ileum,50512,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,2116.0,
10437,CHEMBL627985,,22229,,Solubility in water was determined; values expressed as -log,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
10438,CHEMBL627986,,22224,,Ratio of Kcat to that of Km was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10439,CHEMBL627987,,22224,,Observed first order rate constant,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10440,CHEMBL627988,,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10441,CHEMBL627989,,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10442,CHEMBL627990,,50597,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10443,CHEMBL876805,,50597,,Oral Bioavailability after administration of 10 mg/kg in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10444,CHEMBL627991,,50597,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10445,CHEMBL627992,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10446,CHEMBL627993,,50597,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10447,CHEMBL622817,,50597,,Oral bioavailability at 1 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10448,CHEMBL622818,,50597,,Oral bioavailability at 10 mg/kg was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10449,CHEMBL622819,,50597,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10450,CHEMBL872267,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10451,CHEMBL622820,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10452,CHEMBL622821,,50597,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10453,CHEMBL622822,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10454,CHEMBL622823,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10455,CHEMBL622824,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10456,CHEMBL622825,,50597,,Oral bioavailability in rat at a dose of 3 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10457,CHEMBL622901,,50597,,Oral bioavailability in rat after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10458,CHEMBL622902,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10459,CHEMBL621844,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10460,CHEMBL621845,,50597,,Oral bioavailability in Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10461,CHEMBL621846,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10462,CHEMBL621847,,50597,,Oral bioavailability in rat (dose 30 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10463,CHEMBL877609,,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10464,CHEMBL621848,,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10465,CHEMBL621849,,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10466,CHEMBL622030,,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10467,CHEMBL622031,,50597,,Percent oral bioavailability determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10468,CHEMBL622032,,50597,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10469,CHEMBL622033,,50597,,The compound was evaluated for bioavailability in rats; 32-51,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10470,CHEMBL622034,,50597,,Bioavailability in rat (dose 20 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10471,CHEMBL622035,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10472,CHEMBL882966,,50597,,Bioavailability percent in rat at the dose of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10473,CHEMBL622036,,50597,,Bioavailability was evaluated after 20 uM/kg of peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10474,CHEMBL622037,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10475,CHEMBL622038,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10476,CHEMBL622039,,50597,,Bioavailability in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10477,CHEMBL622040,Blood,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10478,CHEMBL622041,Blood,50597,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10479,CHEMBL622042,Blood,50597,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10480,CHEMBL622043,Blood,50597,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10481,CHEMBL622044,Blood,50597,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10482,CHEMBL622045,Bone,50597,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
10483,CHEMBL622046,Bone,50597,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
10484,CHEMBL622047,Bone,50597,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
10485,CHEMBL877610,Bone,50597,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
10486,CHEMBL622048,Brain,50597,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10487,CHEMBL622049,Brain,50597,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10488,CHEMBL622050,Brain,50597,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10489,CHEMBL622051,Brain,50597,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10490,CHEMBL622052,,50597,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10491,CHEMBL622053,,50597,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10492,CHEMBL622054,,50597,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10493,CHEMBL622055,,50597,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10494,CHEMBL622056,,50597,,Oral bioavailability in rats was determined; High,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10495,CHEMBL622057,,50597,,Oral bioavailability in the rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10496,CHEMBL628008,,50597,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10497,CHEMBL622058,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10498,CHEMBL622059,,50597,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10499,CHEMBL622060,,50597,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10500,CHEMBL622061,,50597,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10501,CHEMBL622062,,50597,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10502,CHEMBL622063,,50597,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10503,CHEMBL877611,,50597,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10504,CHEMBL622064,,50597,,Oral bioavailability of compound in Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10505,CHEMBL622065,,50597,,Oral bioavailability of compound in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10506,CHEMBL622066,,50597,,Oral bioavailability in rat (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10507,CHEMBL622067,,50597,,Oral bioavailability of compound in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10508,CHEMBL622068,,50597,,Oral bioavailability of compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10509,CHEMBL622069,,50597,,Oral bioavailability of compound was determined in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10510,CHEMBL624796,,50597,,Oral bioavailability at a dose of 30 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10511,CHEMBL624797,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10512,CHEMBL623053,,50597,,Oral bioavailability in rat (dose 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10513,CHEMBL623054,,50597,,Oral bioavailability evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10514,CHEMBL623055,,50597,,Oral bioavailability in fasted rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10515,CHEMBL623056,,50597,,Oral bioavailability in fed rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10516,CHEMBL623057,,50597,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10517,CHEMBL623058,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10518,CHEMBL623059,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10519,CHEMBL623060,,50597,,Oral bioavailability in rat after administration of 10 mg/kg po,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10520,CHEMBL623061,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10521,CHEMBL623062,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10522,CHEMBL623063,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10523,CHEMBL623064,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10524,CHEMBL623065,,50597,,Oral bioavailability in ratrs,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10525,CHEMBL623066,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10526,CHEMBL623067,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10527,CHEMBL623068,,50597,,Oral bioavailability in rats was determined; High,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10528,CHEMBL623069,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10529,CHEMBL623070,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10530,CHEMBL623071,,50597,,Oral bioavailability was calculated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10531,CHEMBL623072,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10532,CHEMBL623073,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10533,CHEMBL623074,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10534,CHEMBL623075,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10535,CHEMBL623076,,50597,,Oral bioavailability after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10536,CHEMBL623077,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10537,CHEMBL623078,,50597,,Oral bioavailability in rat (Sprague-Dawley),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10538,CHEMBL623079,,50597,,Oral bioavailability in Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10539,CHEMBL623080,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10540,CHEMBL623081,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10541,CHEMBL623082,,50597,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10542,CHEMBL874400,,50597,,Oral bioavailability in fasted rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10543,CHEMBL623083,,50597,,Oral bioavailability in fed rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10544,CHEMBL623084,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10545,CHEMBL623085,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10546,CHEMBL623086,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10547,CHEMBL623087,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10548,CHEMBL623088,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10549,CHEMBL623089,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10550,CHEMBL623090,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10551,CHEMBL623091,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10552,CHEMBL623092,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10553,CHEMBL623093,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10554,CHEMBL874401,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10555,CHEMBL623094,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10556,CHEMBL623095,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10557,CHEMBL623096,,50597,,Oral bioavailability in rat after peroral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10558,CHEMBL624913,,50597,,Oral bioavailability in rat after peroral administration at 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10559,CHEMBL624914,,50597,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10560,CHEMBL624915,,50597,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10561,CHEMBL624916,,50597,,Oral bioavailability in rat; Not measured,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10562,CHEMBL624917,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10563,CHEMBL625157,,50597,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10564,CHEMBL625158,Liver,50597,,In vitro metabolic potential in rat liver microsomes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10565,CHEMBL625159,,50597,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10566,CHEMBL625160,,50597,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10567,CHEMBL625161,,50597,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10568,CHEMBL625162,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10569,CHEMBL625163,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10570,CHEMBL625164,,50597,,Oral bioavailability in rats at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10571,CHEMBL625165,,50597,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10572,CHEMBL625166,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10573,CHEMBL625167,,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10574,CHEMBL625168,,50597,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10575,CHEMBL625169,,50597,,Plasma clearance of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10576,CHEMBL626264,,50597,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10577,CHEMBL626265,,50597,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10578,CHEMBL626266,Plasma,50597,,The compound was tested for plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10579,CHEMBL626267,Plasma,50597,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10580,CHEMBL626268,,50597,,Plasma concentration upon oral administration of 1 mg/Kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10581,CHEMBL626269,,50597,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10582,CHEMBL626270,,50597,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10583,CHEMBL626271,,50597,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10584,CHEMBL626272,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10585,CHEMBL626273,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10586,CHEMBL875346,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10587,CHEMBL626274,,50597,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10588,CHEMBL626275,,50597,,Compound was tested for protein binding in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10589,CHEMBL624646,,50597,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10590,CHEMBL624647,,50597,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10591,CHEMBL624648,Liver,50597,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10592,CHEMBL624649,,50597,,Area under curve ratio was determined (po/iv) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10593,CHEMBL624650,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10594,CHEMBL624651,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10595,CHEMBL624652,,50597,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10596,CHEMBL624653,,50597,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10597,CHEMBL624654,,50597,,Ratio of AUCbrain to AUCplasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10598,CHEMBL624655,,50597,,Ratio of brain to plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10599,CHEMBL624656,,50597,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10600,CHEMBL624657,,50597,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10601,CHEMBL624658,,50597,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10602,CHEMBL624659,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10603,CHEMBL624660,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10604,CHEMBL624661,,50597,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10605,CHEMBL624662,,50597,,Steady state brain :blood ratio was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10606,CHEMBL625199,,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10607,CHEMBL625200,,50597,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10608,CHEMBL625201,,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10609,CHEMBL625202,,50597,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10610,CHEMBL625203,,50597,,Percentage recovery after 3h incubation with rat hapatocytes was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10611,CHEMBL625204,,50597,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10612,CHEMBL625205,,50597,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10613,CHEMBL625206,,50597,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10614,CHEMBL625207,,22224,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10615,CHEMBL625208,,22224,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10616,CHEMBL625209,,50587,,In vivo absorption in Caco-2 cell line monolayers was determined,N,9606.0,Caco-2,Intermediate,,1,,A,Homo sapiens,495.0,1,BAO_0000218,,
10617,CHEMBL625210,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
10618,CHEMBL625211,,50597,,Area under curve was determine after peroral administration at 10 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10619,CHEMBL625212,,50797,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
10620,CHEMBL625213,,50597,,Area under curve was determine after peroral administration at 160 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10621,CHEMBL625214,,50597,,Area under curve was determine after peroral administration at 20 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10622,CHEMBL874542,,50597,,Area under curve was determine after peroral administration at 50 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10623,CHEMBL625215,,22229,,Calculated partition coefficient (clogP) (AlogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
10624,CHEMBL625216,,22224,,Activated partial thromboplastin time measured,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10625,CHEMBL625217,,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
10626,CHEMBL625218,,22224,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
10627,CHEMBL622864,Plasma,50588,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
10628,CHEMBL622865,Plasma,50597,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10629,CHEMBL622866,Plasma,50597,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10630,CHEMBL622867,Plasma,50588,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
10631,CHEMBL876808,Plasma,50512,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,1969.0,
10632,CHEMBL627725,Brain,22224,,AUC in brain,U,,,Autocuration,,0,,A,,,1,BAO_0000019,955.0,
10633,CHEMBL627726,Serum,22224,,AUC in serum,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1977.0,
10634,CHEMBL627727,Plasma,22224,,AUC was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10635,CHEMBL627728,Plasma,22224,,AUC of the compound.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10636,CHEMBL627729,Plasma,22224,,AUC value (0-4 hr),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10637,CHEMBL627730,Plasma,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10638,CHEMBL627731,Plasma,22224,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10639,CHEMBL627732,Plasma,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10640,CHEMBL627733,Plasma,22224,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
10641,CHEMBL627734,Plasma,50597,,AUC(area under curve) was determined after intravenous administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10642,CHEMBL627735,Plasma,50597,,AUC(area under curve) was determined after oral administration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10643,CHEMBL627736,Plasma,50512,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,1969.0,
10644,CHEMBL876809,Plasma,50597,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10645,CHEMBL627737,,22224,,Area Under Curve after oral dosing of 100 uM/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10646,CHEMBL627738,,22224,,Area Under Curve after oral dosing of 30 uM/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10647,CHEMBL627739,,22224,,Area Under Curve was measured by ploting the graph between concentration verses time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10648,CHEMBL626143,,50588,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10649,CHEMBL626144,,22224,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
10650,CHEMBL626145,,50592,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
10651,CHEMBL626146,,50597,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10652,CHEMBL626147,Blood,50597,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10653,CHEMBL626148,,22224,,Area under curve (AUC) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10654,CHEMBL626149,,22224,,Area under curve (AUC) following ip administration at 1 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10655,CHEMBL626150,,22224,,Area under curve (AUC) was determined; ND is Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10656,CHEMBL626151,,50588,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10657,CHEMBL626152,,50588,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10658,CHEMBL626153,,50588,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10659,CHEMBL626154,,22224,,Area under curve (AUR) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10660,CHEMBL626155,,22224,,Area under curve at 1 uM/dg administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10661,CHEMBL626156,,22224,,Area under curve at 10 uM/dg administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10662,CHEMBL626157,,22224,,Area under curve at 2 uM/dg administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10663,CHEMBL626158,,22224,,Area under curve at 20 uM/dg administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10664,CHEMBL626159,,50588,,Area under curve at a peroral dose of 3 mg/kg in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10665,CHEMBL626160,,50597,,Area under curve at a peroral dose of 3 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10666,CHEMBL626161,,50588,,Area under curve at an iv dose of 1 mg/kg in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10667,CHEMBL626162,,50597,,Area under curve at an iv dose of 1 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10668,CHEMBL626163,,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10669,CHEMBL626164,,22224,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
10670,CHEMBL626165,,50594,,Area under curve measured as conc vs time after intravenous administration to mice.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10671,CHEMBL626166,,50594,,Area under curve measured as conc vs time after peroral administration to mice.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10672,CHEMBL626167,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10673,CHEMBL626168,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10674,CHEMBL877463,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10675,CHEMBL626169,,50588,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10676,CHEMBL626170,Heart,50597,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10677,CHEMBL626171,Heart,50597,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10678,CHEMBL626172,Heart,50597,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10679,CHEMBL626173,Heart,50597,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10680,CHEMBL626174,Kidney,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10681,CHEMBL626175,Kidney,50597,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10682,CHEMBL626176,Kidney,50597,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10683,CHEMBL626177,Kidney,50597,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10684,CHEMBL622499,Kidney,50597,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10685,CHEMBL622500,Liver,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10686,CHEMBL622501,Liver,50597,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10687,CHEMBL622502,Liver,50597,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10688,CHEMBL622503,Liver,50597,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10689,CHEMBL877614,Liver,50597,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10690,CHEMBL624839,Lung,50597,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10691,CHEMBL624840,Lung,50597,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10692,CHEMBL624841,Lung,50597,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10693,CHEMBL624842,Lung,50597,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10694,CHEMBL624843,Muscle tissue,50597,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10695,CHEMBL624844,Muscle tissue,50597,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10696,CHEMBL624845,Muscle tissue,50597,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10697,CHEMBL621904,Muscle tissue,50597,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10698,CHEMBL621905,Blood,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10699,CHEMBL874382,Blood,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10700,CHEMBL621906,Blood,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
10701,CHEMBL621907,Brain,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10702,CHEMBL622096,Brain,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10703,CHEMBL622097,Brain,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
10704,CHEMBL622098,Heart,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10705,CHEMBL622099,Heart,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10706,CHEMBL622100,Heart,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10707,CHEMBL622101,Kidney,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10708,CHEMBL622102,Kidney,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10709,CHEMBL622103,Kidney,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10710,CHEMBL622104,Liver,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10711,CHEMBL622105,Liver,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10712,CHEMBL622106,Liver,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10713,CHEMBL622107,Lung,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10714,CHEMBL622108,Lung,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10715,CHEMBL622109,Lung,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
10716,CHEMBL622110,Muscle tissue,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10717,CHEMBL622111,Muscle tissue,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10718,CHEMBL874383,Muscle tissue,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
10719,CHEMBL622112,Zone of skin,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
10720,CHEMBL622113,Zone of skin,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
10721,CHEMBL622114,Zone of skin,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
10722,CHEMBL622115,Spleen,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
10723,CHEMBL622116,Spleen,50597,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
10724,CHEMBL622117,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10725,CHEMBL622118,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10726,CHEMBL622119,,50597,,Oral bioavailability in rats at 6 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10727,CHEMBL622120,,50597,,Oral bioavailability in rat (dose 6 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10728,CHEMBL622121,,50597,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10729,CHEMBL622122,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10730,CHEMBL622123,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10731,CHEMBL622124,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10732,CHEMBL622125,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10733,CHEMBL622126,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10734,CHEMBL620455,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10735,CHEMBL620456,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10736,CHEMBL620457,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10737,CHEMBL620458,,50597,,Oral bioavailability was evaluated; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10738,CHEMBL620459,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10739,CHEMBL620460,,50597,,Oral bioavailability in rat by oral dosing,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10740,CHEMBL620461,,50597,,Oral bioavailability in rat (dose 10 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10741,CHEMBL620462,,50597,,Oral bioavailability in rat (Sprague-Dawley),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10742,CHEMBL620463,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10743,CHEMBL620464,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10744,CHEMBL620465,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10745,CHEMBL620466,,50597,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10746,CHEMBL620467,,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10747,CHEMBL620468,,50597,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10748,CHEMBL620469,,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10749,CHEMBL620470,,50597,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10750,CHEMBL620471,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10751,CHEMBL620472,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10752,CHEMBL620473,,50597,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10753,CHEMBL620474,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10754,CHEMBL620475,,50597,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10755,CHEMBL620476,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10756,CHEMBL620477,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10757,CHEMBL620478,,50597,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10758,CHEMBL618768,,50597,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10759,CHEMBL618769,,50597,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10760,CHEMBL618770,,50597,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10761,CHEMBL618771,,50597,,Oral bioavailability (dose 20 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10762,CHEMBL618772,,50597,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10763,CHEMBL618773,,50597,,Oral bioavailability in rat at 10 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10764,CHEMBL875842,,50597,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10765,CHEMBL618774,,50597,,Bioavailability in rat (dose 3 mg/kg i.v.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10766,CHEMBL618775,,50597,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10767,CHEMBL618776,,50597,,Oral bioavailability in rat (dose 60 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10768,CHEMBL618777,,50597,,Percent bioavailability (F) in rats after iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10769,CHEMBL618778,,50597,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10770,CHEMBL618779,,50597,,Bioavailability in rat (dose 5 uM/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10771,CHEMBL618780,,50597,,Oral bioavailability,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10772,CHEMBL618781,,50597,,Bioavailability in rat (dose 2 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10773,CHEMBL618782,,50597,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10774,CHEMBL618783,,50597,,Oral bioavailability in rat (dose 20 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10775,CHEMBL618784,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10776,CHEMBL618785,,50597,,Percent oral bioavailability evaluated in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10777,CHEMBL618786,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10778,CHEMBL618787,,50597,,Percent oral bioavailability in rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10779,CHEMBL618788,,50597,,Oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10780,CHEMBL618789,,50597,,Bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10781,CHEMBL618790,,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10782,CHEMBL618791,,50597,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10783,CHEMBL875843,,50597,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10784,CHEMBL618792,,50597,,Oral bioavailability in rat (dose 20 mg/kg p.o.),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10785,CHEMBL623395,,50597,,Cmax at a dose of 30 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10786,CHEMBL623396,,22224,,Cmax in monkeys at a dose of 1 mg/kg,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
10787,CHEMBL623397,,50597,,Cmax in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10788,CHEMBL623398,,50597,,Cmax in rats at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10789,CHEMBL623399,,50594,,Cmax was measured in mice after an oral dose of 50 mg/kg.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10790,CHEMBL623400,,22224,,"Cmax value at a dose of 12.7 uM/kg, po",U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10791,CHEMBL623401,,22224,,"Cmax value at a dose of 6.3 uM/kg, iv",U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10792,CHEMBL623402,,22224,,"Cmax value at a dose of 7.1 uM/kg, iv",U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10793,CHEMBL623403,,22224,,Cmax value of compound was determined after 1 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10794,CHEMBL623404,,22224,,Cmax value of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10795,CHEMBL625997,,50597,,Cmax value administered intraintestinal in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10796,CHEMBL625998,,50597,,Cmax value administered perorally was determined in rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10797,CHEMBL625999,,22224,,Cmax value at the dose of 2.3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10798,CHEMBL626000,,22224,,Cmax value at the dose of 5 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10799,CHEMBL626001,,22224,,Cmax value in the period of 8 hr after dosing. ,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10800,CHEMBL626002,,22224,,Cmax value at a oral dose of 20 mg/kg; Not tested,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10801,CHEMBL626003,,22224,,Cmax value at a oral dose of 20 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10802,CHEMBL626004,,50597,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10803,CHEMBL626005,,50512,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
10804,CHEMBL626006,,50597,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10805,CHEMBL626007,Plasma,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10806,CHEMBL626008,Plasma,50594,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10807,CHEMBL626009,Liver,50588,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2107.0,
10808,CHEMBL626010,,50588,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10809,CHEMBL626011,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
10810,CHEMBL626012,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
10811,CHEMBL626013,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
10812,CHEMBL626014,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
10813,CHEMBL877496,Blood,50594,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
10814,CHEMBL626015,,50588,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,N,9615.0,,Intermediate,,1,,F,Canis lupus familiaris,,1,BAO_0000218,,
10815,CHEMBL626016,,50588,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,N,9615.0,,Intermediate,,1,,F,Canis lupus familiaris,,1,BAO_0000218,,
10816,CHEMBL626017,,50588,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,N,9615.0,,Intermediate,,1,,F,Canis lupus familiaris,,1,BAO_0000218,,
10817,CHEMBL626018,Plasma,50588,,Bioavailability as maximal plasma concentration in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
10818,CHEMBL626692,Plasma,50588,,Bioavailability as maximal plasma concentration in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
10819,CHEMBL626693,Plasma,50597,,Bioavailability as maximal plasma concentration in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10820,CHEMBL626694,Plasma,22224,,Bioavailability as maximal plasma concentration in rats,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10821,CHEMBL626695,Blood,50588,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10822,CHEMBL626696,Blood,50588,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10823,CHEMBL626697,Blood,50588,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10824,CHEMBL626859,Blood,50588,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10825,CHEMBL626860,Blood,50588,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10826,CHEMBL626861,Blood,50588,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
10827,CHEMBL626296,,50597,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10828,CHEMBL626297,,22224,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10829,CHEMBL626298,Plasma,22224,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
10830,CHEMBL626299,Plasma,50597,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10831,CHEMBL626300,Plasma,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10832,CHEMBL626301,Plasma,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10833,CHEMBL626962,Plasma,50597,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10834,CHEMBL626963,Plasma,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10835,CHEMBL626964,Plasma,50597,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10836,CHEMBL626965,Plasma,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
10837,CHEMBL626966,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10838,CHEMBL626967,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10839,CHEMBL626968,Plasma,100710,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
10840,CHEMBL626969,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10841,CHEMBL627126,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10842,CHEMBL631276,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10843,CHEMBL631277,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10844,CHEMBL631278,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10845,CHEMBL874457,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10846,CHEMBL631279,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10847,CHEMBL631280,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10848,CHEMBL631281,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10849,CHEMBL631968,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10850,CHEMBL631969,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10851,CHEMBL631970,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10852,CHEMBL631971,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10853,CHEMBL631972,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10854,CHEMBL630435,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10855,CHEMBL630436,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10856,CHEMBL630437,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10857,CHEMBL630438,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10858,CHEMBL630439,Heart,50597,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
10859,CHEMBL630440,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10860,CHEMBL630441,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10861,CHEMBL630442,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10862,CHEMBL625234,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10863,CHEMBL625235,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10864,CHEMBL625236,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10865,CHEMBL625237,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10866,CHEMBL626125,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10867,CHEMBL626126,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10868,CHEMBL626127,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10869,CHEMBL626128,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10870,CHEMBL626129,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10871,CHEMBL626130,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10872,CHEMBL626131,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10873,CHEMBL626132,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10874,CHEMBL626752,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10875,CHEMBL626753,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10876,CHEMBL626754,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10877,CHEMBL626755,Kidney,50597,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
10878,CHEMBL626756,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10879,CHEMBL626757,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10880,CHEMBL626758,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10881,CHEMBL626759,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10882,CHEMBL626760,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
10883,CHEMBL626394,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10884,CHEMBL626395,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10885,CHEMBL626396,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10886,CHEMBL626397,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10887,CHEMBL626398,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10888,CHEMBL626399,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10889,CHEMBL874653,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10890,CHEMBL626400,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10891,CHEMBL626401,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10892,CHEMBL626402,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10893,CHEMBL626403,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10894,CHEMBL626404,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10895,CHEMBL626405,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10896,CHEMBL625529,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10897,CHEMBL625530,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10898,CHEMBL625531,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10899,CHEMBL625532,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10900,CHEMBL625533,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10901,CHEMBL875474,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10902,CHEMBL625534,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10903,CHEMBL625535,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10904,CHEMBL625536,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10905,CHEMBL625537,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10906,CHEMBL625538,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10907,CHEMBL625539,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10908,CHEMBL625540,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10909,CHEMBL625541,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10910,CHEMBL625542,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10911,CHEMBL625543,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10912,CHEMBL625544,,50597,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10913,CHEMBL625545,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10914,CHEMBL625546,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10915,CHEMBL625547,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10916,CHEMBL625548,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10917,CHEMBL625549,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10918,CHEMBL625550,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10919,CHEMBL625551,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10920,CHEMBL875475,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10921,CHEMBL625552,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10922,CHEMBL625553,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10923,CHEMBL625554,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10924,CHEMBL625555,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10925,CHEMBL625556,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10926,CHEMBL624986,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10927,CHEMBL624987,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10928,CHEMBL624988,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10929,CHEMBL624989,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10930,CHEMBL624990,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10931,CHEMBL874391,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10932,CHEMBL624991,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10933,CHEMBL624992,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10934,CHEMBL624993,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10935,CHEMBL624994,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10936,CHEMBL624995,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10937,CHEMBL624996,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10938,CHEMBL624997,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10939,CHEMBL624998,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10940,CHEMBL624999,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10941,CHEMBL882955,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10942,CHEMBL625000,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10943,CHEMBL625001,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10944,CHEMBL625089,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10945,CHEMBL625090,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10946,CHEMBL625091,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10947,CHEMBL625092,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10948,CHEMBL625093,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10949,CHEMBL625094,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10950,CHEMBL625095,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
10951,CHEMBL625096,,50588,,Compound was evaluated for its bioavailability in the dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10952,CHEMBL625097,,50597,,Compound was evaluated for its bioavailability in the rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10953,CHEMBL882956,,22224,,Compound was evaluated for oral bioavailability,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10954,CHEMBL625098,,50597,,Compound was evaluated for percentage of Oral bioavailability in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10955,CHEMBL625099,,22224,,Bioavailability in guinea pig,U,10141.0,,Autocuration,,0,,A,Cavia porcellus,,1,BAO_0000218,,
10956,CHEMBL625100,,50597,,Compound was evaluated for the oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10957,CHEMBL625101,,50588,,Compound was evaluated for the oral bioavailability in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10958,CHEMBL874396,,50597,,Compound was evaluated for the oral bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10959,CHEMBL625102,,22224,,Bioavailability in dog (dosed i.v.),U,9615.0,,Autocuration,,0,,F,Canis lupus familiaris,,1,BAO_0000218,,
10960,CHEMBL625103,,50588,,Compound was tested for in vivo bioavailability in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
10961,CHEMBL625104,,100712,,Compound was tested for in vivo bioavailability in hamsters,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
10962,CHEMBL625105,,22224,,Compound was tested for in vivo bioavailability in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
10963,CHEMBL625106,,50597,,Compound was tested for in vivo bioavailability in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10964,CHEMBL625107,,22224,,Oral bioavailability in mouse,U,10090.0,,Autocuration,,0,,A,Mus musculus,,1,BAO_0000218,,
10965,CHEMBL625108,,50594,,Compound was tested for percent of oral bioavailability in mice; 56-74,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10966,CHEMBL625109,,22224,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),U,10090.0,,Autocuration,,0,,A,Mus musculus,,1,BAO_0000218,,
10967,CHEMBL625110,,22224,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),U,9541.0,,Autocuration,,0,,A,Macaca fascicularis,,1,BAO_0000218,,
10968,CHEMBL625111,,22224,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),U,9541.0,,Autocuration,,0,,A,Macaca fascicularis,,1,BAO_0000218,,
10969,CHEMBL625112,,50594,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10970,CHEMBL875334,,50594,,Oral bioavailability in nude mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10971,CHEMBL628617,,22224,,Bioavailability in monkey (i.d. dosing),U,9443.0,,Autocuration,,0,,A,Primates,,1,BAO_0000218,,
10972,CHEMBL628618,,22224,,Bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
10973,CHEMBL628619,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10974,CHEMBL628620,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
10975,CHEMBL628621,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
10976,CHEMBL628622,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
10977,CHEMBL628623,,100710,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
10978,CHEMBL628624,Plasma,100710,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
10979,CHEMBL628625,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10980,CHEMBL628626,Plasma,100710,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
10981,CHEMBL627041,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10982,CHEMBL627042,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10983,CHEMBL627043,Plasma,50594,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10984,CHEMBL627044,Plasma,22224,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
10985,CHEMBL627045,Plasma,50594,,Cmax in mouse plasma,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
10986,CHEMBL627046,Plasma,22224,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
10987,CHEMBL627047,Plasma,50597,,Maximal plasma concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10988,CHEMBL627048,Plasma,50597,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
10989,CHEMBL627049,,50597,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10990,CHEMBL627050,,50597,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10991,CHEMBL627051,,50597,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10992,CHEMBL627052,,50597,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10993,CHEMBL627053,,50597,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10994,CHEMBL627054,,50597,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
10995,CHEMBL627055,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10996,CHEMBL627056,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10997,CHEMBL627057,,50594,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10998,CHEMBL627058,,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
10999,CHEMBL626211,,50594,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11000,CHEMBL626212,,22224,,Maximum Concentration of the compound.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11001,CHEMBL626213,,50588,,Maximum Concentration was measured after iv administration into Beagle dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11002,CHEMBL626214,,50588,,Maximum Concentration was measured after iv administration into Beagle dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11003,CHEMBL626215,,50588,,Maximum Concentration was measured after po administration into Beagle dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11004,CHEMBL626216,,50588,,Maximum Concentration was measured after po administration into Beagle dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11005,CHEMBL626217,Blood,22224,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11006,CHEMBL626218,Blood,22224,,Maximum blood level reached after an iv dose of 12.2 uM/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11007,CHEMBL626219,Blood,22224,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11008,CHEMBL626220,Blood,22224,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11009,CHEMBL626221,Blood,22224,,Maximum blood level reached after an oral dose of 5.0 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11010,CHEMBL626222,Blood,22224,,Maximum blood level reached at dose of 10.6 uM/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11011,CHEMBL626223,,50512,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
11012,CHEMBL626224,,50512,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
11013,CHEMBL626225,Brain,50597,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11014,CHEMBL626226,Brain,50597,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11015,CHEMBL626227,Brain,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11016,CHEMBL626228,Brain,50597,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11017,CHEMBL626229,,50597,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11018,CHEMBL626921,,50597,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11019,CHEMBL876793,,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11020,CHEMBL625309,,50597,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11021,CHEMBL625310,,50278,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),N,1423.0,,Intermediate,,1,,A,Bacillus subtilis,,1,BAO_0000218,,
11022,CHEMBL625311,,22224,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11023,CHEMBL625312,,50597,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11024,CHEMBL625313,,22224,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11025,CHEMBL625314,,50594,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11026,CHEMBL625315,,50597,,Maximum concentration in male rats after iv administration of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11027,CHEMBL625316,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11028,CHEMBL625317,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11029,CHEMBL625318,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11030,CHEMBL625319,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11031,CHEMBL625320,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11032,CHEMBL625321,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11033,CHEMBL625322,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11034,CHEMBL876801,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11035,CHEMBL625323,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11036,CHEMBL625324,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11037,CHEMBL625325,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11038,CHEMBL625326,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11039,CHEMBL625327,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11040,CHEMBL625328,Liver,50597,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11041,CHEMBL625329,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11042,CHEMBL625330,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11043,CHEMBL627774,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11044,CHEMBL627775,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11045,CHEMBL627949,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11046,CHEMBL627950,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11047,CHEMBL627951,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11048,CHEMBL627952,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11049,CHEMBL627953,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11050,CHEMBL627954,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11051,CHEMBL627955,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11052,CHEMBL627956,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11053,CHEMBL876802,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11054,CHEMBL627957,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11055,CHEMBL627958,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11056,CHEMBL627959,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11057,CHEMBL627960,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11058,CHEMBL627961,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11059,CHEMBL627962,Lung,50597,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11060,CHEMBL627963,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11061,CHEMBL624759,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11062,CHEMBL624760,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11063,CHEMBL624761,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11064,CHEMBL877607,,50597,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11065,CHEMBL624762,Liver,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11066,CHEMBL624763,Liver,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11067,CHEMBL624764,Liver,50597,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11068,CHEMBL624765,Liver,50597,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11069,CHEMBL624766,Liver,50597,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11070,CHEMBL624767,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11071,CHEMBL624768,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11072,CHEMBL624769,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11073,CHEMBL624770,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11074,CHEMBL624771,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11075,CHEMBL624772,,50588,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11076,CHEMBL624773,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11077,CHEMBL624774,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11078,CHEMBL624775,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11079,CHEMBL624776,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11080,CHEMBL624777,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11081,CHEMBL624778,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11082,CHEMBL624779,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11083,CHEMBL624780,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11084,CHEMBL624781,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11085,CHEMBL877608,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11086,CHEMBL624782,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11087,CHEMBL624783,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11088,CHEMBL624784,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11089,CHEMBL624785,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11090,CHEMBL624786,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11091,CHEMBL624787,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11092,CHEMBL628676,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11093,CHEMBL621842,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11094,CHEMBL621843,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11095,CHEMBL623873,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11096,CHEMBL623874,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11097,CHEMBL623875,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11098,CHEMBL623876,,50597,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11099,CHEMBL623877,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11100,CHEMBL623878,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11101,CHEMBL623879,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11102,CHEMBL623880,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11103,CHEMBL623881,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11104,CHEMBL623957,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11105,CHEMBL623958,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11106,CHEMBL623959,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11107,CHEMBL623960,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11108,CHEMBL623961,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11109,CHEMBL623962,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11110,CHEMBL624676,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11111,CHEMBL624677,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11112,CHEMBL624678,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11113,CHEMBL624679,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11114,CHEMBL624680,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11115,CHEMBL624849,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11116,CHEMBL624850,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11117,CHEMBL874399,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11118,CHEMBL624851,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11119,CHEMBL624852,,22224,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11120,CHEMBL624853,,22224,,Oral bioavailability in rat (dose 10 mg/kg),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11121,CHEMBL624854,,22224,,Oral bioavailability in rat (Sprague-Dawley),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11122,CHEMBL624855,,22224,,Oral bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11123,CHEMBL624856,,22224,,Oral bioavailability in rats was determined in vivo,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11124,CHEMBL882957,,22224,,Oral bioavailability in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11125,CHEMBL624857,,22224,,Oral bioavailability of compound in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11126,CHEMBL622202,,50597,,Oral bioavailability of compound in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11127,CHEMBL622203,,22224,,Bioavailability in rat of PMEA prodrug,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11128,CHEMBL625522,,50597,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11129,CHEMBL622868,,22224,,Serum conc at 3 hours following 25 mg/kg dose,U,9544.0,,Autocuration,,0,,A,Macaca mulatta,,1,BAO_0000218,,
11130,CHEMBL622869,Urine,22224,,Urine conc 0-5 hours following 25 mg/kg dose,U,9544.0,,Autocuration,,0,,A,Macaca mulatta,,1,BAO_0000218,1088.0,
11131,CHEMBL622870,Urine,22224,,Urine conc 0-24 hours following 25 mg/kg dose,U,9544.0,,Autocuration,,0,,A,Macaca mulatta,,1,BAO_0000218,1088.0,
11132,CHEMBL622871,,22224,,Oral bioavailability in African green monkeys; 20-25,U,9534.0,,Autocuration,,0,,A,Chlorocebus aethiops,,1,BAO_0000218,,
11133,CHEMBL620560,,100710,,Oral bioavailability in cynomolgus monkey.,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11134,CHEMBL620561,,22224,,Oral bioavailability in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11135,CHEMBL620562,,50588,,Oral bioavailability in dog at 10 mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11136,CHEMBL620563,,100712,,Oral bioavailability in hamster at 10 mg/kg oral dose,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
11137,CHEMBL620564,,50597,,Oral bioavailability in rat at 10 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11138,CHEMBL872265,,22224,,Oral bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11139,CHEMBL620565,,22224,,Oral bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11140,CHEMBL620566,,22224,,Oral bioavailability,U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
11141,CHEMBL620567,,22224,,Oral bioavailability was determined; range 49-102%,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11142,CHEMBL620568,,50588,,Oral bioavailability was determined in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11143,CHEMBL620569,,22224,,Oral bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11144,CHEMBL620570,,22224,,Oral bioavailability,U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
11145,CHEMBL620571,,22224,,Oral bioavailability was determined; Not orally available,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11146,CHEMBL620572,,50594,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11147,CHEMBL620573,,22224,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),U,10090.0,,Autocuration,,0,,A,Mus musculus,,1,BAO_0000218,,
11148,CHEMBL620574,,22224,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,U,10090.0,,Autocuration,,0,,A,Mus musculus,,1,BAO_0000218,,
11149,CHEMBL620575,,22224,,Oral bioavailability in Rhesus monkey,U,9544.0,,Autocuration,,0,,A,Macaca mulatta,,1,BAO_0000218,,
11150,CHEMBL620576,,22224,,Oral bioavailability in dog (female mongrel),U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11151,CHEMBL875846,,22224,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11152,CHEMBL620577,,22224,,Oral bioavailability in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11153,CHEMBL620578,,22224,,Percentage Bioavailability was evaluated.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11154,CHEMBL620579,,22224,,Bioavailability in rat administered i.d.,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11155,CHEMBL621248,,22224,,Bioavailability,U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
11156,CHEMBL625390,,22224,,Bioavailability in dog (male Beagle) i.v. administration,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11157,CHEMBL625391,,22224,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11158,CHEMBL872266,,22224,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),U,9443.0,,Autocuration,,0,,A,Primates,,1,BAO_0000218,,
11159,CHEMBL625392,,22224,,Oral bioavailability in rat (Sprague-Dawley) (male),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11160,CHEMBL625393,,50597,,The oral bioavailability was measured on rats after oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11161,CHEMBL625394,,50597,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11162,CHEMBL625395,,50797,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
11163,CHEMBL625396,,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11164,CHEMBL625397,,22224,,Bioavailability in dog (male Beagle) i.v. administration,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
11165,CHEMBL625398,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11166,CHEMBL625399,Blood,50594,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11167,CHEMBL626074,Cerebellum,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2037.0,
11168,CHEMBL626075,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11169,CHEMBL626076,Plasma,50597,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11170,CHEMBL626077,Plasma,50797,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
11171,CHEMBL626078,Blood,50597,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11172,CHEMBL625846,Blood,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11173,CHEMBL625847,Blood,22224,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11174,CHEMBL625848,,50597,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11175,CHEMBL625849,Plasma,50597,,Maximum concentration of compound in plasma administered orally to rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11176,CHEMBL626023,Plasma,50588,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11177,CHEMBL626024,Plasma,50588,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11178,CHEMBL626025,Plasma,50588,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11179,CHEMBL626026,,22224,,Maximum concentration after 10 mg/kg by oral administration,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11180,CHEMBL626027,,22224,,Maximum concentration at a dose of 1.5 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11181,CHEMBL626028,,22224,,Maximum concentration at a dose of 2.0 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11182,CHEMBL626029,Plasma,50588,,Maximum concentration in dog plasma,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11183,CHEMBL626030,Plasma,22224,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11184,CHEMBL626031,Plasma,22224,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11185,CHEMBL626032,Plasma,22224,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11186,CHEMBL626033,Plasma,22224,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11187,CHEMBL626034,Plasma,22224,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11188,CHEMBL626035,Plasma,50588,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11189,CHEMBL626036,Plasma,22224,,Maximum concentration in plasma at Tmax,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11190,CHEMBL626037,Plasma,50588,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,N,9615.0,,Expert,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11191,CHEMBL626038,Plasma,100712,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,1969.0,
11192,CHEMBL626039,Plasma,50597,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11193,CHEMBL626040,Plasma,50597,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11194,CHEMBL626041,Plasma,50592,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
11195,CHEMBL626042,,22224,,Maximum concentration was calculated,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11196,CHEMBL626043,,22224,,Maximum concentration was calculated.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11197,CHEMBL626044,,22224,,Maximum concentration at a peroral dose of 10 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11198,CHEMBL626045,,22224,,Maximum concentration of the drug at 10 uM/dg administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11199,CHEMBL626046,,22224,,Maximum concentration of the drug at 2 uM/dg administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11200,CHEMBL626047,Plasma,50588,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11201,CHEMBL626048,Plasma,100712,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,1969.0,
11202,CHEMBL626049,Plasma,50597,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11203,CHEMBL626050,Plasma,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11204,CHEMBL874541,Plasma,50588,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11205,CHEMBL622826,Plasma,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,1969.0,
11206,CHEMBL622827,Plasma,100712,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,1969.0,
11207,CHEMBL622828,Plasma,50597,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11208,CHEMBL622829,Plasma,50597,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11209,CHEMBL876806,,50597,,Maximum concentration reached following intravenous administration in male rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11210,CHEMBL622830,,50588,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11211,CHEMBL622831,,50597,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11212,CHEMBL626794,,50588,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11213,CHEMBL626795,,50597,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11214,CHEMBL626796,,50597,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11215,CHEMBL626797,,50597,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11216,CHEMBL626798,,50597,,Maximum drug concentration is determined after oral dosing in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11217,CHEMBL626799,,50588,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11218,CHEMBL626800,,50588,,Maximum observed concentration in oral (5 mg/kg) fed dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11219,CHEMBL626801,Plasma,22224,,Maximum plasma concentration,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11220,CHEMBL876816,Plasma,50597,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11221,CHEMBL626802,Plasma,50597,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11222,CHEMBL626803,Plasma,50588,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11223,CHEMBL626804,Plasma,22224,,Maximum plasma concentration following oral administration of 30 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11224,CHEMBL626805,Plasma,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11225,CHEMBL626309,Plasma,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11226,CHEMBL626310,Plasma,50597,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11227,CHEMBL626311,Plasma,50597,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11228,CHEMBL626312,Plasma,50597,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11229,CHEMBL626313,Uterus,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11230,CHEMBL626314,Uterus,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11231,CHEMBL626315,Uterus,50597,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11232,CHEMBL626316,Uterus,50597,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11233,CHEMBL626317,Uterus,50597,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11234,CHEMBL626318,,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11235,CHEMBL626319,,50597,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11236,CHEMBL626320,,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11237,CHEMBL875053,,50597,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11238,CHEMBL626321,,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11239,CHEMBL626322,,50597,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11240,CHEMBL626323,,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11241,CHEMBL626324,,50597,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11242,CHEMBL626325,,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11243,CHEMBL626326,,50597,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11244,CHEMBL626327,,50597,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11245,CHEMBL626328,,50597,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11246,CHEMBL626329,Blood,50597,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11247,CHEMBL626330,Blood,50597,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11248,CHEMBL626331,Blood,50597,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11249,CHEMBL626332,Blood,50597,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11250,CHEMBL626333,Blood,50597,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11251,CHEMBL626334,Blood,50597,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11252,CHEMBL626335,Blood,50597,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11253,CHEMBL624798,Blood,50597,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11254,CHEMBL624799,Brain,50597,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11255,CHEMBL624800,Brain,50597,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11256,CHEMBL624801,Brain,50597,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11257,CHEMBL624802,Brain,50597,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11258,CHEMBL624803,Brain,50597,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11259,CHEMBL624804,Brain,50597,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11260,CHEMBL624805,Brain,50597,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11261,CHEMBL624806,Brain,50597,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11262,CHEMBL624807,,50597,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11263,CHEMBL624808,,50597,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11264,CHEMBL624809,,50597,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11265,CHEMBL624810,,50597,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11266,CHEMBL877618,,50597,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11267,CHEMBL624811,,50597,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11268,CHEMBL624812,,50597,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11269,CHEMBL624813,,50597,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11270,CHEMBL624814,,50597,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11271,CHEMBL624815,,50597,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11272,CHEMBL624816,,50597,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11273,CHEMBL624817,,50597,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11274,CHEMBL624818,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11275,CHEMBL624819,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11276,CHEMBL624820,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11277,CHEMBL624821,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11278,CHEMBL624822,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11279,CHEMBL624823,,50588,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11280,CHEMBL624824,,50212,,Observed diffusion coefficient in organic solvent for Escherichia coli,N,562.0,,Intermediate,,1,,A,Escherichia coli,,1,BAO_0000218,,
11281,CHEMBL624825,Blood,50597,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11282,CHEMBL624826,Blood,50597,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11283,CHEMBL876817,Cardiac atrium,50597,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2081.0,
11284,CHEMBL624827,Cardiac atrium,50597,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2081.0,
11285,CHEMBL624828,,50597,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11286,CHEMBL624829,,50597,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11287,CHEMBL624830,Liver,50597,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11288,CHEMBL624831,Liver,50597,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11289,CHEMBL624832,Cardiac atrium,50597,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2081.0,
11290,CHEMBL624833,Cardiac atrium,50597,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2081.0,
11291,CHEMBL624834,,50597,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11292,CHEMBL624835,,50597,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11293,CHEMBL624836,Spleen,50597,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11294,CHEMBL624837,Spleen,50597,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11295,CHEMBL624838,Blood,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11296,CHEMBL622188,Blood,50597,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11297,CHEMBL622189,Heart,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11298,CHEMBL622190,Heart,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11299,CHEMBL625170,Heart,50597,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11300,CHEMBL625171,Kidney,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11301,CHEMBL625172,Kidney,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11302,CHEMBL625173,Kidney,50597,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11303,CHEMBL625174,Liver,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11304,CHEMBL625175,Liver,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11305,CHEMBL625176,Liver,50597,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11306,CHEMBL625177,Lung,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11307,CHEMBL625178,Lung,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11308,CHEMBL625179,Lung,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11309,CHEMBL625180,Lung,50597,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11310,CHEMBL625181,,22224,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11311,CHEMBL625182,Urine,50594,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
11312,CHEMBL625183,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11313,CHEMBL875848,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11314,CHEMBL622260,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11315,CHEMBL622261,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11316,CHEMBL622262,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11317,CHEMBL622263,Kidney,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11318,CHEMBL622418,Kidney,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11319,CHEMBL622419,Liver,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11320,CHEMBL623388,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11321,CHEMBL623389,Liver,50594,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11322,CHEMBL623390,,50594,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11323,CHEMBL623391,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11324,CHEMBL623392,Blood,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11325,CHEMBL623393,Cerebellum,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2037.0,
11326,CHEMBL623394,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11327,CHEMBL618885,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11328,CHEMBL618886,Liver,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11329,CHEMBL618887,,50594,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11330,CHEMBL619535,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11331,CHEMBL619536,Blood,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11332,CHEMBL619537,Cerebellum,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2037.0,
11333,CHEMBL619705,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11334,CHEMBL619706,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11335,CHEMBL619707,Liver,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11336,CHEMBL619708,,50594,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11337,CHEMBL625219,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11338,CHEMBL625220,Blood,50594,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11339,CHEMBL625221,Cerebellum,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2037.0,
11340,CHEMBL625222,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11341,CHEMBL625223,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11342,CHEMBL625224,Liver,50594,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11343,CHEMBL625225,,50594,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11344,CHEMBL625226,Blood,50597,,Biodistribution in Rat blood after 24 hours of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11345,CHEMBL625227,Blood,50597,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11346,CHEMBL625228,Blood,50597,,Biodistribution in Rat blood after 30 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11347,CHEMBL875354,Blood,50597,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11348,CHEMBL625229,Blood,50597,,Biodistribution in Rat blood after 5 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11349,CHEMBL625230,Blood,50597,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11350,CHEMBL625231,Heart,50597,,Biodistribution in Rat heart after 24 hours of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11351,CHEMBL625900,Heart,50597,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11352,CHEMBL625901,Heart,50597,,Biodistribution in Rat heart after 30 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11353,CHEMBL625902,Heart,50597,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11354,CHEMBL625903,Heart,50597,,Biodistribution in Rat heart after 5 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11355,CHEMBL625904,Heart,50597,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11356,CHEMBL625905,Liver,50597,,Biodistribution in Rat liver after 24 hours of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11357,CHEMBL627861,Liver,50597,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11358,CHEMBL627862,Liver,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11359,CHEMBL627863,Liver,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11360,CHEMBL627769,Liver,50597,,Biodistribution in Rat liver after 30 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11361,CHEMBL627770,Plasma,50588,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11362,CHEMBL627771,,100710,,Cmax in cynomolgus monkey (PO dose),N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11363,CHEMBL627772,,50597,,Cmax in rat (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11364,CHEMBL627773,,50597,,Cmax in rat (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11365,CHEMBL621922,Plasma,50597,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11366,CHEMBL621923,Plasma,50597,,Cmax in rat plasma after oral dose (10 mg/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11367,CHEMBL621924,Plasma,22224,,Cmax in plasma after oral dose (10 mg/kg),U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11368,CHEMBL621925,Plasma,50588,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11369,CHEMBL621926,Plasma,22224,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11370,CHEMBL621927,Plasma,50592,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
11371,CHEMBL621928,Plasma,50597,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11372,CHEMBL621929,Plasma,50597,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11373,CHEMBL621930,Plasma,50594,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11374,CHEMBL621931,Plasma,50597,,Maximum plasma concentration after oral dosing in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11375,CHEMBL621932,Plasma,22224,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11376,CHEMBL621933,Plasma,22224,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11377,CHEMBL621934,Plasma,50588,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11378,CHEMBL621935,Plasma,50588,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11379,CHEMBL621936,Plasma,50597,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11380,CHEMBL621937,Plasma,22224,,Maximum plasma concentration was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11381,CHEMBL621938,Plasma,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11382,CHEMBL621939,Plasma,22224,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11383,CHEMBL621940,Plasma,22224,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11384,CHEMBL621941,Plasma,22224,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11385,CHEMBL621942,Plasma,22224,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11386,CHEMBL626178,Plasma,22224,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11387,CHEMBL626179,Plasma,22224,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11388,CHEMBL626180,Plasma,22224,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11389,CHEMBL626181,Plasma,50597,,Plasma Cmax in rat (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11390,CHEMBL626182,,50597,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11391,CHEMBL626183,,50597,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11392,CHEMBL626184,,50597,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11393,CHEMBL626185,,50597,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11394,CHEMBL626186,Plasma,50588,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11395,CHEMBL877589,Plasma,50588,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11396,CHEMBL626187,,22224,,Maximum concentration of the drug at 1 uM/dg administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11397,CHEMBL626188,,22224,,Maximum concentration of the drug at 20 uM/dg administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11398,CHEMBL626189,,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11399,CHEMBL626855,Blood,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11400,CHEMBL623781,Blood,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11401,CHEMBL623782,Blood,22224,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11402,CHEMBL623783,Plasma,50597,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11403,CHEMBL623784,Plasma,50588,,Cmax in dog plasma after 1mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11404,CHEMBL623785,Plasma,50588,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11405,CHEMBL623786,Plasma,50597,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11406,CHEMBL623787,,50597,,Oral maximum concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11407,CHEMBL623788,,50597,,Oral maximum concentration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11408,CHEMBL623789,Plasma,50594,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11409,CHEMBL623790,Blood,50594,,Peak concentration in blood after intravenous administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11410,CHEMBL623791,Blood,50594,,Peak concentration in blood after peroral administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
11411,CHEMBL623792,Plasma,50597,,Peak concentration in rat plasma was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11412,CHEMBL623793,Plasma,22224,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11413,CHEMBL623794,Plasma,50594,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11414,CHEMBL623795,Plasma,50597,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11415,CHEMBL623796,,50597,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11416,CHEMBL623797,,50597,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11417,CHEMBL623798,,50597,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11418,CHEMBL623799,,50597,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11419,CHEMBL624490,Intestine,50597,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11420,CHEMBL624491,Intestine,50597,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11421,CHEMBL624492,Intestine,50597,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11422,CHEMBL624493,Intestine,50597,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11423,CHEMBL877595,Intestine,50597,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11424,CHEMBL624494,Intestine,50597,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11425,CHEMBL624495,Intestine,50597,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11426,CHEMBL624681,Intestine,50597,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
11427,CHEMBL624682,,50597,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11428,CHEMBL624683,,50597,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11429,CHEMBL624684,,50597,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11430,CHEMBL624685,,50597,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11431,CHEMBL624686,,50597,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11432,CHEMBL624687,,50597,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11433,CHEMBL624688,,50597,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11434,CHEMBL627161,,50597,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11435,CHEMBL622127,,50597,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11436,CHEMBL622128,,50597,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11437,CHEMBL874384,,50597,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11438,CHEMBL624898,,50597,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11439,CHEMBL624899,,50597,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11440,CHEMBL624900,,50597,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11441,CHEMBL624901,,50597,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11442,CHEMBL624902,,50597,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11443,CHEMBL624903,,50597,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11444,CHEMBL624904,,50597,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11445,CHEMBL624905,,50597,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11446,CHEMBL624906,,50597,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11447,CHEMBL624907,,50597,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11448,CHEMBL624908,,50597,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11449,CHEMBL624909,,50597,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11450,CHEMBL624910,,50597,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11451,CHEMBL624911,Muscle tissue,50597,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11452,CHEMBL874388,Muscle tissue,50597,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11453,CHEMBL624912,Muscle tissue,50597,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11454,CHEMBL622930,Muscle tissue,50597,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11455,CHEMBL623121,Muscle tissue,50597,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11456,CHEMBL623122,Muscle tissue,50597,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11457,CHEMBL623123,Muscle tissue,50597,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11458,CHEMBL623124,Muscle tissue,50597,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11459,CHEMBL623125,,50597,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11460,CHEMBL623126,,50597,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11461,CHEMBL623127,,50597,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11462,CHEMBL623128,,50597,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11463,CHEMBL623129,,50597,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11464,CHEMBL623130,,50597,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11465,CHEMBL623131,,50597,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11466,CHEMBL623132,,50597,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11467,CHEMBL623133,Liver,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11468,CHEMBL623134,,50597,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11469,CHEMBL874389,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11470,CHEMBL623135,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11471,CHEMBL623136,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11472,CHEMBL623137,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11473,CHEMBL623138,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11474,CHEMBL623139,Kidney,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11475,CHEMBL623140,Kidney,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11476,CHEMBL623141,Liver,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11477,CHEMBL623142,Liver,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11478,CHEMBL623143,,50597,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11479,CHEMBL623144,Urine,50594,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
11480,CHEMBL623405,Urine,50597,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
11481,CHEMBL624074,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11482,CHEMBL624075,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11483,CHEMBL624076,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11484,CHEMBL624077,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11485,CHEMBL624078,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11486,CHEMBL624079,Kidney,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11487,CHEMBL624261,Kidney,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11488,CHEMBL624262,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11489,CHEMBL624263,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11490,CHEMBL624264,,50597,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11491,CHEMBL624265,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11492,CHEMBL624266,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11493,CHEMBL624267,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11494,CHEMBL624268,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11495,CHEMBL875227,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11496,CHEMBL624269,Kidney,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11497,CHEMBL624270,Kidney,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11498,CHEMBL624271,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11499,CHEMBL624272,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11500,CHEMBL624273,,50597,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11501,CHEMBL624274,Urine,50597,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
11502,CHEMBL624275,Urine,50597,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
11503,CHEMBL624276,Urine,50597,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
11504,CHEMBL624277,Urine,50597,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
11505,CHEMBL624278,,22224,,% dose converted to 2-amino-5-chlorophenyl sulfate,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11506,CHEMBL624279,,22224,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11507,CHEMBL624280,Feces,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
11508,CHEMBL624281,Feces,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
11509,CHEMBL622933,Feces,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
11510,CHEMBL622934,Feces,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
11511,CHEMBL622935,Liver,50597,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11512,CHEMBL622936,Liver,50597,,Biodistribution in Rat liver after 5 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11513,CHEMBL875228,Liver,50597,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11514,CHEMBL622937,Lung,50597,,Biodistribution in Rat lung after 24 hours of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11515,CHEMBL622938,Lung,50597,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11516,CHEMBL619736,Lung,50597,,Biodistribution in Rat lung after 30 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11517,CHEMBL625117,Lung,50597,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11518,CHEMBL625118,Lung,50597,,Biodistribution in Rat lung after 5 minutes of iv administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11519,CHEMBL625119,Lung,50597,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11520,CHEMBL625120,Cerebellum,50597,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
11521,CHEMBL625121,,50597,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11522,CHEMBL625122,Thalamus,50597,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000006.0,
11523,CHEMBL622204,Blood,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11524,CHEMBL877503,Blood,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11525,CHEMBL627127,Blood,50597,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11526,CHEMBL627128,Hippocampus,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,U,,,Autocuration,,0,,A,,,1,BAO_0000218,10000000.0,
11527,CHEMBL627129,Hippocampus,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,U,,,Autocuration,,0,,A,,,1,BAO_0000218,10000000.0,
11528,CHEMBL627130,Hippocampus,22224,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,U,,,Autocuration,,0,,A,,,1,BAO_0000218,10000000.0,
11529,CHEMBL627131,Brain,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11530,CHEMBL627132,Brain,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11531,CHEMBL627133,Brain,50597,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11532,CHEMBL627134,Cerebellum,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
11533,CHEMBL627135,Cerebellum,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
11534,CHEMBL627136,Cerebellum,50597,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
11535,CHEMBL628435,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11536,CHEMBL628436,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11537,CHEMBL628437,,50597,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11538,CHEMBL628438,Heart,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11539,CHEMBL628439,Heart,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11540,CHEMBL628440,Heart,50597,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
11541,CHEMBL628441,Hippocampus,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
11542,CHEMBL628442,Hippocampus,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
11543,CHEMBL628443,Hippocampus,50597,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
11544,CHEMBL628444,Kidney,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11545,CHEMBL628445,Kidney,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11546,CHEMBL877504,Kidney,50597,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11547,CHEMBL628446,Liver,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11548,CHEMBL626874,Liver,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11549,CHEMBL626875,Liver,50597,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11550,CHEMBL626876,Lung,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11551,CHEMBL626877,Lung,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11552,CHEMBL626878,Lung,50597,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11553,CHEMBL626879,Muscle tissue,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11554,CHEMBL626880,Plasma,22224,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11555,CHEMBL626881,Plasma,50594,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11556,CHEMBL626882,Plasma,50597,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11557,CHEMBL626883,Plasma,50588,,Peak plasma concentration was measured in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11558,CHEMBL626884,,50597,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11559,CHEMBL626885,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11560,CHEMBL626886,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11561,CHEMBL626887,,50597,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11562,CHEMBL626888,,50597,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11563,CHEMBL626889,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11564,CHEMBL626761,,22224,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11565,CHEMBL626762,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11566,CHEMBL626763,,50588,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11567,CHEMBL626764,,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11568,CHEMBL626765,,50597,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11569,CHEMBL626766,,50588,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11570,CHEMBL626767,,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11571,CHEMBL626768,,50597,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11572,CHEMBL626769,,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11573,CHEMBL874463,,50588,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11574,CHEMBL626770,,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11575,CHEMBL626771,,22224,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11576,CHEMBL626772,,50597,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11577,CHEMBL626773,,100710,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11578,CHEMBL626774,,50594,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11579,CHEMBL626775,,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11580,CHEMBL626776,,50588,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11581,CHEMBL626777,,50597,,Maximum concentration (Cmax) in rat when administered orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11582,CHEMBL626778,Plasma,22224,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11583,CHEMBL626779,,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11584,CHEMBL626780,,22224,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
11585,CHEMBL626781,Plasma,22224,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
11586,CHEMBL632164,,50597,,Pharmacokinetic profile Cmax was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11587,CHEMBL632165,,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11588,CHEMBL632166,,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11589,CHEMBL632167,,50588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11590,CHEMBL632168,,50594,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11591,CHEMBL632169,Plasma,22224,,Cmax in rat plasma,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11592,CHEMBL632170,Plasma,50588,,Cmax in dog plasma after 30mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11593,CHEMBL632171,Plasma,50597,,Cmax in rat plasma after 30mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11594,CHEMBL632172,Plasma,50597,,Plasma level in rats at 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11595,CHEMBL632173,Plasma,50594,,Tested for maximum plasma concentration in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11596,CHEMBL632174,,50597,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11597,CHEMBL632175,,50597,,The Cmax values in female wistar rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11598,CHEMBL632176,Plasma,50588,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11599,CHEMBL632177,Plasma,50597,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11600,CHEMBL632178,Plasma,50597,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11601,CHEMBL632179,,50597,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11602,CHEMBL632180,Blood,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11603,CHEMBL632181,Blood,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11604,CHEMBL632182,Blood,50597,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11605,CHEMBL632183,Blood,22224,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,U,10090.0,,Autocuration,,0,,A,Mus musculus,,1,BAO_0000218,178.0,
11606,CHEMBL632184,,50588,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11607,CHEMBL874470,,50597,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11608,CHEMBL631302,,50597,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11609,CHEMBL631303,,50597,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11610,CHEMBL631304,,50597,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11611,CHEMBL631305,,50597,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11612,CHEMBL631306,,50597,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11613,CHEMBL631307,,50597,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11614,CHEMBL631308,,50597,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11615,CHEMBL625557,,50597,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11616,CHEMBL625558,Spleen,50597,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11617,CHEMBL625559,Spleen,50597,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11618,CHEMBL625560,Spleen,50597,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11619,CHEMBL625561,Spleen,50597,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11620,CHEMBL625562,Spleen,50597,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11621,CHEMBL875320,Spleen,50597,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11622,CHEMBL625563,Spleen,50597,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11623,CHEMBL625564,Spleen,50597,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11624,CHEMBL625565,Uterus,50597,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11625,CHEMBL625566,Uterus,50597,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11626,CHEMBL625567,Uterus,50597,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11627,CHEMBL625568,Uterus,50597,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11628,CHEMBL628217,Uterus,50597,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11629,CHEMBL628218,Uterus,50597,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11630,CHEMBL628219,Uterus,50597,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11631,CHEMBL628220,Uterus,50597,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
11632,CHEMBL628221,,22224,,Distribution in the blood after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11633,CHEMBL628222,,22224,,Distribution in the blood after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11634,CHEMBL628223,,22224,,Distribution in the blood after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11635,CHEMBL628224,,22224,,Distribution in the blood after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11636,CHEMBL628225,,22224,,Distribution in the blood after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11637,CHEMBL628226,,22224,,Distribution in the blood after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11638,CHEMBL628227,,22224,,Distribution in the bone after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11639,CHEMBL875481,,22224,,Distribution in the bone after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11640,CHEMBL628228,,22224,,Distribution in the bone after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11641,CHEMBL628229,,22224,,Distribution in the bone after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11642,CHEMBL628230,,22224,,Distribution in the bone after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11643,CHEMBL628231,,22224,,Distribution in the bone after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11644,CHEMBL628232,,22224,,Distribution in the heart after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11645,CHEMBL628233,,22224,,Distribution in the heart after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11646,CHEMBL628234,,22224,,Distribution in the heart after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11647,CHEMBL628235,,22224,,Distribution in the heart after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11648,CHEMBL628236,,22224,,Distribution in the heart after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11649,CHEMBL628237,,22224,,Distribution in the heart after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11650,CHEMBL628238,,22224,,Distribution in the kidneys after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11651,CHEMBL628239,,22224,,Distribution in the kidneys after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11652,CHEMBL628240,,22224,,Distribution in the kidneys after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11653,CHEMBL628241,,22224,,Distribution in the kidneys after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11654,CHEMBL628242,,22224,,Distribution in the kidneys after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11655,CHEMBL875482,,22224,,Distribution in the kidneys after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11656,CHEMBL628243,,22224,,Distribution in the liver after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11657,CHEMBL628244,,22224,,Distribution in the liver after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11658,CHEMBL628245,,22224,,Distribution in the liver after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11659,CHEMBL628246,,22224,,Distribution in the liver after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11660,CHEMBL628247,,22224,,Distribution in the liver after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11661,CHEMBL628248,,22224,,Distribution in the liver after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11662,CHEMBL628249,,22224,,Distribution in the lung after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11663,CHEMBL625452,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11664,CHEMBL625453,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11665,CHEMBL625454,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11666,CHEMBL623844,,50594,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11667,CHEMBL623845,,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11668,CHEMBL623846,,50597,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11669,CHEMBL623847,,22224,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11670,CHEMBL623848,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11671,CHEMBL623849,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11672,CHEMBL623850,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11673,CHEMBL623851,,100710,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11674,CHEMBL623852,,22224,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11675,CHEMBL624551,,50506,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
11676,CHEMBL624552,,50506,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
11677,CHEMBL624553,,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11678,CHEMBL624554,,22224,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
11679,CHEMBL624555,,50597,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11680,CHEMBL624741,,50597,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11681,CHEMBL624742,,50588,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11682,CHEMBL624743,,100712,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
11683,CHEMBL877606,,50597,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11684,CHEMBL624744,,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11685,CHEMBL624745,Blood,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11686,CHEMBL624746,Blood,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11687,CHEMBL624747,Blood,22224,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
11688,CHEMBL624748,,22224,,Oral absorption expressed as Area under curve was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11689,CHEMBL622504,,50588,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11690,CHEMBL622505,,50588,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11691,CHEMBL622506,,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
11692,CHEMBL622507,,100712,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
11693,CHEMBL622508,,50597,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11694,CHEMBL622509,,22224,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11695,CHEMBL622510,,50597,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11696,CHEMBL622511,,50597,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11697,CHEMBL622512,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11698,CHEMBL622513,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11699,CHEMBL622514,,100710,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11700,CHEMBL622515,,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11701,CHEMBL622516,,50588,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11702,CHEMBL622517,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11703,CHEMBL622518,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11704,CHEMBL622519,,50597,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11705,CHEMBL622520,Muscle tissue,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11706,CHEMBL622521,Muscle tissue,50597,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11707,CHEMBL625113,Zone of skin,50594,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
11708,CHEMBL625114,Zone of skin,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
11709,CHEMBL874397,Zone of skin,50597,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
11710,CHEMBL625115,Spleen,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11711,CHEMBL625116,Spleen,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11712,CHEMBL623932,Spleen,50597,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
11713,CHEMBL623933,Striatum,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
11714,CHEMBL623934,Striatum,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
11715,CHEMBL623935,Striatum,50597,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
11716,CHEMBL623936,Thyroid gland,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
11717,CHEMBL623937,Thyroid gland,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
11718,CHEMBL623938,Thyroid gland,50597,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
11719,CHEMBL623939,,50594,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11720,CHEMBL623940,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11721,CHEMBL623941,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11722,CHEMBL627216,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11723,CHEMBL623942,,50594,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11724,CHEMBL618793,Brain,50594,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
11725,CHEMBL618794,Brain,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
11726,CHEMBL618795,Brain,50594,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
11727,CHEMBL618796,,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11728,CHEMBL618797,,50594,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11729,CHEMBL618798,Kidney,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11730,CHEMBL618799,Kidney,50594,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11731,CHEMBL618800,Kidney,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11732,CHEMBL618801,Kidney,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11733,CHEMBL618802,Kidney,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11734,CHEMBL618803,Kidney,50594,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
11735,CHEMBL618804,Liver,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11736,CHEMBL618805,Liver,50594,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11737,CHEMBL618806,Liver,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11738,CHEMBL618807,Liver,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11739,CHEMBL618808,Liver,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11740,CHEMBL618809,Liver,50594,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
11741,CHEMBL618810,Muscle tissue,50594,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11742,CHEMBL618811,Muscle tissue,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11743,CHEMBL875844,Muscle tissue,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11744,CHEMBL618812,Muscle tissue,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11745,CHEMBL618813,Muscle tissue,50594,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11746,CHEMBL618814,,50594,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11747,CHEMBL618815,,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11748,CHEMBL618816,,50594,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11749,CHEMBL618817,,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11750,CHEMBL620544,,50594,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11751,CHEMBL626230,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11752,CHEMBL626231,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11753,CHEMBL626232,,50597,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11754,CHEMBL626233,Plasma,50588,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11755,CHEMBL626234,Plasma,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11756,CHEMBL875341,Plasma,50597,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11757,CHEMBL626235,Plasma,50587,,The maximum plasma concentration (100 mg/kg) administered orally in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
11758,CHEMBL626236,Plasma,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000218,1969.0,
11759,CHEMBL626237,Plasma,22224,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11760,CHEMBL626238,Plasma,50588,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11761,CHEMBL622412,Plasma,50587,,The maximum plasma concentration (200 mg/kg) administered orally in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
11762,CHEMBL623114,Plasma,50597,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11763,CHEMBL623115,Plasma,22224,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000218,1969.0,
11764,CHEMBL623116,Plasma,22224,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11765,CHEMBL623117,Plasma,22224,,The maximum plasma concentration (30 mg/kg) administered orally in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11766,CHEMBL623118,Plasma,50587,,The maximum plasma concentration (400 mg/kg) administered orally in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
11767,CHEMBL623119,Plasma,50597,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11768,CHEMBL623120,Plasma,50597,,The maximum plasma concentration (50 mg/kg) administered orally in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11769,CHEMBL623286,Plasma,50587,,The maximum plasma concentration (800 mg/kg) administered orally in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
11770,CHEMBL623287,Plasma,50597,,The maximum plasma concentration was measured on rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11771,CHEMBL623288,Plasma,50597,,The maximum plasma concentration was measured on rats after oral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11772,CHEMBL623289,Plasma,50597,,Plasma drug Cmax in rat (PO dose),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11773,CHEMBL623290,,22224,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11774,CHEMBL623291,Plasma,50588,,maximum Plasma concentration in Dog was determined after Peroral administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11775,CHEMBL623292,Plasma,50597,,maximum Plasma concentration in Rats was determined after Peroral administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11776,CHEMBL623293,Plasma,50588,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
11777,CHEMBL623294,Plasma,22224,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
11778,CHEMBL623295,Plasma,50597,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11779,CHEMBL623296,,50594,,maximum concentration was measured when administered through oral route in mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11780,CHEMBL875349,,50594,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11781,CHEMBL623297,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
11782,CHEMBL623298,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
11783,CHEMBL623299,,22224,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
11784,CHEMBL623300,,50597,,Pharmacokinetic parameter was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11785,CHEMBL623301,,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11786,CHEMBL623302,,50594,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11787,CHEMBL623303,,50594,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11788,CHEMBL623304,,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11789,CHEMBL623305,,50594,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11790,CHEMBL623306,Plasma,50597,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11791,CHEMBL623307,Plasma,50597,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11792,CHEMBL623308,Plasma,50597,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
11793,CHEMBL623309,Plasma,50594,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
11794,CHEMBL623310,,50594,,Plasma Concentration after 120 min of oral administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11795,CHEMBL623311,,50594,,Plasma Concentration after 30 min of oral administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11796,CHEMBL623312,,100710,,Plasma Concentration after 60 min of oral administration to mice,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11797,CHEMBL875350,,50594,,Plasma Concentration after 60 min of oral administration to mice; Not determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11798,CHEMBL628635,,50594,,Plasma Concentration after 90 min of oral administration to mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11799,CHEMBL628636,,50597,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11800,CHEMBL628637,,50597,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11801,CHEMBL628058,,50597,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11802,CHEMBL628059,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11803,CHEMBL628060,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11804,CHEMBL628061,,22224,,Distribution in the lung after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11805,CHEMBL628062,,22224,,Distribution in the lung after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11806,CHEMBL628063,,22224,,Distribution in the lung after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11807,CHEMBL628064,,22224,,Distribution in the lung after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11808,CHEMBL628065,,22224,,Distribution in the lung after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11809,CHEMBL628066,Muscle tissue,22224,,Distribution in the muscle after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2385.0,
11810,CHEMBL628067,Muscle tissue,22224,,Distribution in the muscle after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2385.0,
11811,CHEMBL874646,Muscle tissue,50594,,Distribution in the muscle after 30 min of intravenous administration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2385.0,
11812,CHEMBL628068,Muscle tissue,22224,,Distribution in the muscle after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2385.0,
11813,CHEMBL628069,Muscle tissue,22224,,Distribution in the muscle after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2385.0,
11814,CHEMBL628070,Muscle tissue,22224,,Distribution in the muscle after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2385.0,
11815,CHEMBL628071,Spleen,22224,,Distribution in the spleen after 120 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11816,CHEMBL628072,Spleen,22224,,Distribution in the spleen after 15 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11817,CHEMBL628073,Spleen,22224,,Distribution in the spleen after 30 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11818,CHEMBL628074,Spleen,22224,,Distribution in the spleen after 5 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11819,CHEMBL628075,Spleen,22224,,Distribution in the spleen after 60 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11820,CHEMBL628076,Spleen,22224,,Distribution in the spleen after 90 min of intravenous administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,2106.0,
11821,CHEMBL628077,Adrenal cortex,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1235.0,
11822,CHEMBL628078,Blood,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11823,CHEMBL628079,Liver,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11824,CHEMBL628080,Female gonad,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
11825,CHEMBL628081,Thyroid gland,50597,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
11826,CHEMBL628082,Adrenal cortex,50597,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1235.0,
11827,CHEMBL874647,Blood,50597,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11828,CHEMBL626406,Liver,50597,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11829,CHEMBL626407,Female gonad,50597,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
11830,CHEMBL626408,Thyroid gland,50597,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
11831,CHEMBL626409,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11832,CHEMBL626410,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11833,CHEMBL626411,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11834,CHEMBL626412,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11835,CHEMBL626413,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11836,CHEMBL626414,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11837,CHEMBL626415,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11838,CHEMBL626416,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11839,CHEMBL627062,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11840,CHEMBL627063,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11841,CHEMBL627064,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11842,CHEMBL627227,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11843,CHEMBL627228,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11844,CHEMBL627229,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11845,CHEMBL625792,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11846,CHEMBL625793,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11847,CHEMBL625794,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11848,CHEMBL625795,Blood,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11849,CHEMBL625796,,50594,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11850,CHEMBL625797,,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11851,CHEMBL625798,,50588,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
11852,CHEMBL875613,,22224,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11853,CHEMBL625799,,22224,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11854,CHEMBL625800,,22224,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11855,CHEMBL625801,,22224,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11856,CHEMBL625802,,22224,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11857,CHEMBL625803,,22224,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11858,CHEMBL625804,,22224,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11859,CHEMBL622530,,22224,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11860,CHEMBL622531,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11861,CHEMBL622532,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11862,CHEMBL623176,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11863,CHEMBL623177,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11864,CHEMBL623178,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11865,CHEMBL623179,,50594,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11866,CHEMBL623180,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11867,CHEMBL623181,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11868,CHEMBL624131,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11869,CHEMBL624132,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11870,CHEMBL624133,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11871,CHEMBL624846,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11872,CHEMBL624847,,50594,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11873,CHEMBL624848,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11874,CHEMBL625012,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11875,CHEMBL625013,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11876,CHEMBL625014,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11877,CHEMBL625015,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11878,CHEMBL625016,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11879,CHEMBL625017,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11880,CHEMBL625018,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11881,CHEMBL625019,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11882,CHEMBL625020,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11883,CHEMBL625021,,50594,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11884,CHEMBL625022,,50597,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11885,CHEMBL625023,,50594,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11886,CHEMBL625024,,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11887,CHEMBL627626,,100710,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
11888,CHEMBL627627,Brain,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,,Autocuration,,0,,A,,,1,BAO_0000218,955.0,
11889,CHEMBL627628,Serum,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1977.0,
11890,CHEMBL627629,Brain,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,,Autocuration,,0,,A,,,1,BAO_0000218,955.0,
11891,CHEMBL627630,Serum,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1977.0,
11892,CHEMBL627631,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
11893,CHEMBL629515,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
11894,CHEMBL629516,Spleen,50594,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
11895,CHEMBL629517,Spleen,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
11896,CHEMBL629518,Spleen,50594,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
11897,CHEMBL877499,,50594,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11898,CHEMBL629519,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11899,CHEMBL629520,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11900,CHEMBL629521,,50594,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11901,CHEMBL629522,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11902,CHEMBL629523,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11903,CHEMBL629524,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11904,CHEMBL629525,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11905,CHEMBL629526,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11906,CHEMBL629527,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11907,CHEMBL629528,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11908,CHEMBL629529,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11909,CHEMBL629530,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11910,CHEMBL629531,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11911,CHEMBL628656,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11912,CHEMBL628657,,50594,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
11913,CHEMBL628658,,50597,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11914,CHEMBL628659,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11915,CHEMBL877500,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11916,CHEMBL628660,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11917,CHEMBL628661,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11918,CHEMBL628662,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11919,CHEMBL628663,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11920,CHEMBL628664,,50597,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11921,CHEMBL628665,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11922,CHEMBL628666,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11923,CHEMBL628667,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11924,CHEMBL628668,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11925,CHEMBL628669,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11926,CHEMBL628670,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11927,CHEMBL628671,Blood,50597,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11928,CHEMBL628672,Bone,50597,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
11929,CHEMBL630300,Bone,50597,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
11930,CHEMBL629787,Bone,50597,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
11931,CHEMBL629788,Bone,50597,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
11932,CHEMBL629789,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11933,CHEMBL629790,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11934,CHEMBL629791,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11935,CHEMBL629792,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11936,CHEMBL629793,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11937,CHEMBL629794,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11938,CHEMBL874459,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11939,CHEMBL629795,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11940,CHEMBL629796,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11941,CHEMBL629797,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11942,CHEMBL629798,,50597,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11943,CHEMBL629799,Adrenal gland,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2369.0,
11944,CHEMBL629800,Adrenal gland,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2369.0,
11945,CHEMBL629801,Adrenal gland,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2369.0,
11946,CHEMBL629802,Adrenal gland,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2369.0,
11947,CHEMBL629803,Adrenal gland,50597,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2369.0,
11948,CHEMBL629804,Blood,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11949,CHEMBL629805,Blood,50597,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11950,CHEMBL629806,Blood,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11951,CHEMBL629807,Blood,50597,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11952,CHEMBL629808,Blood,50597,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
11953,CHEMBL629809,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11954,CHEMBL629810,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11955,CHEMBL629811,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11956,CHEMBL629812,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11957,CHEMBL629813,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11958,CHEMBL874460,Brain,50597,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
11959,CHEMBL629814,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11960,CHEMBL629815,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11961,CHEMBL629816,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11962,CHEMBL629817,,50597,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11963,CHEMBL626643,Kidney,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11964,CHEMBL626644,Kidney,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11965,CHEMBL626806,Kidney,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11966,CHEMBL626807,Kidney,50597,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
11967,CHEMBL627261,Liver,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11968,CHEMBL627262,Liver,50597,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11969,CHEMBL627263,Liver,50597,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11970,CHEMBL627264,Liver,50597,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
11971,CHEMBL627265,Lung,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11972,CHEMBL627266,Lung,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11973,CHEMBL627267,Lung,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11974,CHEMBL627268,Lung,50597,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
11975,CHEMBL627269,Muscle tissue,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11976,CHEMBL627270,Muscle tissue,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
11977,CHEMBL627271,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11978,CHEMBL627946,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11979,CHEMBL875472,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11980,CHEMBL627947,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11981,CHEMBL627948,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11982,CHEMBL628113,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11983,CHEMBL628114,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11984,CHEMBL628115,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11985,CHEMBL628116,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11986,CHEMBL628117,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11987,CHEMBL628118,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11988,CHEMBL628119,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11989,CHEMBL628120,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11990,CHEMBL628121,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11991,CHEMBL628122,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11992,CHEMBL627297,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11993,CHEMBL627298,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11994,CHEMBL627299,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11995,CHEMBL627300,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11996,CHEMBL627301,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11997,CHEMBL627302,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11998,CHEMBL627303,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
11999,CHEMBL627304,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12000,CHEMBL627305,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12001,CHEMBL627306,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12002,CHEMBL623982,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12003,CHEMBL623983,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12004,CHEMBL623984,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12005,CHEMBL623985,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12006,CHEMBL623986,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12007,CHEMBL623987,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12008,CHEMBL623988,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12009,CHEMBL623989,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12010,CHEMBL622215,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12011,CHEMBL622216,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12012,CHEMBL877481,,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12013,CHEMBL622217,,22224,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12014,CHEMBL622218,,50594,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12015,CHEMBL622219,,50597,,Pharmacokinetic profile AUC was evaluated in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12016,CHEMBL622220,,22224,,Pharmacokinetic property (Area under curve),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12017,CHEMBL622221,,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12018,CHEMBL622222,,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12019,CHEMBL622223,,50588,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12020,CHEMBL622224,,50594,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12021,CHEMBL622225,,22224,,Plasma concentration (AUC) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12022,CHEMBL622226,,22224,,Plasma concentration (AUC) was determined; Not detectable,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12023,CHEMBL624154,,50512,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
12024,CHEMBL624155,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12025,CHEMBL624156,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12026,CHEMBL624157,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12027,CHEMBL624158,,50597,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12028,CHEMBL624159,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12029,CHEMBL624160,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12030,CHEMBL624161,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12031,CHEMBL624162,,50597,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12032,CHEMBL624163,,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12033,CHEMBL624164,,50597,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12034,CHEMBL624165,,50597,,The AUC(0-infinity) values in female wistar rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12035,CHEMBL624166,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12036,CHEMBL624167,,50597,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12037,CHEMBL624168,,50597,,The AUC(0-t)values in female wistar rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12038,CHEMBL624169,,50597,,The Area under the concentration time curve of compound was measured on rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12039,CHEMBL624170,,50587,,The area under curve (100 mg/kg) administered orally in humans,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12040,CHEMBL624171,,22224,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000218,,
12041,CHEMBL624172,,22224,,The area under curve (12.5 mg/kg) administered intravenously in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12042,CHEMBL624173,,50588,,The area under curve (15 mg/kg) administered intravenously in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12043,CHEMBL877488,,50587,,The area under curve (200 mg/kg) administered orally in humans,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12044,CHEMBL624174,,50597,,The area under curve (25 mg/kg) administered intravenously in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12045,CHEMBL624175,,22224,,The area under curve (25 mg/kg) administered orally in marmoset,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000218,,
12046,CHEMBL624176,,22224,,The area under curve (25 mg/kg) administered orally in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12047,CHEMBL624177,,50588,,The area under curve (30 mg/kg) administered orally in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12048,CHEMBL624178,,50587,,The area under curve (400 mg/kg) administered orally in humans,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12049,CHEMBL624179,,50597,,The area under curve (50 mg/kg) administered orally in fasted rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12050,CHEMBL627689,,50597,,The area under curve (50 mg/kg) administered orally in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12051,CHEMBL627690,,50587,,The area under curve (800 mg/kg) administered orally in humans,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12052,CHEMBL627691,,22224,,The compound was evaluated for area under the curve,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12053,CHEMBL627692,,22224,,The compound was evaluated for area under the curve in marmosets,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000019,,
12054,CHEMBL627693,,22224,,The compound was evaluated for area under the curve in marmosets,U,9481.0,,Autocuration,,0,,A,Callithrix,,1,BAO_0000019,,
12055,CHEMBL627694,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12056,CHEMBL627695,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12057,CHEMBL627696,,22224,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12058,CHEMBL627697,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12059,CHEMBL627698,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12060,CHEMBL627699,,50597,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12061,CHEMBL627700,,50597,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12062,CHEMBL627701,,50597,,Total drug exposure is determined after oral dosing in rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12063,CHEMBL627702,,22224,,Total drug exposure (5 mg/kg) when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12064,CHEMBL627703,,22224,,Total drug exposure (5 mg/kg) when administered orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12065,CHEMBL626873,,22224,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12066,CHEMBL629583,,50597,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12067,CHEMBL629584,,50588,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12068,CHEMBL629585,,50588,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12069,CHEMBL629586,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
12070,CHEMBL629587,Brain,50597,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
12071,CHEMBL629588,,50597,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12072,CHEMBL629589,,50597,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12073,CHEMBL629590,,50597,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12074,CHEMBL629591,,50597,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12075,CHEMBL629592,,50597,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12076,CHEMBL629593,,50597,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12077,CHEMBL629594,,50597,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12078,CHEMBL629595,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12079,CHEMBL630290,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12080,CHEMBL627137,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12081,CHEMBL627138,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12082,CHEMBL627139,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12083,CHEMBL627140,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12084,CHEMBL627141,Heart,50597,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12085,CHEMBL627142,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12086,CHEMBL627143,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12087,CHEMBL874449,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12088,CHEMBL627144,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12089,CHEMBL627145,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12090,CHEMBL627146,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12091,CHEMBL627147,Kidney,50597,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12092,CHEMBL627148,Liver,50597,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12093,CHEMBL627149,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12094,CHEMBL632160,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12095,CHEMBL632161,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12096,CHEMBL632162,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12097,CHEMBL632163,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12098,CHEMBL874469,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12099,CHEMBL627182,Lung,50597,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12100,CHEMBL627183,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12101,CHEMBL627184,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12102,CHEMBL627185,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12103,CHEMBL627186,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12104,CHEMBL627187,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12105,CHEMBL627188,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12106,CHEMBL627189,Muscle tissue,50597,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12107,CHEMBL627190,,50597,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12108,CHEMBL627191,Liver,50597,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12109,CHEMBL627192,Liver,50597,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12110,CHEMBL627193,Liver,50597,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12111,CHEMBL874590,Muscle tissue,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12112,CHEMBL627194,Muscle tissue,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12113,CHEMBL627195,Muscle tissue,50597,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12114,CHEMBL627196,Female gonad,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
12115,CHEMBL627197,Female gonad,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
12116,CHEMBL627198,Female gonad,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
12117,CHEMBL627199,Female gonad,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
12118,CHEMBL627200,Female gonad,50597,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,992.0,
12119,CHEMBL627201,Plasma,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12120,CHEMBL627202,Plasma,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12121,CHEMBL627203,Plasma,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12122,CHEMBL627204,Plasma,50597,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12123,CHEMBL627205,Spleen,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12124,CHEMBL627206,Spleen,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12125,CHEMBL627207,Spleen,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12126,CHEMBL627208,Spleen,50597,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12127,CHEMBL627209,Thyroid gland,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12128,CHEMBL627210,Thyroid gland,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12129,CHEMBL627211,Thyroid gland,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12130,CHEMBL627212,Thyroid gland,50597,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12131,CHEMBL627213,Uterus,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12132,CHEMBL626599,Uterus,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12133,CHEMBL626600,Uterus,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12134,CHEMBL626601,Uterus,50597,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12135,CHEMBL627484,,22224,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12136,CHEMBL627485,Plasma,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
12137,CHEMBL628147,Plasma,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
12138,CHEMBL628148,Plasma,100710,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
12139,CHEMBL628149,Plasma,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12140,CHEMBL628150,Plasma,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12141,CHEMBL628318,Plasma,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12142,CHEMBL628319,Plasma,50588,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12143,CHEMBL875609,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12144,CHEMBL628320,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12145,CHEMBL628321,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12146,CHEMBL628322,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12147,CHEMBL628323,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12148,CHEMBL628324,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12149,CHEMBL628325,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12150,CHEMBL628326,,22224,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12151,CHEMBL628327,Adrenal medulla,50588,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12152,CHEMBL628328,Adrenal medulla,50588,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12153,CHEMBL628329,Blood,50588,,"Concentration of compound in blood of dog 1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
12154,CHEMBL628330,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12155,CHEMBL628331,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12156,CHEMBL628332,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12157,CHEMBL628333,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12158,CHEMBL628334,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12159,CHEMBL628335,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12160,CHEMBL628336,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12161,CHEMBL628337,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12162,CHEMBL628338,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12163,CHEMBL875610,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12164,CHEMBL628339,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12165,CHEMBL628340,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12166,CHEMBL628341,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12167,CHEMBL622214,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12168,CHEMBL623167,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12169,CHEMBL623168,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12170,CHEMBL623169,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12171,CHEMBL623170,Liver,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12172,CHEMBL627224,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12173,CHEMBL875634,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12174,CHEMBL627225,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12175,CHEMBL627226,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12176,CHEMBL626083,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12177,CHEMBL626084,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12178,CHEMBL626085,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12179,CHEMBL626086,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12180,CHEMBL626087,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12181,CHEMBL626088,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12182,CHEMBL626089,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12183,CHEMBL626090,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12184,CHEMBL626091,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12185,CHEMBL626092,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12186,CHEMBL626093,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12187,CHEMBL626094,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12188,CHEMBL626095,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12189,CHEMBL626096,Lung,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12190,CHEMBL626097,,22224,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12191,CHEMBL626098,,50597,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12192,CHEMBL626099,Plasma,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
12193,CHEMBL626100,Plasma,22224,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
12194,CHEMBL626101,Plasma,50588,,AUC 0-inf in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12195,CHEMBL626102,Plasma,50512,,AUC 0-inf in guinea pig,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,1969.0,
12196,CHEMBL626103,Plasma,50588,,AUC 0-t in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12197,CHEMBL628391,Plasma,50512,,AUC 0-t in guinea pig,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,1969.0,
12198,CHEMBL628392,,50597,,The compound was tested for brain to plasma partition in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12199,CHEMBL628393,,50597,,The compound was tested for brain to plasma partition in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12200,CHEMBL628394,Blood,22224,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,U,,,Autocuration,,0,,A,,,1,BAO_0000019,178.0,
12201,CHEMBL628395,,50588,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12202,CHEMBL628396,,22224,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12203,CHEMBL628397,,50592,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12204,CHEMBL628398,,50597,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12205,CHEMBL628399,,50797,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
12206,CHEMBL628400,,50588,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12207,CHEMBL874907,,50597,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12208,CHEMBL628401,,22224,,Area under curve of the compound was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12209,CHEMBL628402,Plasma,22224,,AUC in monkeys at a dose of 1 mg/kg,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
12210,CHEMBL628403,Plasma,50597,,AUC in rats at a dose of 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12211,CHEMBL628404,,22224,,Compound was evaluated for the overall absorbance loss at pH of 2,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12212,CHEMBL628405,,22224,,Compound was evaluated for the overall absorbance loss at pH of 4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12213,CHEMBL628406,,22224,,Compound was evaluated for the overall absorbance loss at pH of 7,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12214,CHEMBL628407,,50597,,Compound was evaluated for its absorption in the rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12215,CHEMBL628408,Urine,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
12216,CHEMBL629171,Urine,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
12217,CHEMBL629172,Urine,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
12218,CHEMBL629173,Urine,50597,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
12219,CHEMBL629174,,50597,,In vitro percent permeability into rat ileum,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12220,CHEMBL629175,,50597,,In vitro percent permeability into rat ileum; Range is 10-17,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12221,CHEMBL629176,,50597,,In vitro percent permeability into rat ileum; Range is 10-18,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12222,CHEMBL629177,,50597,,In vitro percent permeability into rat ileum; Range is 10-19,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12223,CHEMBL629178,,50597,,In vitro percent permeability into rat ileum; Range is 12-15,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12224,CHEMBL631869,,50597,,In vitro percent permeability into rat ileum; Range is 13-19,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12225,CHEMBL631870,,50597,,In vitro percent permeability into rat ileum; Range is 14-17,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12226,CHEMBL631871,,50597,,In vitro percent permeability into rat ileum; Range is 15-18,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12227,CHEMBL631872,,50597,,In vitro percent permeability into rat ileum; Range is 2-5,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12228,CHEMBL875775,Ileum,22224,,In vitro percent permeability into rat ileum; Range is 23-42,U,,,Autocuration,,0,,A,,,1,BAO_0000221,2116.0,
12229,CHEMBL631873,,50597,,In vitro percent permeability into rat ileum; Range is 28-36,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12230,CHEMBL631874,,50597,,In vitro percent permeability into rat ileum; Range is 29-35,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12231,CHEMBL631875,,50597,,In vitro percent permeability into rat ileum; Range is 46-66,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12232,CHEMBL631876,,50597,,In vitro percent permeability into rat ileum; Range is 50-68,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12233,CHEMBL631877,,50597,,In vitro percent permeability into rat ileum; Range is 78-81,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12234,CHEMBL631878,,50597,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12235,CHEMBL631879,,50597,,In vitro percent permeability into rat ileum; nd indicates not detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12236,CHEMBL631880,,50597,,In vitro percent permeability into rat ileum; nt indicates not detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12237,CHEMBL631881,,50597,,In vitro percent permeability into rat ileum; nt indicates not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12238,CHEMBL631882,,50597,,Compound was tested for oral absorption in bile-duct cannulated rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12239,CHEMBL630749,,50597,,Compound was tested for oral absorption in bile-duct cannulated rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12240,CHEMBL630750,,50587,,Oral absorption using Caco-2 cell monolayers.,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12241,CHEMBL630253,,50587,,Percent of the drug absorbed after administration to humans was determined,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12242,CHEMBL630254,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12243,CHEMBL630255,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12244,CHEMBL630256,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12245,CHEMBL875781,Liver,50597,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12246,CHEMBL630257,Liver,50597,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12247,CHEMBL630258,Liver,50597,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12248,CHEMBL630259,,50597,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12249,CHEMBL630260,Striatum,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
12250,CHEMBL630261,Striatum,50597,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
12251,CHEMBL630262,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12252,CHEMBL630263,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12253,CHEMBL630264,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12254,CHEMBL630265,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12255,CHEMBL630266,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12256,CHEMBL630267,Kidney,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12257,CHEMBL630268,Kidney,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12258,CHEMBL630269,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12259,CHEMBL630270,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12260,CHEMBL630141,Lung,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12261,CHEMBL630142,Lung,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12262,CHEMBL630143,Muscle tissue,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12263,CHEMBL630144,Muscle tissue,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12264,CHEMBL630145,Prostate gland,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2367.0,
12265,CHEMBL630146,Prostate gland,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2367.0,
12266,CHEMBL630147,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12267,CHEMBL630148,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12268,CHEMBL630149,,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12269,CHEMBL630150,Spleen,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12270,CHEMBL630151,Spleen,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
12271,CHEMBL632031,Thyroid gland,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12272,CHEMBL632032,Thyroid gland,50597,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12273,CHEMBL632033,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12274,CHEMBL632034,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12275,CHEMBL632035,Muscle tissue,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12276,CHEMBL632036,,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12277,CHEMBL632037,Thyroid gland,50597,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12278,CHEMBL632038,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12279,CHEMBL632039,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12280,CHEMBL632040,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12281,CHEMBL632041,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12282,CHEMBL632042,Blood,50588,,"Concentration of compound in blood of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,178.0,
12283,CHEMBL632043,,50588,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12284,CHEMBL632044,,50588,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12285,CHEMBL632045,Liver,50588,,"Concentration of compound in liver of dog 1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2107.0,
12286,CHEMBL632046,Liver,50588,,"Concentration of compound in liver of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2107.0,
12287,CHEMBL632047,Lung,50588,,"Concentration of compound in lung of dog 1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2048.0,
12288,CHEMBL632048,Lung,50588,,"Concentration of compound in lung of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2048.0,
12289,CHEMBL632049,Muscle tissue,50588,,"Concentration of compound in muscle of dog 1, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2385.0,
12290,CHEMBL876418,Muscle tissue,50588,,"Concentration of compound in muscle of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2385.0,
12291,CHEMBL632050,Spleen,50588,,"Concentration of compound in spleen of dog 1,after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2106.0,
12292,CHEMBL632051,Spleen,50588,,"Concentration of compound in spleen of dog 2, after administering intravenously",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2106.0,
12293,CHEMBL632052,,22224,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
12294,CHEMBL632053,,22224,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
12295,CHEMBL632054,,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12296,CHEMBL632055,,22224,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
12297,CHEMBL631181,,22224,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
12298,CHEMBL631182,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12299,CHEMBL631183,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12300,CHEMBL631184,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12301,CHEMBL629774,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12302,CHEMBL629775,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12303,CHEMBL876549,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12304,CHEMBL628172,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12305,CHEMBL628173,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12306,CHEMBL628174,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12307,CHEMBL628175,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12308,CHEMBL628176,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12309,CHEMBL628177,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12310,CHEMBL628178,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12311,CHEMBL628179,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12312,CHEMBL628180,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12313,CHEMBL628181,,22224,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12314,CHEMBL628182,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12315,CHEMBL628183,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12316,CHEMBL628184,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12317,CHEMBL628185,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12318,CHEMBL875617,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12319,CHEMBL628186,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12320,CHEMBL628187,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12321,CHEMBL628188,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12322,CHEMBL628189,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12323,CHEMBL628190,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12324,CHEMBL628191,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12325,CHEMBL626513,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12326,CHEMBL626514,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12327,CHEMBL626515,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12328,CHEMBL626516,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12329,CHEMBL626517,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12330,CHEMBL626518,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12331,CHEMBL626519,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12332,CHEMBL626520,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12333,CHEMBL626521,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12334,CHEMBL626522,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12335,CHEMBL626523,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12336,CHEMBL626524,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12337,CHEMBL626688,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12338,CHEMBL626689,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12339,CHEMBL626690,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12340,CHEMBL626691,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12341,CHEMBL627319,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12342,CHEMBL624052,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12343,CHEMBL624053,Thyroid gland,50597,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12344,CHEMBL624054,,50597,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12345,CHEMBL624055,,50597,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12346,CHEMBL624056,,50597,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12347,CHEMBL624057,Uterus,50597,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12348,CHEMBL622281,Uterus,50597,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12349,CHEMBL622282,Uterus,50597,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12350,CHEMBL622283,Uterus,50597,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12351,CHEMBL622284,Uterus,50597,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12352,CHEMBL622285,Uterus,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12353,CHEMBL622286,Uterus,50597,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
12354,CHEMBL622287,,22224,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12355,CHEMBL622288,,50594,,Partition coefficient (logD7.4),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12356,CHEMBL622289,,50594,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12357,CHEMBL622290,Brain,50594,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12358,CHEMBL622291,,50594,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12359,CHEMBL622292,Brain,50594,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12360,CHEMBL622293,,50594,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12361,CHEMBL622294,Brain,50594,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12362,CHEMBL622295,,50594,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12363,CHEMBL622296,Brain,50597,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
12364,CHEMBL874409,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12365,CHEMBL622297,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12366,CHEMBL622298,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12367,CHEMBL622299,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12368,CHEMBL622300,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12369,CHEMBL622301,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12370,CHEMBL622302,Plasma,50597,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12371,CHEMBL622303,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12372,CHEMBL622304,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12373,CHEMBL622305,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12374,CHEMBL622306,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12375,CHEMBL626864,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12376,CHEMBL626865,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12377,CHEMBL626866,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12378,CHEMBL626867,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12379,CHEMBL626868,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12380,CHEMBL626869,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12381,CHEMBL626870,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12382,CHEMBL626871,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12383,CHEMBL626872,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12384,CHEMBL632185,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12385,CHEMBL632186,Plasma,50597,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12386,CHEMBL629310,,22224,,Amount of acetic acid produced by the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12387,CHEMBL629311,,22224,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12388,CHEMBL629312,,50597,,Log of (Cbrain/Cblood) in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12389,CHEMBL629313,,22224,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000221,,
12390,CHEMBL629314,,22224,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000221,,
12391,CHEMBL629315,,22224,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000221,,
12392,CHEMBL629316,,22224,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),U,,,Autocuration,,0,,B,,,1,BAO_0000219,,
12393,CHEMBL629317,,22224,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000221,,
12394,CHEMBL629318,,22224,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12395,CHEMBL877497,,22224,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12396,CHEMBL629319,,22224,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12397,CHEMBL629320,,22224,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12398,CHEMBL629496,,22224,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12399,CHEMBL629497,,22224,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12400,CHEMBL629498,,22224,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12401,CHEMBL629499,,22224,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12402,CHEMBL629500,,22224,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12403,CHEMBL629501,,22224,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12404,CHEMBL629502,,22224,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12405,CHEMBL629503,,22224,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
12406,CHEMBL629504,,50588,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12407,CHEMBL629505,,22224,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12408,CHEMBL629506,,22224,,Compound was evaluated for total body clearance,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12409,CHEMBL629507,,22224,,Compound was evaluated for volume of distribution at steady state,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12410,CHEMBL877498,,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12411,CHEMBL629508,,22224,,Percentage of the diamine which is monoprotonated at pH 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12412,CHEMBL629509,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12413,CHEMBL629510,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12414,CHEMBL629511,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12415,CHEMBL629512,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12416,CHEMBL629513,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12417,CHEMBL629514,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12418,CHEMBL628447,Blood,50597,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12419,CHEMBL628448,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12420,CHEMBL628449,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12421,CHEMBL631119,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12422,CHEMBL631120,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12423,CHEMBL631121,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12424,CHEMBL874458,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12425,CHEMBL631122,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12426,CHEMBL631123,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12427,CHEMBL631124,Blood,50597,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12428,CHEMBL631125,Blood,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12429,CHEMBL631290,Blood,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12430,CHEMBL631291,Blood,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12431,CHEMBL631292,Blood,50597,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12432,CHEMBL631293,Blood,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12433,CHEMBL631294,Blood,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12434,CHEMBL631295,Blood,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12435,CHEMBL631296,Blood,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12436,CHEMBL631297,Blood,50597,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12437,CHEMBL631298,,22224,,Maximum biodistribution (Bmax) was determined.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12438,CHEMBL631299,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12439,CHEMBL631300,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12440,CHEMBL631301,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12441,CHEMBL630291,,50594,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12442,CHEMBL630292,,22224,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12443,CHEMBL630293,,22224,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12444,CHEMBL630294,,22224,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12445,CHEMBL630295,,22224,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12446,CHEMBL630296,,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12447,CHEMBL626782,,22224,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12448,CHEMBL626783,,22224,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12449,CHEMBL626784,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12450,CHEMBL626785,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12451,CHEMBL626786,,22224,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12452,CHEMBL626787,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12453,CHEMBL626788,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12454,CHEMBL625927,,22224,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12455,CHEMBL625928,Blood,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12456,CHEMBL625929,Blood,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12457,CHEMBL625930,Blood,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12458,CHEMBL625931,Blood,50597,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12459,CHEMBL627230,Blood,50597,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12460,CHEMBL627231,Blood,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12461,CHEMBL627232,Blood,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12462,CHEMBL627233,Blood,50597,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12463,CHEMBL875470,Blood,50597,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12464,CHEMBL627234,Blood,50597,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12465,CHEMBL627235,Blood,50597,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12466,CHEMBL627236,Blood,50597,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12467,CHEMBL627237,Blood,50597,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12468,CHEMBL627238,Blood,50597,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12469,CHEMBL627239,Blood,50597,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12470,CHEMBL627240,Blood,50597,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12471,CHEMBL627241,Blood,50597,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12472,CHEMBL627242,Blood,50597,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12473,CHEMBL627243,Blood,50597,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12474,CHEMBL627244,Blood,50597,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12475,CHEMBL627245,Blood,50597,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12476,CHEMBL627246,Blood,50597,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12477,CHEMBL627247,Blood,50597,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12478,CHEMBL627248,Blood,50597,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12479,CHEMBL627249,Blood,50597,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12480,CHEMBL625569,Blood,50597,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12481,CHEMBL625570,Blood,50597,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12482,CHEMBL625571,Blood,50597,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12483,CHEMBL625572,Blood,50597,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12484,CHEMBL625573,Blood,50597,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12485,CHEMBL625574,Blood,50597,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12486,CHEMBL626245,Blood,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12487,CHEMBL626246,Blood,50597,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12488,CHEMBL626247,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12489,CHEMBL626248,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12490,CHEMBL626249,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12491,CHEMBL626420,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12492,CHEMBL626421,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12493,CHEMBL626422,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12494,CHEMBL626423,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12495,CHEMBL626424,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12496,CHEMBL626425,,50588,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12497,CHEMBL875476,,50597,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12498,CHEMBL626426,,100710,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
12499,CHEMBL626427,,22224,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12500,CHEMBL626428,,22224,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12501,CHEMBL626429,,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12502,CHEMBL625025,Urine,22224,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
12503,CHEMBL625026,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12504,CHEMBL625027,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12505,CHEMBL874410,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12506,CHEMBL625028,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12507,CHEMBL625029,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12508,CHEMBL625030,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12509,CHEMBL625031,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12510,CHEMBL625032,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12511,CHEMBL625033,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12512,CHEMBL625034,Blood,50597,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12513,CHEMBL624872,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12514,CHEMBL624873,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12515,CHEMBL624874,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12516,CHEMBL624875,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12517,CHEMBL624876,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12518,CHEMBL624877,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12519,CHEMBL624878,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12520,CHEMBL624879,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12521,CHEMBL624880,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12522,CHEMBL624881,Heart,50597,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12523,CHEMBL624882,Heart,50597,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12524,CHEMBL624883,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12525,CHEMBL624884,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12526,CHEMBL624885,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12527,CHEMBL624886,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12528,CHEMBL624887,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12529,CHEMBL624888,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12530,CHEMBL624889,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12531,CHEMBL624890,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12532,CHEMBL621964,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12533,CHEMBL621965,Kidney,50597,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12534,CHEMBL621966,Liver,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12535,CHEMBL621967,Liver,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12536,CHEMBL622164,Liver,50597,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12537,CHEMBL623097,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12538,CHEMBL623098,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12539,CHEMBL623099,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12540,CHEMBL623100,,22224,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12541,CHEMBL628673,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12542,CHEMBL628674,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12543,CHEMBL628675,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12544,CHEMBL627644,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12545,CHEMBL627645,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12546,CHEMBL627646,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12547,CHEMBL627647,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12548,CHEMBL627648,,50597,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12549,CHEMBL627649,,50597,,Free level in rat plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12550,CHEMBL628313,,22224,,Level reaching in blood plasma of rat or human was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12551,CHEMBL628314,,50597,,Log (Cbrain/Cblood) in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12552,CHEMBL628315,,22224,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12553,CHEMBL628316,,22224,,Mean percentage of compound transport through membrane; expressed as membrane transport,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12554,CHEMBL628317,,22224,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12555,CHEMBL628473,,22224,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12556,CHEMBL628474,,22224,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12557,CHEMBL628475,,22224,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12558,CHEMBL628476,,22224,,Net water uptake by a carrier mediated transport (%cm) mechanism,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12559,CHEMBL628477,,22224,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12560,CHEMBL628478,,50506,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
12561,CHEMBL628479,,50506,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
12562,CHEMBL628480,,22224,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12563,CHEMBL628481,,22224,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12564,CHEMBL628482,,50597,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12565,CHEMBL628483,,50597,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12566,CHEMBL628484,Plasma,50597,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12567,CHEMBL628485,Plasma,50597,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12568,CHEMBL628486,Plasma,100710,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
12569,CHEMBL628487,Plasma,50587,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
12570,CHEMBL628488,Plasma,50597,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12571,CHEMBL628489,Plasma,50597,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12572,CHEMBL628490,Plasma,50597,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12573,CHEMBL628491,,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
12574,CHEMBL877507,,100710,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
12575,CHEMBL628492,,22224,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12576,CHEMBL628493,,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
12577,CHEMBL628494,,22224,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
12578,CHEMBL628495,,22224,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000019,,
12579,CHEMBL628496,,50587,,Permeability in Caco-2 assay at 10E-6,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12580,CHEMBL628497,Brain,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,U,,,Autocuration,,0,,A,,,1,BAO_0000218,955.0,
12581,CHEMBL628498,Brain,22224,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,U,,,Autocuration,,0,,A,,,1,BAO_0000218,955.0,
12582,CHEMBL628499,,22224,,Plasma protein binding was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12583,CHEMBL627656,,22224,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12584,CHEMBL627657,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12585,CHEMBL626808,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12586,CHEMBL626809,,22224,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12587,CHEMBL626810,,22224,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12588,CHEMBL626811,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12589,CHEMBL874465,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12590,CHEMBL626812,,22224,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12591,CHEMBL626813,,22224,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12592,CHEMBL626814,,22224,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12593,CHEMBL626815,,22224,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12594,CHEMBL628566,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12595,CHEMBL628567,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12596,CHEMBL628568,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12597,CHEMBL628569,,50588,,C max in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12598,CHEMBL628570,,50512,,C max in guinea pig,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
12599,CHEMBL628571,,22224,,C max value was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12600,CHEMBL628572,,22224,,Cmax value after oral dose of 0.1 mg//kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12601,CHEMBL628573,,22224,,Cmax value after oral dose of 0.3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12602,CHEMBL628574,,22224,,Cmax value after oral dose of 1 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12603,CHEMBL628575,,22224,,Cmax value after oral dose of 10 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12604,CHEMBL628576,,22224,,Cmax value after oral dose of 23.4 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12605,CHEMBL628577,,22224,,Cmax value after oral dose of 3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12606,CHEMBL628578,,22224,,Cmax value after oral dose of 3.87 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12607,CHEMBL874466,,50588,,Cmax value in female Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12608,CHEMBL628579,,50597,,Cmax value in male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12609,CHEMBL628580,Plasma,50597,,Cmax value in rat plasma when administered 20 mg/kg perorally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12610,CHEMBL628581,Plasma,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12611,CHEMBL628582,Plasma,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12612,CHEMBL628583,,50588,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12613,CHEMBL625782,,22224,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12614,CHEMBL625783,,50592,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12615,CHEMBL625784,,50597,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12616,CHEMBL625785,Plasma,50797,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
12617,CHEMBL625786,,50597,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12618,CHEMBL874467,,22224,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12619,CHEMBL625787,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12620,CHEMBL625964,,50677,,cytotoxicity against HIV protease enzyme.,N,12721.0,,Intermediate,,1,,A,Human immunodeficiency virus,,1,BAO_0000218,,
12621,CHEMBL625965,,50594,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12622,CHEMBL625966,,50594,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12623,CHEMBL625967,Plasma,50588,,The plasma clearance in dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12624,CHEMBL625968,Plasma,50597,,The plasma clearance in rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12625,CHEMBL625969,Plasma,50597,,Clearance from plasma in male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12626,CHEMBL625970,Plasma,100710,,Clearance from plasma in male cynomolgus monkeys,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,1969.0,
12627,CHEMBL625971,Plasma,50588,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12628,CHEMBL625972,Plasma,50588,,Clearance of compound in dog plasma,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12629,CHEMBL625973,Plasma,50587,,Clearance of compound in human plasma,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
12630,CHEMBL625974,,50588,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12631,CHEMBL625975,,50588,,Clearance of compound when administered intravenously as an individual dose to a single dog.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12632,CHEMBL625976,Plasma,50588,,"Clearance (10 mg/kg, intravenously) in dog plasma",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12633,CHEMBL625977,,50588,,Clearance value in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12634,CHEMBL625978,,50512,,Clearance value in guinea pig,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
12635,CHEMBL874468,,50597,,Clearance values in rats after iv administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12636,CHEMBL625421,Plasma,22224,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
12637,CHEMBL625422,,50592,,In vivo clearance (5 mg/kg) was determined in rabbits,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12638,CHEMBL625423,,50597,,Plasma Clearance rate was determined for the compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12639,CHEMBL625424,,22224,,Plasma Clearance rate was determined for the compound in squirrel monkeys,U,9520.0,,Autocuration,,0,,A,Saimiri,,1,BAO_0000218,,
12640,CHEMBL625425,,50597,,Plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12641,CHEMBL625426,,22224,,Plasma clearance of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12642,CHEMBL625427,,50512,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
12643,CHEMBL625428,,50512,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
12644,CHEMBL625429,,22224,,Plasma clearance was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12645,CHEMBL625430,,50588,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12646,CHEMBL625431,,50597,,Plasma clearance rate was determined for the compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12647,CHEMBL627307,,22224,,Plasma clearance rate was determined for the compound in squirrel monkeys,U,9520.0,,Autocuration,,0,,A,Saimiri,,1,BAO_0000218,,
12648,CHEMBL627308,,22224,,Slow clearance (CL) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12649,CHEMBL627309,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12650,CHEMBL627310,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12651,CHEMBL627311,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12652,CHEMBL627312,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12653,CHEMBL627313,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12654,CHEMBL627314,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12655,CHEMBL627315,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12656,CHEMBL627316,,22224,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12657,CHEMBL627317,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12658,CHEMBL627318,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12659,CHEMBL627999,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12660,CHEMBL628000,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12661,CHEMBL628001,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12662,CHEMBL628002,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12663,CHEMBL625610,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12664,CHEMBL625611,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12665,CHEMBL625612,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12666,CHEMBL625613,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12667,CHEMBL875479,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12668,CHEMBL625614,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12669,CHEMBL625615,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12670,CHEMBL626302,,22224,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12671,CHEMBL626303,Blood,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12672,CHEMBL627420,Blood,50597,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12673,CHEMBL627421,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12674,CHEMBL625695,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12675,CHEMBL625696,,50597,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12676,CHEMBL875606,Brain,50594,,Distribution of compound in mice brain was measured after 1 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12677,CHEMBL625697,Brain,50594,,Distribution of compound in mice brain was measured after 24 hr r,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12678,CHEMBL625698,Brain,50594,,Distribution of compound in mice brain was measured after 2 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12679,CHEMBL625699,Brain,50594,,Distribution of compound in mice brain was measured after 3 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12680,CHEMBL625700,Brain,50594,,Distribution of compound in mice brain was measured after 6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
12681,CHEMBL625701,,50594,,Distribution of compound in mice liver was measured after 1 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12682,CHEMBL625702,,50594,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12683,CHEMBL625703,,50594,,Distribution of compound in mice liver was measured after 2 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12684,CHEMBL625704,,50594,,Distribution of compound in mice liver was measured after 3 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12685,CHEMBL625705,,50594,,Distribution of compound in mice liver was measured after 6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12686,CHEMBL625706,Adrenal medulla,50588,,Distribution in dog adrenal medulla 30 min after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12687,CHEMBL625707,Adrenal medulla,50588,,Distribution in dog adrenal medulla 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12688,CHEMBL625708,,50588,,Distribution in female dog Ovary 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12689,CHEMBL625709,,50588,,Distribution in female dog Ovary 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12690,CHEMBL624180,,50588,,Distribution in female dog adipose 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12691,CHEMBL624181,,50588,,Distribution in female dog adipose 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12692,CHEMBL624182,Adrenal cortex,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1235.0,
12693,CHEMBL624183,Adrenal cortex,50588,,Distribution in female dog adrenal cortex 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1235.0,
12694,CHEMBL624184,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12695,CHEMBL877489,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12696,CHEMBL624185,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12697,CHEMBL624186,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12698,CHEMBL624187,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12699,CHEMBL624188,Liver,50597,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12700,CHEMBL624189,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12701,CHEMBL624190,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12702,CHEMBL624191,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12703,CHEMBL624192,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12704,CHEMBL624193,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12705,CHEMBL624194,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12706,CHEMBL624891,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12707,CHEMBL624892,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12708,CHEMBL624893,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12709,CHEMBL627632,Lung,50597,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12710,CHEMBL627633,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12711,CHEMBL627634,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12712,CHEMBL627635,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12713,CHEMBL627636,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12714,CHEMBL626816,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12715,CHEMBL626817,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12716,CHEMBL626818,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12717,CHEMBL626819,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12718,CHEMBL626820,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12719,CHEMBL626821,,50597,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12720,CHEMBL626822,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12721,CHEMBL626823,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12722,CHEMBL626824,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12723,CHEMBL626825,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12724,CHEMBL626826,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12725,CHEMBL626827,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12726,CHEMBL626828,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12727,CHEMBL626829,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12728,CHEMBL626830,Thyroid gland,50597,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12729,CHEMBL627150,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12730,CHEMBL627151,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12731,CHEMBL627152,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12732,CHEMBL627153,,50597,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12733,CHEMBL627154,,22224,,Rate of acetate production by the compound was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12734,CHEMBL627155,,22224,,Rate of acetate production by the compound was determined; Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12735,CHEMBL627156,,22224,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12736,CHEMBL627157,,22224,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12737,CHEMBL627158,,50592,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12738,CHEMBL627159,Plasma,50592,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1969.0,
12739,CHEMBL627160,,50594,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12740,CHEMBL628540,,50597,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12741,CHEMBL628541,Plasma,50597,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12742,CHEMBL628542,Plasma,50597,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12743,CHEMBL628543,,22229,,Solubility after at a pH 1.2,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12744,CHEMBL628544,,22229,,Solubility after at pH 1.2,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12745,CHEMBL628545,,22229,,Solubility after injection of water,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12746,CHEMBL628546,,22224,,Statistical significance of IC 50 values; Expressed as R value,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12747,CHEMBL874455,,22224,,Systemic availability with respect to methyldopa was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12748,CHEMBL628547,,50597,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12749,CHEMBL628548,Plasma,50597,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12750,CHEMBL628549,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12751,CHEMBL628550,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12752,CHEMBL628551,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12753,CHEMBL628552,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12754,CHEMBL628553,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12755,CHEMBL628554,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12756,CHEMBL628555,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12757,CHEMBL628556,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12758,CHEMBL628557,Kidney,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,2113.0,
12759,CHEMBL628558,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12760,CHEMBL628559,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12761,CHEMBL628560,Feces,50592,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12762,CHEMBL874456,Urine,50592,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12763,CHEMBL628561,Feces,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12764,CHEMBL628562,Feces,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12765,CHEMBL628563,Urine,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12766,CHEMBL628564,Urine,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12767,CHEMBL628565,Urine,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12768,CHEMBL631248,Urine,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12769,CHEMBL631249,Urine,50592,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
12770,CHEMBL627214,Kidney,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,2113.0,
12771,CHEMBL874591,Feces,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12772,CHEMBL627215,Feces,50592,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12773,CHEMBL625471,Feces,50592,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
12774,CHEMBL625472,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12775,CHEMBL625473,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12776,CHEMBL625474,,50588,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12777,CHEMBL625475,,50588,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12778,CHEMBL625476,,50597,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12779,CHEMBL625477,,50597,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12780,CHEMBL625478,,50597,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12781,CHEMBL625479,esophageal tunica muscularis mucosae,50597,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12782,CHEMBL625480,esophageal tunica muscularis mucosae,50597,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12783,CHEMBL625481,Plasma,50597,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12784,CHEMBL625482,,50597,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12785,CHEMBL625483,,50597,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12786,CHEMBL625484,,50597,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12787,CHEMBL625485,,50597,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12788,CHEMBL625486,Plasma,50588,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12789,CHEMBL625487,Plasma,50597,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12790,CHEMBL625488,Plasma,50597,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12791,CHEMBL625489,Plasma,50597,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12792,CHEMBL625490,Plasma,50597,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12793,CHEMBL625491,Plasma,50588,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
12794,CHEMBL625492,Plasma,50597,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
12795,CHEMBL625493,Plasma,50587,,plasma clearance in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1969.0,
12796,CHEMBL625494,,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12797,CHEMBL625495,,50597,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12798,CHEMBL625496,,50597,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12799,CHEMBL625497,,22229,,1-Octanol/water partition coefficient measured at 7.4,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12800,CHEMBL625498,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12801,CHEMBL625499,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12802,CHEMBL625500,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12803,CHEMBL625501,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12804,CHEMBL625502,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12805,CHEMBL625503,,22229,,Calculated partition coefficient (clogP) (relative to BAY K 8644),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12806,CHEMBL625504,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12807,CHEMBL625505,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12808,CHEMBL625506,,22229,,Calculated partition coefficient of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12809,CHEMBL625507,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12810,CHEMBL625508,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12811,CHEMBL625509,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12812,CHEMBL625510,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12813,CHEMBL883125,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12814,CHEMBL625511,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12815,CHEMBL874650,,22224,,Partition coefficient of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12816,CHEMBL625512,,22224,,Partition coefficient of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12817,CHEMBL625513,,22224,,Partition coefficient of compound was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12818,CHEMBL625514,,22224,,Partition coefficient was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12819,CHEMBL625515,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12820,CHEMBL625516,,22229,,partition coefficient of compound was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12821,CHEMBL625517,,50588,,The total body administered intravenously in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12822,CHEMBL625518,,50597,,The total body administered intravenously in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12823,CHEMBL625519,,50594,,Time taken for the administration to female NIH mice weighing 25-30 g.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
12824,CHEMBL625520,,22224,,Time taken for the administration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12825,CHEMBL874651,,50588,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12826,CHEMBL625521,,22224,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
12827,CHEMBL623171,,50592,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12828,CHEMBL623853,,50597,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12829,CHEMBL623854,,22224,,Plasma clearance for the compound was determined.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12830,CHEMBL874405,,22224,,CLog P value of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12831,CHEMBL623855,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12832,CHEMBL623856,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12833,CHEMBL623857,,22224,,ClogP value of the compound; nd ='no data',U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12834,CHEMBL623858,,22224,,ClogP value of the compound; nd ='not determined',U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12835,CHEMBL623859,,22224,,CLog P was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12836,CHEMBL839829,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12837,CHEMBL623860,,22224,,CLogP was calculated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12838,CHEMBL623861,,22224,,CLogP value was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12839,CHEMBL623862,,22224,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12840,CHEMBL874406,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12841,CHEMBL623863,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12842,CHEMBL624021,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12843,CHEMBL624022,Adrenal medulla,50588,,Distribution in female dog adrenal medulla 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12844,CHEMBL624023,Adrenal medulla,50588,,Distribution in female dog adrenal medulla 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1236.0,
12845,CHEMBL624024,,50588,,Distribution in female dog bile 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12846,CHEMBL624025,,50588,,Distribution in female dog bile 72 hr after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12847,CHEMBL624026,,50588,,Distribution in female dog blood 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12848,CHEMBL624027,,50588,,Distribution in female dog blood 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12849,CHEMBL624028,,50588,,Distribution in female dog heart 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12850,CHEMBL624029,,50588,,Distribution in female dog heart 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12851,CHEMBL624030,,50588,,Distribution in female dog kidney 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12852,CHEMBL624031,,50588,,Distribution in female dog kidney 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12853,CHEMBL624032,Intestine,50588,,Distribution in female dog large intestine 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,160.0,
12854,CHEMBL874407,Intestine,50588,,Distribution in female dog large intestine 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,160.0,
12855,CHEMBL624033,,50588,,Distribution in female dog liver 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12856,CHEMBL624034,,50588,,Distribution in female dog liver 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12857,CHEMBL624035,,50588,,Distribution in female dog lung 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12858,CHEMBL624036,,50588,,Distribution in female dog lung 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12859,CHEMBL624037,Muscle tissue,50588,,Distribution in female dog muscle 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2385.0,
12860,CHEMBL624038,Muscle tissue,50588,,Distribution in female dog muscle 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2385.0,
12861,CHEMBL624039,,50588,,Distribution in female dog pancreas 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12862,CHEMBL624040,,50588,,Distribution in female dog pancreas 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12863,CHEMBL624041,Intestine,50588,,Distribution in female dog small intestine 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,160.0,
12864,CHEMBL624042,Intestine,50588,,Distribution in female dog small intestine 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,160.0,
12865,CHEMBL624043,Spleen,50588,,Distribution in female dog spleen 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2106.0,
12866,CHEMBL624044,Spleen,50588,,Distribution in female dog spleen 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2106.0,
12867,CHEMBL624045,Stomach,50588,,Distribution in female dog stomach 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,945.0,
12868,CHEMBL624046,Stomach,50588,,Distribution in female dog stomach 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,945.0,
12869,CHEMBL624047,Thyroid gland,50588,,Distribution in female dog thyroid 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2046.0,
12870,CHEMBL624048,Thyroid gland,50588,,Distribution in female dog thyroid 72 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2046.0,
12871,CHEMBL874408,Urine,50588,,Distribution in female dog urine 24 hours after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
12872,CHEMBL624049,Urine,50588,,Distribution in female dog urine 72 hr after administration.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
12873,CHEMBL624050,Plasma,22224,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
12874,CHEMBL624051,,22224,,Plasma concentration at 7 hr after intravenous dosing,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12875,CHEMBL623278,,50597,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12876,CHEMBL623279,,50597,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12877,CHEMBL623280,,50597,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12878,CHEMBL623963,,50597,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12879,CHEMBL623964,,50597,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12880,CHEMBL623965,,50597,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12881,CHEMBL623966,,50597,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12882,CHEMBL874415,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12883,CHEMBL623967,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12884,CHEMBL623968,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12885,CHEMBL623969,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12886,CHEMBL628409,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12887,CHEMBL628410,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12888,CHEMBL628411,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12889,CHEMBL628412,,50597,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12890,CHEMBL628413,,22224,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12891,CHEMBL628414,Plasma,22224,,The concentration in plasmat; Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1969.0,
12892,CHEMBL628415,,50597,,Tissue level at 10 mg/kg/po in wistar rats in blood,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12893,CHEMBL628416,,50597,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12894,CHEMBL628417,,50597,,Tissue level at 10 mg/kg/po in wistar rats in heart,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12895,CHEMBL874908,Liver,50597,,Tissue level at 10 mg/kg/po in wistar rats in liver,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12896,CHEMBL628418,,50597,,Tissue level at 10 mg/kg/po in wistar rats in plasma,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12897,CHEMBL628419,Muscle tissue,50597,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
12898,CHEMBL628420,,50597,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12899,CHEMBL628421,,22224,,Water solubility at 37 degree C.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12900,CHEMBL626726,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12901,CHEMBL626727,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12902,CHEMBL626728,Blood,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12903,CHEMBL626729,Blood,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12904,CHEMBL626730,Blood,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12905,CHEMBL626731,Blood,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12906,CHEMBL626732,Blood,50597,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
12907,CHEMBL626733,Heart,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12908,CHEMBL626734,Heart,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12909,CHEMBL626735,Heart,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12910,CHEMBL874909,Heart,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12911,CHEMBL626736,Heart,50597,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
12912,CHEMBL626737,Kidney,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12913,CHEMBL630999,Kidney,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12914,CHEMBL631000,Kidney,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12915,CHEMBL631001,Kidney,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12916,CHEMBL631002,Kidney,50597,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
12917,CHEMBL631003,Liver,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12918,CHEMBL631004,Liver,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12919,CHEMBL631005,Liver,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12920,CHEMBL631006,Liver,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12921,CHEMBL631007,Liver,50597,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
12922,CHEMBL631008,Lung,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12923,CHEMBL631009,Lung,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12924,CHEMBL631010,Lung,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12925,CHEMBL631011,Lung,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12926,CHEMBL631012,Lung,50597,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
12927,CHEMBL630271,Thyroid gland,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12928,CHEMBL630272,Thyroid gland,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12929,CHEMBL630273,Thyroid gland,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12930,CHEMBL630274,Thyroid gland,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12931,CHEMBL630275,Thyroid gland,50597,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
12932,CHEMBL875782,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12933,CHEMBL630276,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12934,CHEMBL630277,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12935,CHEMBL630278,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12936,CHEMBL630279,,50597,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12937,CHEMBL630280,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12938,CHEMBL630281,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12939,CHEMBL630282,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12940,CHEMBL630283,,50592,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12941,CHEMBL630284,,22224,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12942,CHEMBL630285,,22224,,Alkylating activity was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12943,CHEMBL630286,,22224,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),U,,,Autocuration,,0,,A,,,1,BAO_0000251,,
12944,CHEMBL630069,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12945,CHEMBL630070,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12946,CHEMBL630071,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12947,CHEMBL630072,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12948,CHEMBL875110,,50592,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12949,CHEMBL630073,,50597,,Compound was tested for antidiuretic activity in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12950,CHEMBL630074,,22224,,Compound was tested for inactivation kinetic values,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12951,CHEMBL630075,,22224,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
12952,CHEMBL630076,,22224,,Dissociation rate calculated from the first-order equation using the t1/2 value,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12953,CHEMBL630077,,22229,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12954,CHEMBL630078,,22229,,Aqueous solubility was measured,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12955,CHEMBL630079,,22229,,Aqueous solubility was measured at a pH 4,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12956,CHEMBL630080,,22229,,Aqueous solubility (pH 7),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12957,CHEMBL630081,,22229,,Aqueous solubility was measured at a pH 9,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12958,CHEMBL630082,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12959,CHEMBL630083,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12960,CHEMBL630084,,22224,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12961,CHEMBL629198,,22229,,Aqueous solubility of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12962,CHEMBL629199,,22229,,Aqueous solubility at 37 degree Celsius at pH 7.38,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12963,CHEMBL629200,,22229,,Aqueous solubility in pH 7.4 phosphate buffer,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12964,CHEMBL629201,,50588,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12965,CHEMBL629202,,50588,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
12966,CHEMBL875111,,50587,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12967,CHEMBL629203,,50587,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12968,CHEMBL629204,,50587,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12969,CHEMBL629205,,50587,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12970,CHEMBL629206,,50587,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
12971,CHEMBL631185,,22224,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12972,CHEMBL631186,,50597,,Compound was evaluated for the average bile flow rat in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
12973,CHEMBL631187,,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12974,CHEMBL631188,,50592,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
12975,CHEMBL876419,,22224,,Average half life period was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12976,CHEMBL631189,,22224,,Average half life period was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12977,CHEMBL631190,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12978,CHEMBL631191,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12979,CHEMBL631192,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12980,CHEMBL632400,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12981,CHEMBL630564,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12982,CHEMBL630565,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12983,CHEMBL630566,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12984,CHEMBL631229,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12985,CHEMBL631230,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
12986,CHEMBL876428,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12987,CHEMBL631231,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12988,CHEMBL631232,,22229,,Calculated partition coefficient (clogP) (MacLogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12989,CHEMBL631233,,22224,,Hydrophilicity was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12990,CHEMBL631234,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12991,CHEMBL883126,,22224,,Increased absorption was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12992,CHEMBL631235,,22224,,Lipophilicity value was evaluated,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12993,CHEMBL631236,,22224,,Log P value of the compound.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12994,CHEMBL631237,,22224,,Partition coefficient of compound was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12995,CHEMBL631238,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12996,CHEMBL876429,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12997,CHEMBL631414,,22224,,Partition coefficient was measured by medchem software; Not calculated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
12998,CHEMBL631415,,22224,,Partition coefficient was measured by octanol-water using standard shake-flask method,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
12999,CHEMBL631416,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13000,CHEMBL631417,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13001,CHEMBL631418,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13002,CHEMBL631419,,22229,,The Octanol/Water partition coefficient CLogP,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13003,CHEMBL631420,,22224,,The pharmacokinetic parameter C Log p was reported,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13004,CHEMBL631421,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13005,CHEMBL631422,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13006,CHEMBL631423,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13007,CHEMBL876430,Plasma,50597,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13008,CHEMBL631424,Plasma,50597,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13009,CHEMBL631425,Plasma,50588,,Compound was administered intravenously in dog to evaluate plasma clearance values,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
13010,CHEMBL631426,Plasma,22224,,Compound was administered intravenously in monkey to evaluate plasma clearance values,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
13011,CHEMBL631427,Plasma,50594,,Compound was administered intravenously in mouse to evaluate plasma clearance values,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1969.0,
13012,CHEMBL631428,Plasma,50588,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
13013,CHEMBL631429,Liver,50797,,Intrinsic clearance in Rhesus liver microsome,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,2107.0,
13014,CHEMBL631430,Liver,50588,,Intrinsic clearance in dog liver microsome,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,2107.0,
13015,CHEMBL631431,Liver,50597,,Intrinsic clearance in rat liver microsome,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13016,CHEMBL631432,Plasma,50797,,Low plasma clearance was calculated in rhesus monkey,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,1969.0,
13017,CHEMBL631433,,50588,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13018,CHEMBL631434,,22224,,Plasma clearance after intravenous dose of 0.3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13019,CHEMBL631435,,22224,,Plasma clearance after intravenous dose of 1 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13020,CHEMBL631436,,22224,,Plasma clearance after intravenous dose of 3 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13021,CHEMBL631437,,22224,,Plasma clearance after intravenous dose of 3.87 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13022,CHEMBL631438,,50597,,Plasma clearance after peroral administration at 10 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13023,CHEMBL876431,,50797,,Plasma clearance after peroral administration at 10 mpk in Rhesus,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
13024,CHEMBL631439,,50588,,Plasma clearance after peroral administration at 10 mpk in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13025,CHEMBL631440,,50597,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13026,CHEMBL631441,,22224,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13027,CHEMBL631442,,22224,,Critical Micellar concentration was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13028,CHEMBL626525,,22224,,Critical Micellar concentration of the compound. was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13029,CHEMBL627168,,22224,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13030,CHEMBL875618,,22224,,Critical micellar concentration was measured in water by the dye solubilization method,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13031,CHEMBL626612,,22224,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
13032,CHEMBL626613,,22224,,CMR value (relative to BAY K 8644),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13033,CHEMBL626614,,22224,,Carbamoylating activity was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13034,CHEMBL626615,,22224,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
13035,CHEMBL626616,,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13036,CHEMBL626617,,22224,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13037,CHEMBL626618,Plasma,50588,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
13038,CHEMBL626619,Plasma,50597,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13039,CHEMBL626620,,50588,,"Clearance rate at 0.46 mg/kg, iv, in dogs",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13040,CHEMBL626621,,50597,,"Clearance rate at 5.5 mg/kg, iv, in rat",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13041,CHEMBL626622,,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
13042,CHEMBL626623,,100710,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
13043,CHEMBL626624,,50588,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13044,CHEMBL626625,,50597,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13045,CHEMBL626626,Liver,50597,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13046,CHEMBL626627,,22224,,Tested for the total clearance of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13047,CHEMBL626628,,50588,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13048,CHEMBL626629,,22224,,Total body clearance was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13049,CHEMBL626630,,50597,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13050,CHEMBL626631,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13051,CHEMBL626632,,22229,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13052,CHEMBL626633,,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13053,CHEMBL626634,,22229,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13054,CHEMBL626635,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13055,CHEMBL626636,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13056,CHEMBL626637,,22229,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13057,CHEMBL626638,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13058,CHEMBL626639,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13059,CHEMBL626640,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13060,CHEMBL626641,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13061,CHEMBL627272,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13062,CHEMBL627273,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13063,CHEMBL627441,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13064,CHEMBL628355,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13065,CHEMBL628356,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13066,CHEMBL628357,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13067,CHEMBL628358,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13068,CHEMBL622307,,50339,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),N,4754.0,,Intermediate,,1,,A,Pneumocystis carinii,,1,BAO_0000218,,
13069,CHEMBL622527,,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13070,CHEMBL622528,,22224,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13071,CHEMBL622529,,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13072,CHEMBL622992,,22224,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13073,CHEMBL622993,,22224,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13074,CHEMBL622994,,22224,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13075,CHEMBL622995,,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13076,CHEMBL622996,,50597,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13077,CHEMBL622997,,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13078,CHEMBL622998,,50597,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13079,CHEMBL622999,,22224,,Cp max following ip administration at 1 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13080,CHEMBL623000,Plasma,22224,,Maximum concentration in plasma was reported at 0.5 hour,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
13081,CHEMBL623001,Plasma,22224,,Maximum concentration in plasma was reported at 2 hour,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
13082,CHEMBL623002,,50594,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13083,CHEMBL623003,,22229,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13084,CHEMBL623004,,22224,,Steady state concentration was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13085,CHEMBL623005,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13086,CHEMBL623006,,22224,,Partition coefficient (logD7.4),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13087,CHEMBL623007,Liver,50597,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13088,CHEMBL623008,Bone,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
13089,CHEMBL876654,Cerebellum,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13090,CHEMBL623009,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13091,CHEMBL623010,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13092,CHEMBL623011,Heart,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13093,CHEMBL623012,Intestine,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
13094,CHEMBL623013,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13095,CHEMBL623014,,22224,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13096,CHEMBL623015,Urine,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13097,CHEMBL623016,Urine,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13098,CHEMBL624858,Urine,22224,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13099,CHEMBL624859,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13100,CHEMBL624860,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13101,CHEMBL624861,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13102,CHEMBL624862,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13103,CHEMBL624863,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13104,CHEMBL876655,,50597,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13105,CHEMBL624864,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13106,CHEMBL624865,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13107,CHEMBL624866,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13108,CHEMBL624867,,50588,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,N,9615.0,,Expert,,1,,F,Canis lupus familiaris,,1,BAO_0000218,,
13109,CHEMBL624868,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13110,CHEMBL628450,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13111,CHEMBL628451,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13112,CHEMBL628452,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13113,CHEMBL628453,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13114,CHEMBL628454,,50588,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13115,CHEMBL628455,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13116,CHEMBL628456,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13117,CHEMBL628457,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13118,CHEMBL877505,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13119,CHEMBL628458,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13120,CHEMBL628459,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13121,CHEMBL628460,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13122,CHEMBL628461,,50588,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13123,CHEMBL628462,,22224,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",U,,,Autocuration,,0,,B,,,1,BAO_0000218,,
13124,CHEMBL628463,,50588,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13125,CHEMBL625666,,50597,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",N,10116.0,,Expert,,1,,F,Rattus norvegicus,,1,BAO_0000218,,
13126,CHEMBL625667,,22224,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,U,,,Autocuration,,0,,B,,,1,BAO_0000218,,
13127,CHEMBL625668,,50597,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,10116.0,,Expert,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13128,CHEMBL625669,,50597,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13129,CHEMBL625670,,22224,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13130,CHEMBL625671,,50597,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13131,CHEMBL625672,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13132,CHEMBL625673,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13133,CHEMBL625674,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13134,CHEMBL625675,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13135,CHEMBL627637,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13136,CHEMBL627638,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13137,CHEMBL627639,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13138,CHEMBL627640,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13139,CHEMBL627641,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13140,CHEMBL627642,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13141,CHEMBL877506,,50602,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
13142,CHEMBL627275,,50594,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13143,CHEMBL627643,,50506,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13144,CHEMBL631246,,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13145,CHEMBL631247,,50506,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13146,CHEMBL629532,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13147,CHEMBL629533,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13148,CHEMBL629534,,50506,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13149,CHEMBL629535,,50506,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,N,9669.0,,Intermediate,,1,,A,Mustela putorius furo,,1,BAO_0000218,,
13150,CHEMBL625932,,22224,,Pharmacokinetic parameter :drug bound to plasma was reported,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13151,CHEMBL625933,,22224,,compound was evaluated for drug bound in plasma,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13152,CHEMBL625934,,50597,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13153,CHEMBL625935,,22224,,Bioavailability,U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
13154,CHEMBL625936,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13155,CHEMBL625937,,50597,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13156,CHEMBL625938,,50588,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13157,CHEMBL625939,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13158,CHEMBL625940,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13159,CHEMBL874464,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13160,CHEMBL625941,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13161,CHEMBL625942,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13162,CHEMBL625943,Bile,50597,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1970.0,
13163,CHEMBL625944,Serum,50587,,In vitro protein binding in human serum at 5 ug/ml,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1977.0,
13164,CHEMBL625945,,22224,,Serum protein binding ability was measured,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13165,CHEMBL625946,,22224,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13166,CHEMBL625947,,22224,,Oral bioavailability in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
13167,CHEMBL625948,,50597,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13168,CHEMBL625949,,22224,,Absolute oral bioavailability at an iv dose of 14 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13169,CHEMBL625950,,22224,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13170,CHEMBL625951,,22224,,Oral bioavailability (dose 15 mg/kg i.v.),U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
13171,CHEMBL625952,,22224,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13172,CHEMBL625953,,22224,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13173,CHEMBL625954,,22224,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13174,CHEMBL882959,,22224,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13175,CHEMBL625955,,50588,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13176,CHEMBL625956,,22224,,Bioavailability in ferret,U,9669.0,,Autocuration,,0,,A,Mustela putorius furo,,1,BAO_0000218,,
13177,CHEMBL625957,,100710,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
13178,CHEMBL625958,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13179,CHEMBL625959,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13180,CHEMBL626642,,50597,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13181,CHEMBL631330,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13182,CHEMBL631331,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13183,CHEMBL631332,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13184,CHEMBL631333,,50597,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13185,CHEMBL632018,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13186,CHEMBL632019,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13187,CHEMBL632020,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13188,CHEMBL632021,,50597,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13189,CHEMBL632022,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13190,CHEMBL632023,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13191,CHEMBL632024,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13192,CHEMBL874472,,50597,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13193,CHEMBL632025,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13194,CHEMBL632026,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13195,CHEMBL632027,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13196,CHEMBL632028,,50597,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13197,CHEMBL626430,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13198,CHEMBL626431,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13199,CHEMBL626432,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13200,CHEMBL626433,,50597,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13201,CHEMBL626434,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13202,CHEMBL627280,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13203,CHEMBL627281,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13204,CHEMBL627282,,50597,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13205,CHEMBL627283,,22224,,Total body clearance was measured at given dose,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13206,CHEMBL627284,,22224,,Total body clearance was measured at given dose.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13207,CHEMBL627285,,50597,,Metabolic clearance from the body in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13208,CHEMBL627286,,22224,,Renal clearance from the body,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13209,CHEMBL875477,,50597,,Renal clearance from the body in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13210,CHEMBL627287,,50597,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13211,CHEMBL627288,,50588,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13212,CHEMBL627289,,50597,,Total clearance from the body in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13213,CHEMBL627290,Plasma,50597,,Clearance into cortex from rat plasma or PBS,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13214,CHEMBL627291,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13215,CHEMBL627292,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13216,CHEMBL627293,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13217,CHEMBL627294,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13218,CHEMBL875478,,22224,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13219,CHEMBL627295,,22224,,Clearance was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13220,CHEMBL627296,,50594,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13221,CHEMBL626119,,50592,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,,
13222,CHEMBL626120,,50597,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13223,CHEMBL626121,,50597,,Clearance in rat after iv dose (100 ug/kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13224,CHEMBL626122,,22224,,Clearance in guinea pig,U,10141.0,,Autocuration,,0,,A,Cavia porcellus,,1,BAO_0000218,,
13225,CHEMBL626123,,50597,,Compound was evaluated for clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13226,CHEMBL623456,,50588,,Compound was evaluated for the clearance in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13227,CHEMBL623457,,50597,,Compound was evaluated for the clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13228,CHEMBL623458,,50597,,Compound was tested in vivo for clearance after iv administration in the rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13229,CHEMBL623459,,22224,,IV clearance determined at an iv dose of 14 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13230,CHEMBL875484,,22224,,IV clearance determined at an iv dose of 15.2 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13231,CHEMBL623460,,22224,,IV clearance determined at an iv dose of 15 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13232,CHEMBL623461,,22224,,IV clearance determined at an peroral dose of 30 mg/kg.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13233,CHEMBL623462,,22224,,IV clearance determined at an peroral dose of 30.2 mg/kg.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13234,CHEMBL627386,,22224,,IV clearance determined at an peroral dose of 30.3 mg/kg.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13235,CHEMBL627387,Kidney,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13236,CHEMBL627388,Liver,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13237,CHEMBL627389,Lung,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13238,CHEMBL627390,Muscle tissue,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13239,CHEMBL627391,Plasma,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13240,CHEMBL627392,,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13241,CHEMBL627393,Spleen,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13242,CHEMBL627394,Trachea,50597,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,3126.0,
13243,CHEMBL627395,Bone,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
13244,CHEMBL875485,Cerebellum,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13245,CHEMBL627396,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13246,CHEMBL627397,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13247,CHEMBL627398,Heart,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13248,CHEMBL627399,Bone,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
13249,CHEMBL627400,Kidney,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13250,CHEMBL627401,Liver,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13251,CHEMBL627402,Lung,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13252,CHEMBL627403,Muscle tissue,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13253,CHEMBL627404,Plasma,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13254,CHEMBL623101,,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13255,CHEMBL877480,Spleen,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13256,CHEMBL623102,Trachea,50597,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,3126.0,
13257,CHEMBL623103,Bone,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
13258,CHEMBL623104,Cerebellum,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13259,CHEMBL623105,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13260,CHEMBL623106,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13261,CHEMBL623107,Heart,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13262,CHEMBL623108,Intestine,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
13263,CHEMBL623109,Kidney,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13264,CHEMBL623110,Liver,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13265,CHEMBL623111,Lung,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13266,CHEMBL625060,Muscle tissue,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13267,CHEMBL625061,Plasma,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13268,CHEMBL625062,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13269,CHEMBL625063,Spleen,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13270,CHEMBL625064,Trachea,50597,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,3126.0,
13271,CHEMBL625065,Bone,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000001.0,
13272,CHEMBL625066,Cerebellum,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13273,CHEMBL625067,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13274,CHEMBL625068,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13275,CHEMBL622159,Heart,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13276,CHEMBL622160,Intestine,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,160.0,
13277,CHEMBL622161,Kidney,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13278,CHEMBL622162,Lung,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13279,CHEMBL622163,Muscle tissue,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13280,CHEMBL622313,Plasma,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13281,CHEMBL622314,,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13282,CHEMBL622315,Spleen,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13283,CHEMBL622316,Trachea,50597,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,3126.0,
13284,CHEMBL877486,,50212,,Normal diffusion coefficient in water for Escherichia coli,N,562.0,,Intermediate,,1,,A,Escherichia coli,,1,BAO_0000218,,
13285,CHEMBL622317,,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13286,CHEMBL622318,,22224,,Average max percent decrease in RVR (renal vascular resistance) was determined.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13287,CHEMBL622319,,22224,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13288,CHEMBL622320,,22224,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13289,CHEMBL622321,,22224,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13290,CHEMBL622322,,22224,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13291,CHEMBL622323,,22224,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13292,CHEMBL622324,,50597,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13293,CHEMBL622325,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13294,CHEMBL622326,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13295,CHEMBL877487,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13296,CHEMBL622327,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13297,CHEMBL622328,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13298,CHEMBL622329,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13299,CHEMBL622330,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13300,CHEMBL622331,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13301,CHEMBL622332,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13302,CHEMBL622333,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13303,CHEMBL627658,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13304,CHEMBL630428,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13305,CHEMBL630429,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13306,CHEMBL630430,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13307,CHEMBL630431,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13308,CHEMBL630432,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13309,CHEMBL630433,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13310,CHEMBL630434,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13311,CHEMBL629372,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13312,CHEMBL629553,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13313,CHEMBL629554,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13314,CHEMBL874447,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13315,CHEMBL629555,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13316,CHEMBL629556,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13317,CHEMBL629557,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13318,CHEMBL629558,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13319,CHEMBL629559,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13320,CHEMBL629560,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13321,CHEMBL629561,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13322,CHEMBL629562,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13323,CHEMBL629563,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13324,CHEMBL629564,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13325,CHEMBL629565,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13326,CHEMBL629566,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13327,CHEMBL629567,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13328,CHEMBL629568,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13329,CHEMBL629569,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13330,CHEMBL629570,Urine,50588,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13331,CHEMBL629571,Urine,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13332,CHEMBL629572,,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13333,CHEMBL629573,,22224,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13334,CHEMBL629574,,22224,,Bioavailability (dose 20 mg/kg),U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
13335,CHEMBL629575,,22224,,Bioavailability in dog,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
13336,CHEMBL874448,,22224,,Bioavailability in rat (Sprague-Dawley) (male),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13337,CHEMBL629576,,22224,,Bioavailability in monkey (dose 10 mg/kg i.d.),U,9443.0,,Autocuration,,0,,A,Primates,,1,BAO_0000218,,
13338,CHEMBL629577,,22224,,Bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13339,CHEMBL629578,,22224,,Bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13340,CHEMBL629579,,22224,,Bioavailability in dog (dose 3.0 mg/kg p.o.),U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
13341,CHEMBL882958,,22224,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
13342,CHEMBL629580,,50505,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,N,9598.0,,Intermediate,,1,,A,Pan troglodytes,,1,BAO_0000218,,
13343,CHEMBL629581,,22224,,Bioavailability,U,9347.0,,Autocuration,,0,,A,Eutheria,,1,BAO_0000218,,
13344,CHEMBL629582,,22224,,Bioavailability in squirrel monkey,U,9520.0,,Autocuration,,0,,A,Saimiri,,1,BAO_0000218,,
13345,CHEMBL628522,,50588,,Bioavailability was evaluated in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13346,CHEMBL625432,,100712,,Bioavailability was evaluated in hamster,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
13347,CHEMBL625433,,22224,,Bioavailability in rat,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13348,CHEMBL625434,Plasma,50597,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13349,CHEMBL625435,Plasma,50597,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13350,CHEMBL625436,,22224,,Bioavailability in rat (dose 10 mg/kg p.o.),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13351,CHEMBL874588,,100710,,Bioavailability was measured in cynomolgus monkeys.,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
13352,CHEMBL625437,,50594,,Bioavailability was measured in nude mice.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13353,CHEMBL625438,,22224,,Bioavailability in ferret (dose 10 mg/kg i.d.),U,9669.0,,Autocuration,,0,,A,Mustela putorius furo,,1,BAO_0000218,,
13354,CHEMBL625439,,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
13355,CHEMBL625440,,22224,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
13356,CHEMBL625441,,22224,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,,
13357,CHEMBL625442,,22224,,Bioavailability in rat (dose 10 mg/kg i.d.),U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13358,CHEMBL625443,,50597,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13359,CHEMBL625444,,22224,,Bioavailability was determined; extremely poor,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13360,CHEMBL625445,,50594,,% bioavailability in mice after oral administration of prodrug,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13361,CHEMBL625446,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13362,CHEMBL882960,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13363,CHEMBL625447,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13364,CHEMBL625448,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13365,CHEMBL625449,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13366,CHEMBL874589,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13367,CHEMBL625450,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13368,CHEMBL625451,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13369,CHEMBL626584,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13370,CHEMBL626585,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13371,CHEMBL626586,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13372,CHEMBL626587,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13373,CHEMBL626588,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13374,CHEMBL626589,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13375,CHEMBL626590,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13376,CHEMBL626591,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13377,CHEMBL627181,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13378,CHEMBL628083,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13379,CHEMBL628084,,22224,,IV clearance determined at an peroral dose of 15 mg/kg.,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13380,CHEMBL628085,,50064,,Mouse oral clearance was measured against Hymenolepiasis nana.,N,102285.0,,Expert,,1,,F,Hymenolepis nana,,1,BAO_0000218,,
13381,CHEMBL628086,,50545,,Mouse oral clearance was measured against Nematospiroides dubius,N,6339.0,,Expert,,1,,F,Heligmosomoides polygyrus,,1,BAO_0000218,,
13382,CHEMBL628087,,22224,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,U,,,Autocuration,,0,,F,,,1,BAO_0000218,,
13383,CHEMBL628088,,50594,,Mouse oral clearance was measured against N. nana; NT is Not Tested,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13384,CHEMBL628089,,22224,,Mouse oral clearance was measured against N. nana; NT is Not Tested,U,,,Autocuration,,0,,B,,,1,BAO_0000218,,
13385,CHEMBL628090,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13386,CHEMBL628091,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13387,CHEMBL628092,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13388,CHEMBL628093,,22224,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13389,CHEMBL875607,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13390,CHEMBL625710,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13391,CHEMBL625711,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13392,CHEMBL625712,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13393,CHEMBL625713,,22224,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13394,CHEMBL625714,,50588,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13395,CHEMBL625715,,50797,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
13396,CHEMBL625716,,50597,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13397,CHEMBL625717,,50597,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13398,CHEMBL625718,,50597,,Plasma clearance was determined for the compound in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13399,CHEMBL625719,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13400,CHEMBL625720,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13401,CHEMBL625721,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13402,CHEMBL625722,,50597,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13403,CHEMBL625723,,50597,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13404,CHEMBL625724,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,N,6339.0,,Intermediate,,1,,A,Heligmosomoides polygyrus,,1,BAO_0000218,,
13405,CHEMBL625725,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,N,6339.0,,Intermediate,,1,,A,Heligmosomoides polygyrus,,1,BAO_0000218,,
13406,CHEMBL625726,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,N,6339.0,,Intermediate,,1,,A,Heligmosomoides polygyrus,,1,BAO_0000218,,
13407,CHEMBL875608,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,N,6339.0,,Intermediate,,1,,A,Heligmosomoides polygyrus,,1,BAO_0000218,,
13408,CHEMBL625727,,50545,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,N,6339.0,,Intermediate,,1,,A,Heligmosomoides polygyrus,,1,BAO_0000218,,
13409,CHEMBL625728,Urine,22224,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13410,CHEMBL625729,,22224,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13411,CHEMBL625730,,22224,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
13412,CHEMBL625731,Urine,22224,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13413,CHEMBL626417,Urine,22224,,Urinary clearance was determined in rat at 25 mg/kg os dosage,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13414,CHEMBL626418,Urine,50587,,Urinary clearance was determined at 100 mg/kg oral dosage in human,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,1088.0,
13415,CHEMBL626419,Urine,50588,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13416,CHEMBL626592,Plasma,50588,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
13417,CHEMBL626593,Plasma,50597,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13418,CHEMBL626594,,50597,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13419,CHEMBL625035,,50588,,Clearance rate in dogs,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13420,CHEMBL625036,,22224,,Compound was measured for intrinsic clearance,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13421,CHEMBL625037,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13422,CHEMBL625038,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13423,CHEMBL625039,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13424,CHEMBL625040,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13425,CHEMBL625041,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13426,CHEMBL625042,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13427,CHEMBL874411,,22224,,Partition coefficient of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13428,CHEMBL625043,,22224,,Permeability,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13429,CHEMBL625044,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13430,CHEMBL625045,,22224,,Partition coefficient (logD),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13431,CHEMBL625046,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13432,CHEMBL625047,,22229,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13433,CHEMBL625048,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13434,CHEMBL625049,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13435,CHEMBL625050,,22229,,Calculated logarithm of partition coefficient (P) was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13436,CHEMBL625051,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13437,CHEMBL874412,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13438,CHEMBL625052,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13439,CHEMBL625053,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13440,CHEMBL623250,,22224,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13441,CHEMBL623251,,22224,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13442,CHEMBL623252,,22224,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13443,CHEMBL623253,,22224,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13444,CHEMBL623254,,22224,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13445,CHEMBL623255,,22224,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13446,CHEMBL626831,,22224,,Percent degradation of compound at a pH of 1 over a 18 hr period,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13447,CHEMBL877494,,22224,,Percent degradation of compound at pH of 1 over an 18 hr period,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13448,CHEMBL626832,,22224,,Delta Logarithm of Partition Coefficient value was determined.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13449,CHEMBL626833,,22224,,Delta logPoct-cyc,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13450,CHEMBL626834,,22224,,Lipophilicity estimated on reversed phase TLC,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13451,CHEMBL626835,,22224,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13452,CHEMBL626836,,22224,,Delta logPoct-cyc,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13453,CHEMBL626837,,22229,,Change in logarithm of partition coefficient of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13454,CHEMBL626838,,22224,,Delta logD (pH 6.5),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13455,CHEMBL626839,,22224,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13456,CHEMBL626840,,22224,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13457,CHEMBL626841,,22224,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13458,CHEMBL626842,,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,U,,,Autocuration,,0,,A,,,1,BAO_0000219,,
13459,CHEMBL626843,,22224,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,U,,,Autocuration,,0,,A,,,1,BAO_0000219,,
13460,CHEMBL626844,,50597,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13461,CHEMBL877495,,50597,,Amount of deuterium retained was reported after normal workup in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13462,CHEMBL626845,,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13463,CHEMBL626846,,50597,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13464,CHEMBL626847,,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13465,CHEMBL628677,,50597,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13466,CHEMBL628678,,50597,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13467,CHEMBL628679,,22224,,Compound was subjected to electrochemical oxidation,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13468,CHEMBL628680,,22224,,Compound was subjected to photochemical oxidation,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13469,CHEMBL628681,,22224,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13470,CHEMBL628682,,22224,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13471,CHEMBL628683,,22224,,Oxidation of compound by methemoglobin in presence of hydroperoxide,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13472,CHEMBL628684,,50597,,Percent diffusion through fuzzy rat skin after 48 h of incubation,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13473,CHEMBL877501,,22229,,Dissociation constant (pKa),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13474,CHEMBL628685,,22224,,Dissociation constant value of the compound; ND means not determined.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13475,CHEMBL628686,Blood,50597,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13476,CHEMBL628687,Blood,50597,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13477,CHEMBL628688,,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13478,CHEMBL628689,,50597,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13479,CHEMBL628690,Liver,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13480,CHEMBL629363,Liver,50597,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13481,CHEMBL629364,Spleen,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13482,CHEMBL629365,Spleen,50597,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13483,CHEMBL629366,,50597,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13484,CHEMBL629367,Urine,50597,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13485,CHEMBL629368,Feces,50597,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
13486,CHEMBL877502,Urine,50597,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13487,CHEMBL629369,Cerebellum,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2037.0,
13488,CHEMBL629370,Brain,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
13489,CHEMBL629371,Urine,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13490,CHEMBL626276,Urine,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13491,CHEMBL626277,Urine,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13492,CHEMBL631250,Urine,22224,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13493,CHEMBL631251,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13494,CHEMBL631252,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13495,CHEMBL631253,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13496,CHEMBL631254,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13497,CHEMBL631255,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13498,CHEMBL631256,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13499,CHEMBL631257,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13500,CHEMBL628009,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13501,CHEMBL628010,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13502,CHEMBL628011,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13503,CHEMBL628012,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13504,CHEMBL628013,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13505,CHEMBL628014,Urine,50597,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13506,CHEMBL628015,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13507,CHEMBL628016,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13508,CHEMBL874461,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13509,CHEMBL628017,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13510,CHEMBL628018,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13511,CHEMBL628019,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13512,CHEMBL628020,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13513,CHEMBL628021,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13514,CHEMBL628022,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13515,CHEMBL628023,Urine,50588,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13516,CHEMBL628024,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13517,CHEMBL628025,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13518,CHEMBL628026,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13519,CHEMBL628027,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13520,CHEMBL628028,Urine,22224,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1088.0,
13521,CHEMBL628029,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13522,CHEMBL628030,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13523,CHEMBL628031,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13524,CHEMBL628032,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13525,CHEMBL628033,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13526,CHEMBL628034,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13527,CHEMBL628035,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13528,CHEMBL628036,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13529,CHEMBL874462,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13530,CHEMBL628037,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13531,CHEMBL628123,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13532,CHEMBL628124,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13533,CHEMBL628125,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13534,CHEMBL628126,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13535,CHEMBL628127,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13536,CHEMBL628128,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13537,CHEMBL628129,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13538,CHEMBL628130,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13539,CHEMBL628131,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13540,CHEMBL628132,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13541,CHEMBL628133,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13542,CHEMBL628134,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13543,CHEMBL628135,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13544,CHEMBL628136,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13545,CHEMBL628137,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13546,CHEMBL628138,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13547,CHEMBL628139,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13548,CHEMBL628140,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13549,CHEMBL628141,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13550,CHEMBL628142,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13551,CHEMBL628143,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13552,CHEMBL628144,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13553,CHEMBL628145,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13554,CHEMBL628146,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13555,CHEMBL625355,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13556,CHEMBL625356,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13557,CHEMBL625357,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13558,CHEMBL625527,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13559,CHEMBL875473,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13560,CHEMBL625528,,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13561,CHEMBL626304,,50597,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13562,CHEMBL624138,Artery,50588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1637.0,
13563,CHEMBL624139,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13564,CHEMBL624140,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13565,CHEMBL624141,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13566,CHEMBL624142,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13567,CHEMBL624143,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13568,CHEMBL624144,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13569,CHEMBL624145,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13570,CHEMBL624146,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13571,CHEMBL624147,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13572,CHEMBL883123,,22229,,Calculated partition coefficient (clogP) (MacLogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13573,CHEMBL624148,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13574,CHEMBL874416,,22224,,Kinetic parameter was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13575,CHEMBL624149,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13576,CHEMBL624150,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13577,CHEMBL624151,,22224,,Lipophilicity was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13578,CHEMBL624152,,22224,,Lipophilicity was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13579,CHEMBL622139,,22224,,Lipophilicity was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13580,CHEMBL622140,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13581,CHEMBL622141,,22224,,Lipophilicity was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13582,CHEMBL622142,,22224,,Lipophilicity in octanol-water,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13583,CHEMBL622143,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13584,CHEMBL622144,,22229,,Octanol-water partition coefficient was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13585,CHEMBL877473,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13586,CHEMBL622145,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13587,CHEMBL622146,,22224,,Partition coefficient was determined; ND means not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13588,CHEMBL622147,,22229,,Calculated partition coefficient (clogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13589,CHEMBL622148,,22224,,Partition coefficient of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13590,CHEMBL883124,,22224,,Permeability was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13591,CHEMBL622149,,22229,,The compound was evaluated for the partition coefficient,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13592,CHEMBL622150,,22224,,Partition coefficient (logP),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13593,CHEMBL622151,,22224,,The lipophilicity was reported,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13594,CHEMBL622152,,22229,,logarithm of the octanol-water partition coefficient for the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13595,CHEMBL622153,,22224,,Clogp value was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13596,CHEMBL877474,,22224,,Clp at a dose of 1.5 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13597,CHEMBL622154,,22224,,Clp at a dose of 2.0 mg/kg,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13598,CHEMBL622155,Plasma,22224,,"Clp, plasma clearance at a dose of 10 mg/kg",U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
13599,CHEMBL622156,Plasma,22224,,"Clp, plasma clearance at a dose of 50 mg/kg",U,,,Autocuration,,0,,A,,,1,BAO_0000218,1969.0,
13600,CHEMBL622157,Plasma,50597,,Compound was tested for plasma clearance in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13601,CHEMBL622158,Plasma,50597,,Compound was tested for plasma clearance in rat; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13602,CHEMBL622807,,50597,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13603,CHEMBL622808,,50797,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
13604,CHEMBL622809,,22224,,Plasma clearance by iv administration at a dose 0.003 ug/mL,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13605,CHEMBL622810,,22224,,Plasma clearance determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13606,CHEMBL876653,,100712,,Plasma clearance after iv administration at 3 mg/kg in hamster,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
13607,CHEMBL622811,,100712,,Plasma clearance after iv administration at 4 mg/kg in hamster,N,10026.0,,Intermediate,,1,,A,Cricetinae,,1,BAO_0000218,,
13608,CHEMBL622986,,50597,,Rate of clearance in rat was determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13609,CHEMBL622987,Plasma,50597,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13610,CHEMBL622988,Plasma,50597,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13611,CHEMBL622989,Plasma,50597,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13612,CHEMBL622990,Plasma,50597,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13613,CHEMBL622991,Plasma,22224,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,U,314293.0,,Autocuration,,0,,A,Simiiformes,,1,BAO_0000218,1969.0,
13614,CHEMBL622227,Plasma,50597,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
13615,CHEMBL622228,Plasma,50588,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
13616,CHEMBL622229,,50597,,Clpl value in rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13617,CHEMBL622230,,50512,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,,
13618,CHEMBL622231,,50597,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13619,CHEMBL622232,,100710,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,N,9541.0,,Intermediate,,1,,A,Macaca fascicularis,,1,BAO_0000218,,
13620,CHEMBL622233,,22224,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13621,CHEMBL622234,,22224,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13622,CHEMBL622235,,22224,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13623,CHEMBL622236,,22224,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13624,CHEMBL622237,,22224,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13625,CHEMBL877482,,22224,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13626,CHEMBL622238,,22224,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13627,CHEMBL622239,,22224,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13628,CHEMBL622240,Blood,22224,,Cmax was calculated as maximum concentration reached in the blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
13629,CHEMBL622241,Blood,22224,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
13630,CHEMBL631013,,50597,,Cmax was determine after peroral administration at 10 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13631,CHEMBL631014,,50797,,Cmax was determine after peroral administration at 10 mpk in Rhesus,N,9544.0,,Intermediate,,1,,A,Macaca mulatta,,1,BAO_0000218,,
13632,CHEMBL631015,,50588,,Cmax was determine after peroral administration at 10 mpk in dog,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13633,CHEMBL631016,,50597,,Cmax was determine after peroral administration at 160 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13634,CHEMBL631017,,50597,,Cmax was determine after peroral administration at 20 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13635,CHEMBL631018,,50597,,Cmax was determine after peroral administration at 50 mpk in Rat,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13636,CHEMBL631019,,22224,,Cmax was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
13637,CHEMBL875761,Brain,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
13638,CHEMBL631020,Brain,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
13639,CHEMBL631669,Brain,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
13640,CHEMBL631670,Brain,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
13641,CHEMBL631671,Striatum,50594,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2435.0,
13642,CHEMBL631672,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13643,CHEMBL631673,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13644,CHEMBL631856,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13645,CHEMBL631857,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13646,CHEMBL631858,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13647,CHEMBL631859,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13648,CHEMBL631860,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13649,CHEMBL631861,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13650,CHEMBL631862,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13651,CHEMBL631863,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13652,CHEMBL631864,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13653,CHEMBL631865,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13654,CHEMBL631866,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13655,CHEMBL629360,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13656,CHEMBL629361,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13657,CHEMBL629362,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13658,CHEMBL630740,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13659,CHEMBL630741,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13660,CHEMBL630742,Blood,50597,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13661,CHEMBL630743,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13662,CHEMBL630744,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13663,CHEMBL630745,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13664,CHEMBL630746,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13665,CHEMBL630747,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13666,CHEMBL630748,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13667,CHEMBL632056,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13668,CHEMBL632057,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13669,CHEMBL632058,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13670,CHEMBL632059,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13671,CHEMBL632060,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13672,CHEMBL632061,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13673,CHEMBL629207,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13674,CHEMBL629208,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13675,CHEMBL629209,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13676,CHEMBL629210,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13677,CHEMBL629211,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13678,CHEMBL629212,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13679,CHEMBL629213,,50597,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13680,CHEMBL629214,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13681,CHEMBL629215,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13682,CHEMBL635154,Urine,50597,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13683,CHEMBL629216,,50597,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13684,CHEMBL629217,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13685,CHEMBL629218,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13686,CHEMBL629219,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13687,CHEMBL629220,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13688,CHEMBL629221,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13689,CHEMBL631127,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13690,CHEMBL631128,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13691,CHEMBL631129,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13692,CHEMBL631130,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13693,CHEMBL631131,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13694,CHEMBL631132,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13695,CHEMBL631133,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13696,CHEMBL631134,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13697,CHEMBL875120,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13698,CHEMBL631135,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13699,CHEMBL631136,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13700,CHEMBL631137,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13701,CHEMBL631138,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13702,CHEMBL631139,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13703,CHEMBL631140,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13704,CHEMBL631141,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13705,CHEMBL631142,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13706,CHEMBL631143,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13707,CHEMBL631144,,50597,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13708,CHEMBL631145,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13709,CHEMBL631146,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13710,CHEMBL631147,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13711,CHEMBL631148,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13712,CHEMBL631149,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13713,CHEMBL631150,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13714,CHEMBL631151,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13715,CHEMBL631152,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13716,CHEMBL631443,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13717,CHEMBL631444,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13718,CHEMBL631445,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13719,CHEMBL631446,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13720,CHEMBL631447,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13721,CHEMBL631448,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13722,CHEMBL631449,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13723,CHEMBL631450,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13724,CHEMBL629724,,50588,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
13725,CHEMBL629725,Zone of skin,50594,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
13726,CHEMBL629726,Zone of skin,50594,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,14.0,
13727,CHEMBL629727,Spleen,50594,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
13728,CHEMBL630404,Spleen,50594,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
13729,CHEMBL630405,Spleen,50594,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
13730,CHEMBL630406,Spleen,50594,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
13731,CHEMBL630407,Stomach,50594,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,945.0,
13732,CHEMBL630573,Stomach,50594,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,945.0,
13733,CHEMBL630574,Stomach,50594,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,945.0,
13734,CHEMBL630575,Stomach,50594,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,945.0,
13735,CHEMBL630576,,50594,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13736,CHEMBL630577,,50594,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13737,CHEMBL630578,,50594,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13738,CHEMBL630579,,50594,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13739,CHEMBL630580,Kidney,50594,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
13740,CHEMBL630581,Kidney,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
13741,CHEMBL630582,Kidney,50594,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
13742,CHEMBL630583,,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13743,CHEMBL630584,,50594,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13744,CHEMBL630585,,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13745,CHEMBL630586,,50594,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13746,CHEMBL630587,,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13747,CHEMBL630588,,50594,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13748,CHEMBL630589,,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13749,CHEMBL630590,,50594,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13750,CHEMBL630591,Feces,22224,,Removal of 238-Plutonium(IV) in feces at 24 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1988.0,
13751,CHEMBL630592,Feces,22224,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1988.0,
13752,CHEMBL630593,,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13753,CHEMBL630594,,22224,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13754,CHEMBL630595,Urine,22224,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13755,CHEMBL630596,Urine,22224,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13756,CHEMBL630597,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13757,CHEMBL630598,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13758,CHEMBL630599,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13759,CHEMBL630600,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13760,CHEMBL630601,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13761,CHEMBL630602,Urine,22224,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13762,CHEMBL630603,Urine,22224,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13763,CHEMBL630604,Urine,22224,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),U,,,Autocuration,,0,,A,,,1,BAO_0000019,1088.0,
13764,CHEMBL624869,Blood,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13765,CHEMBL624870,Blood,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13766,CHEMBL623189,Blood,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13767,CHEMBL623190,Blood,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13768,CHEMBL623191,Blood,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13769,CHEMBL623192,,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13770,CHEMBL623193,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13771,CHEMBL623194,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13772,CHEMBL623195,,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13773,CHEMBL623196,,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13774,CHEMBL623197,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13775,CHEMBL623198,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13776,CHEMBL623199,,50597,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13777,CHEMBL623200,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13778,CHEMBL623201,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13779,CHEMBL623202,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13780,CHEMBL623203,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13781,CHEMBL623204,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13782,CHEMBL623205,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13783,CHEMBL623206,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13784,CHEMBL623207,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13785,CHEMBL623208,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13786,CHEMBL623209,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13787,CHEMBL623210,Muscle tissue,50597,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13788,CHEMBL623211,,50597,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13789,CHEMBL623212,Uterus,50597,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
13790,CHEMBL623213,,22224,,Tested in vitro for intrinsic activity relative to quinpirole,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13791,CHEMBL623214,,22224,,"Relative ion enhancement, determined in pulsed ultrafiltration",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13792,CHEMBL623215,,22224,,% ionization at the pH 7.4 at 37 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13793,CHEMBL623216,,22224,,Percentage ionization was measured,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13794,CHEMBL623217,,50591,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,N,9913.0,,Intermediate,,1,,A,Bos taurus,,1,BAO_0000218,,
13795,CHEMBL623218,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13796,CHEMBL623913,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13797,CHEMBL623914,,22224,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13798,CHEMBL623915,,22229,,Compound was evaluated for the partition coefficient in octanol/water,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13799,CHEMBL624080,,22229,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13800,CHEMBL624081,,22224,,Equilibrium constant measured by the pulse radiolysis at pH 7,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13801,CHEMBL624082,,50587,,In vitro hydrolytic rate constant determined in human blood,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
13802,CHEMBL625054,,50587,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
13803,CHEMBL877485,,22224,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13804,CHEMBL625055,,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13805,CHEMBL625056,,50594,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13806,CHEMBL625057,,50587,,In vitro oxidation of compound in presence of human plasma,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
13807,CHEMBL625058,,22224,,In vitro oxidation of compound in presence of hydrogen peroxide,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13808,CHEMBL625059,,50594,,In vitro oxidation of compound in presence of mouse brain homogenate,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13809,CHEMBL629536,,50594,,In vitro oxidation of compound in presence of mouse liver homogenate,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13810,CHEMBL629537,,50597,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13811,CHEMBL629538,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13812,CHEMBL629539,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13813,CHEMBL874445,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13814,CHEMBL629540,,50597,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13815,CHEMBL629541,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13816,CHEMBL629542,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13817,CHEMBL630243,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13818,CHEMBL630244,,50597,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13819,CHEMBL630245,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13820,CHEMBL630246,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13821,CHEMBL630247,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13822,CHEMBL630248,,50597,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13823,CHEMBL630249,Blood,50597,,Biodistribution in rat blood at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13824,CHEMBL630250,Blood,50597,,Biodistribution in rat blood at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13825,CHEMBL630251,Blood,50597,,Biodistribution in rat blood at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13826,CHEMBL630252,Blood,50597,,Biodistribution in rat blood at 3 hr after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13827,CHEMBL630408,Blood,50597,,Biodistribution in rat blood at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
13828,CHEMBL630409,Cerebellum,50597,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13829,CHEMBL874446,Cerebellum,50597,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13830,CHEMBL630410,Cerebellum,50597,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13831,CHEMBL630411,Cerebellum,50597,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13832,CHEMBL630412,Cerebellum,50597,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13833,CHEMBL630413,Cerebellum,50597,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13834,CHEMBL630414,Cerebellum,50597,,Biodistribution in rat cerebellum at 3 hr after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13835,CHEMBL630415,Cerebellum,50597,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
13836,CHEMBL630416,,50597,,Biodistribution in rat cortex at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13837,CHEMBL630417,,50597,,Biodistribution in rat cortex at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13838,CHEMBL630418,,50597,,Biodistribution in rat cortex at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13839,CHEMBL630419,,50597,,Biodistribution in rat cortex at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13840,CHEMBL630420,,50597,,Biodistribution in rat cortex at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13841,CHEMBL630421,,50597,,Biodistribution in rat cortex at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13842,CHEMBL630422,,50597,,Biodistribution in rat cortex at 3 hr after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13843,CHEMBL630423,,50597,,Biodistribution in rat cortex at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13844,CHEMBL630424,Heart,50597,,Biodistribution in rat heart at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13845,CHEMBL630425,Heart,50597,,Biodistribution in rat heart at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13846,CHEMBL629462,Heart,50597,,Biodistribution in rat heart at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13847,CHEMBL630426,Heart,50597,,Biodistribution in rat heart at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13848,CHEMBL630427,Heart,50597,,Biodistribution in rat heart at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13849,CHEMBL625877,Heart,50597,,Biodistribution in rat heart at 3 hr after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13850,CHEMBL625878,Heart,50597,,Biodistribution in rat heart at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
13851,CHEMBL625879,Hippocampus,50597,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
13852,CHEMBL625880,Hippocampus,50597,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
13853,CHEMBL625881,Hippocampus,50597,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
13854,CHEMBL625882,Hippocampus,50597,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
13855,CHEMBL625883,Hippocampus,50597,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
13856,CHEMBL625884,Kidney,50597,,Biodistribution in rat kidney at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13857,CHEMBL625885,Kidney,50597,,Biodistribution in rat kidney at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13858,CHEMBL628649,Kidney,50597,,Biodistribution in rat kidney at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13859,CHEMBL628650,Kidney,50597,,Biodistribution in rat kidney at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13860,CHEMBL628651,Kidney,50597,,Biodistribution in rat kidney at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13861,CHEMBL628652,Kidney,50597,,Biodistribution in rat kidney at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13862,CHEMBL628653,Kidney,50597,,Biodistribution in rat kidney at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13863,CHEMBL628654,Liver,50597,,Biodistribution in rat liver at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13864,CHEMBL628655,Liver,50597,,Biodistribution in rat liver at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13865,CHEMBL625238,Liver,50597,,Biodistribution in rat liver at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13866,CHEMBL625239,Liver,50597,,Biodistribution in rat liver at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13867,CHEMBL625240,Liver,50597,,Biodistribution in rat liver at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13868,CHEMBL625241,Liver,50597,,Biodistribution in rat liver at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13869,CHEMBL625242,Liver,50597,,Biodistribution in rat liver at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13870,CHEMBL874587,Lung,50597,,Biodistribution in rat lung at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13871,CHEMBL625405,Lung,50597,,Biodistribution in rat lung at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13872,CHEMBL625406,Lung,50597,,Biodistribution in rat lung at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13873,CHEMBL625407,Lung,50597,,Biodistribution in rat lung at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13874,CHEMBL625408,Lung,50597,,Biodistribution in rat lung at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13875,CHEMBL625409,Lung,50597,,Biodistribution in rat lung at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13876,CHEMBL625410,Thoracic aorta,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13877,CHEMBL625411,Thoracic aorta,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13878,CHEMBL625412,Thoracic aorta,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13879,CHEMBL625413,Thoracic aorta,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13880,CHEMBL625414,Thoracic aorta,50597,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13881,CHEMBL625415,Thoracic aorta,50597,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13882,CHEMBL625416,Thoracic aorta,50597,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1515.0,
13883,CHEMBL625417,Urine,50597,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13884,CHEMBL625418,Feces,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
13885,CHEMBL625419,Urine,50597,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13886,CHEMBL625420,,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13887,CHEMBL626996,,50597,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13888,CHEMBL626997,Feces,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
13889,CHEMBL626998,Urine,50597,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
13890,CHEMBL626999,,50597,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13891,CHEMBL627000,,50594,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13892,CHEMBL627001,,50594,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13893,CHEMBL627002,,50594,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13894,CHEMBL627003,,50594,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
13895,CHEMBL627004,Urine,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13896,CHEMBL627005,Urine,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13897,CHEMBL874594,Urine,50594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13898,CHEMBL627006,Urine,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13899,CHEMBL627007,Urine,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13900,CHEMBL627884,Urine,50594,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13901,CHEMBL627885,Urine,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13902,CHEMBL627886,Urine,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13903,CHEMBL627887,Urine,50594,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13904,CHEMBL627888,Urine,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13905,CHEMBL628057,Urine,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13906,CHEMBL627405,Urine,50594,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
13907,CHEMBL627406,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13908,CHEMBL627407,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13909,CHEMBL627408,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13910,CHEMBL627409,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13911,CHEMBL875486,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13912,CHEMBL627410,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13913,CHEMBL627411,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13914,CHEMBL627412,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13915,CHEMBL627413,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13916,CHEMBL627414,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13917,CHEMBL627415,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13918,CHEMBL627416,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13919,CHEMBL627417,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13920,CHEMBL627418,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13921,CHEMBL627419,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13922,CHEMBL627320,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13923,CHEMBL627321,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
13924,CHEMBL627322,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13925,CHEMBL627323,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13926,CHEMBL627491,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13927,CHEMBL627492,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13928,CHEMBL627493,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
13929,CHEMBL627494,Liver,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13930,CHEMBL627495,Liver,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13931,CHEMBL627496,Liver,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13932,CHEMBL627497,Liver,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13933,CHEMBL627498,Liver,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
13934,CHEMBL627499,Lung,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13935,CHEMBL627500,Lung,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13936,CHEMBL627501,Lung,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13937,CHEMBL625616,Lung,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13938,CHEMBL625617,Lung,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
13939,CHEMBL625618,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13940,CHEMBL625619,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13941,CHEMBL625620,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13942,CHEMBL625621,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13943,CHEMBL625622,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
13944,CHEMBL625788,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13945,CHEMBL625789,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13946,CHEMBL625790,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13947,CHEMBL625791,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13948,CHEMBL622334,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13949,CHEMBL622335,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
13950,CHEMBL622336,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
13951,CHEMBL622337,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
13952,CHEMBL622338,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
13953,CHEMBL622339,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
13954,CHEMBL624153,,50597,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13955,CHEMBL628430,,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13956,CHEMBL628431,,50597,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13957,CHEMBL628432,,50597,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13958,CHEMBL628433,,50597,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13959,CHEMBL628434,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13960,CHEMBL626789,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13961,CHEMBL626790,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13962,CHEMBL626791,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13963,CHEMBL626792,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13964,CHEMBL626793,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
13965,CHEMBL627436,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13966,CHEMBL627437,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13967,CHEMBL627438,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13968,CHEMBL627439,,50597,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13969,CHEMBL627440,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13970,CHEMBL627602,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13971,CHEMBL627603,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13972,CHEMBL627604,,50597,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13973,CHEMBL627605,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13974,CHEMBL627606,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13975,CHEMBL627607,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13976,CHEMBL627608,,50597,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13977,CHEMBL627609,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13978,CHEMBL627610,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13979,CHEMBL627611,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13980,CHEMBL627612,,50597,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
13981,CHEMBL627613,,22229,,Octanol:water partition coefficient is evaluated,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13982,CHEMBL627614,,22224,,Partition coefficient in 1-octanol/water system,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13983,CHEMBL627615,,22224,,Partition coefficient in 1-octanol/water system measured using radio active compounds,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13984,CHEMBL627616,,22224,,Partition coefficient in octanol/water system was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13985,CHEMBL627617,,22224,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
13986,CHEMBL627618,,22224,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13987,CHEMBL627619,,22224,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13988,CHEMBL627620,,22224,,Pseudo-first-order rate constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13989,CHEMBL627621,,22224,,Pseudo-first-order rate constant with 1-min time point,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13990,CHEMBL627622,,22224,,Pseudo-first-order rate constant without 1-min time point,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13991,CHEMBL627623,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13992,CHEMBL627624,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13993,CHEMBL627625,,22224,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13994,CHEMBL628523,,22224,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13995,CHEMBL628524,,22224,,The alkaline hydrolysis second order rate constant(K OH) of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13996,CHEMBL628525,,22224,,The efflux rate constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13997,CHEMBL625732,,22224,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13998,CHEMBL625733,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
13999,CHEMBL625734,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,U,,,Autocuration,,0,,F,,,1,BAO_0000019,,
14000,CHEMBL625913,,22224,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14001,CHEMBL625914,,22224,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14002,CHEMBL625915,,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14003,CHEMBL625916,,22224,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14004,CHEMBL625917,,22224,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14005,CHEMBL625918,,22224,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14006,CHEMBL625919,,22224,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14007,CHEMBL625920,,22224,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14008,CHEMBL874453,,22224,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14009,CHEMBL625921,,22224,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14010,CHEMBL625922,,22224,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14011,CHEMBL625923,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14012,CHEMBL625924,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14013,CHEMBL625925,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14014,CHEMBL625926,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14015,CHEMBL627704,Lung,50597,,Biodistribution in rat lung at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14016,CHEMBL627705,,50597,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14017,CHEMBL627706,,50597,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14018,CHEMBL627707,,50597,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14019,CHEMBL627708,,50597,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14020,CHEMBL628361,,50597,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14021,CHEMBL628362,,50597,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14022,CHEMBL628363,Striatum,50597,,Biodistribution in rat striatum at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14023,CHEMBL628364,Striatum,50597,,Biodistribution in rat striatum at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14024,CHEMBL628365,Striatum,50597,,Biodistribution in rat striatum at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14025,CHEMBL874454,Striatum,50597,,Biodistribution in rat striatum at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14026,CHEMBL628531,Striatum,50597,,Biodistribution in rat striatum at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14027,CHEMBL628532,Striatum,50597,,Biodistribution in rat striatum at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14028,CHEMBL628533,Striatum,50597,,Biodistribution in rat striatum at 3 hr after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14029,CHEMBL628534,Striatum,50597,,Biodistribution in rat striatum at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2435.0,
14030,CHEMBL628535,Thyroid gland,50597,,Biodistribution in rat thyroid at 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14031,CHEMBL628536,Thyroid gland,50597,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14032,CHEMBL628537,Thyroid gland,50597,,Biodistribution in rat thyroid at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14033,CHEMBL628538,Thyroid gland,50597,,Biodistribution in rat thyroid at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14034,CHEMBL628539,Thyroid gland,50597,,Biodistribution in rat thyroid at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14035,CHEMBL630297,Thyroid gland,50597,,Biodistribution in rat thyroid at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14036,CHEMBL630298,Thyroid gland,50597,,Biodistribution in rat thyroid at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14037,CHEMBL630299,Brain,50597,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14038,CHEMBL628094,Brain,50597,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14039,CHEMBL628095,Brain,50597,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14040,CHEMBL874648,Brain,50597,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14041,CHEMBL628096,Brain,50597,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14042,CHEMBL628097,Brain,50597,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14043,CHEMBL628098,Brain,50597,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14044,CHEMBL628099,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14045,CHEMBL628100,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14046,CHEMBL628101,,22224,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14047,CHEMBL628102,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14048,CHEMBL628103,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14049,CHEMBL628104,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14050,CHEMBL628105,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14051,CHEMBL628106,,22224,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14052,CHEMBL628107,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14053,CHEMBL628108,Urine,22224,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,U,,,Autocuration,,0,,F,,,1,BAO_0000218,1088.0,
14054,CHEMBL628109,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14055,CHEMBL625299,Urine,22224,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,U,,,Autocuration,,0,,F,,,1,BAO_0000218,1088.0,
14056,CHEMBL625300,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14057,CHEMBL625301,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14058,CHEMBL625302,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14059,CHEMBL874649,Urine,50597,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14060,CHEMBL625303,,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14061,CHEMBL625463,,50597,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14062,CHEMBL625464,Liver,50587,,In vitro metabolism in human liver microsomes,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,2107.0,
14063,CHEMBL625465,,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
14064,CHEMBL625466,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14065,CHEMBL625467,Urine,50588,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14066,CHEMBL625468,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14067,CHEMBL625469,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14068,CHEMBL625470,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14069,CHEMBL632418,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14070,CHEMBL627250,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14071,CHEMBL627251,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14072,CHEMBL627252,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14073,CHEMBL627253,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14074,CHEMBL627254,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14075,CHEMBL875471,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14076,CHEMBL627255,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14077,CHEMBL627256,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14078,CHEMBL627257,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14079,CHEMBL627258,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14080,CHEMBL627259,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14081,CHEMBL627260,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14082,CHEMBL623256,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14083,CHEMBL874413,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14084,CHEMBL623257,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14085,CHEMBL623258,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14086,CHEMBL623259,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14087,CHEMBL623260,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14088,CHEMBL623261,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14089,CHEMBL623262,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14090,CHEMBL623263,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14091,CHEMBL623264,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14092,CHEMBL623265,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14093,CHEMBL623266,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14094,CHEMBL623267,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14095,CHEMBL623268,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14096,CHEMBL623269,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14097,CHEMBL623270,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14098,CHEMBL623271,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14099,CHEMBL623272,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14100,CHEMBL623273,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14101,CHEMBL623274,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14102,CHEMBL874414,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14103,CHEMBL623275,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14104,CHEMBL629150,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14105,CHEMBL623276,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14106,CHEMBL623277,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14107,CHEMBL623112,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14108,CHEMBL623113,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14109,CHEMBL623800,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14110,CHEMBL623801,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14111,CHEMBL623802,Spleen,50597,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14112,CHEMBL623803,Uterus,50597,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
14113,CHEMBL623970,Uterus,50597,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
14114,CHEMBL623971,Uterus,50597,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,995.0,
14115,CHEMBL623972,Blood,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14116,CHEMBL623973,Blood,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14117,CHEMBL623974,Blood,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14118,CHEMBL623975,Blood,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14119,CHEMBL623976,Brain,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14120,CHEMBL623977,Brain,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14121,CHEMBL623978,Brain,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14122,CHEMBL623979,Brain,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14123,CHEMBL623980,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14124,CHEMBL623981,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14125,CHEMBL626278,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14126,CHEMBL626279,,50597,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14127,CHEMBL626280,,50594,,Biodistribution in mice bladder plus excreted urine was determined,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14128,CHEMBL626281,,50594,,"Percentage biodistribution in mouse blood, 10 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14129,CHEMBL626282,,50594,,"Percentage biodistribution in mouse blood, 30 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14130,CHEMBL626283,,50594,,"Percentage biodistribution in mouse blood, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14131,CHEMBL626284,,50594,,"Percentage biodistribution in mouse blood, 60 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14132,CHEMBL626285,Brain,50594,,"Percentage biodistribution in mouse brain, 10 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
14133,CHEMBL626286,Brain,50594,,"Percentage biodistribution in mouse brain, 30 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
14134,CHEMBL626287,Brain,50594,,"Percentage biodistribution in mouse brain, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
14135,CHEMBL626288,Brain,50594,,"Percentage biodistribution in mouse brain, 60 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,955.0,
14136,CHEMBL626289,,50594,,"Percentage biodistribution in mouse heart, 10 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14137,CHEMBL626290,,50594,,"Percentage biodistribution in mouse heart, 30 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14138,CHEMBL626291,,50594,,"Percentage biodistribution in mouse heart, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14139,CHEMBL839888,,50594,,"Percentage biodistribution in mouse heart, 60 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14140,CHEMBL626292,Intestine,50594,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,160.0,
14141,CHEMBL626293,Intestine,50594,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,160.0,
14142,CHEMBL626294,Intestine,50594,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,160.0,
14143,CHEMBL626295,Intestine,50594,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,160.0,
14144,CHEMBL627659,Liver,50594,,"Percentage biodistribution in mouse liver, 10 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14145,CHEMBL627660,Liver,50594,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14146,CHEMBL627661,Liver,50594,,"Percentage biodistribution in mouse liver, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14147,CHEMBL627662,Liver,50594,,Biodistribution in mice liver at 60 minutes of post injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14148,CHEMBL627663,Lung,50594,,Biodistribution in mice lungs at 10 min of post injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
14149,CHEMBL627664,,50594,,"Percentage biodistribution in mouse lung, 30 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14150,CHEMBL627665,,50594,,"Percentage biodistribution in mousee lung, 5 minutes post injection",N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14151,CHEMBL627666,Lung,50594,,Biodistribution in mice lungs at 60 min of post injection,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2048.0,
14152,CHEMBL627667,Spleen,50594,,Percentage biodistribution in mouse spleen,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
14153,CHEMBL627668,Stomach,50594,,Percentage biodistribution in mouse stomach,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,945.0,
14154,CHEMBL627669,Urine,50594,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,1088.0,
14155,CHEMBL627670,Urinary bladder,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1255.0,
14156,CHEMBL627671,Blood,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
14157,CHEMBL627672,Bone element,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1474.0,
14158,CHEMBL627673,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14159,CHEMBL627674,Kidney,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2113.0,
14160,CHEMBL627675,Liver,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2107.0,
14161,CHEMBL627676,Lung,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2048.0,
14162,CHEMBL627677,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14163,CHEMBL627678,,22224,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14164,CHEMBL627679,Serum,50597,,Affinity for protein binding expressed as association constant in fresh rat serum,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
14165,CHEMBL627680,,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14166,CHEMBL627681,,22224,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14167,CHEMBL627682,,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14168,CHEMBL627683,,22224,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14169,CHEMBL627684,,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14170,CHEMBL874441,,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14171,CHEMBL627685,,22224,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14172,CHEMBL627686,,22224,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14173,CHEMBL627687,,22224,,Apparent rate constant Koff for inactivation of dTMP synthase.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14174,CHEMBL627688,,22224,,The irreversible inhibitor activity by second order rate equation.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14175,CHEMBL628038,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14176,CHEMBL628039,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14177,CHEMBL628040,,50597,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14178,CHEMBL628041,,22224,,Dissociation rate calculated from the first-order equation using t1/2 value,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14179,CHEMBL630226,,22224,,The compound was tested for Binding constant against DNA,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14180,CHEMBL628042,,22224,,First order rate constant for cyclization of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14181,CHEMBL625232,,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14182,CHEMBL625233,,22224,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14183,CHEMBL625979,,22224,,Hydrolysis rate constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14184,CHEMBL625980,,22224,,Observed first order rate constant,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14185,CHEMBL625981,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14186,CHEMBL625982,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14187,CHEMBL625983,,22224,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14188,CHEMBL625984,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14189,CHEMBL625985,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14190,CHEMBL625986,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14191,CHEMBL625987,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14192,CHEMBL625988,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14193,CHEMBL625989,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14194,CHEMBL625990,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14195,CHEMBL625991,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14196,CHEMBL625992,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14197,CHEMBL625993,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14198,CHEMBL631973,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14199,CHEMBL632143,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14200,CHEMBL632144,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14201,CHEMBL632145,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14202,CHEMBL632146,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14203,CHEMBL632147,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14204,CHEMBL632148,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14205,CHEMBL632149,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14206,CHEMBL632150,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14207,CHEMBL632151,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14208,CHEMBL632152,,50587,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
14209,CHEMBL632153,,50587,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
14210,CHEMBL632154,,50587,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
14211,CHEMBL632155,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14212,CHEMBL632156,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14213,CHEMBL632157,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14214,CHEMBL632158,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14215,CHEMBL632159,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14216,CHEMBL626305,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14217,CHEMBL626306,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14218,CHEMBL626307,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14219,CHEMBL626308,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14220,CHEMBL626479,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14221,CHEMBL626480,,50602,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,N,10298.0,,Intermediate,,1,,A,Human herpesvirus 1,,1,BAO_0000218,,
14222,CHEMBL626481,,22229,,Calculated partition coefficient (clogP) (MlogP),U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14223,CHEMBL626482,,22224,,Equipotent potent ratio relative to carbachol (nicotinic activity),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14224,CHEMBL626483,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14225,CHEMBL626484,,50588,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14226,CHEMBL626485,,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes available,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14227,CHEMBL626486,,22229,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14228,CHEMBL626487,,22229,,Solubility at pH 7.4 in ug/mL;NA denotes not available,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14229,CHEMBL626488,Plasma,50588,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1969.0,
14230,CHEMBL626489,Serum,50597,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1977.0,
14231,CHEMBL626490,,22224,,Area under the MAP curve measured over 5 min; ND means Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14232,CHEMBL626491,,22224,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14233,CHEMBL626492,,22229,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14234,CHEMBL626493,,22224,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14235,CHEMBL626494,,50597,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14236,CHEMBL626495,,22224,,Half life after oral tested,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14237,CHEMBL626496,Plasma,50597,,Half life was determined in plasma of rat; NT indicates not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
14238,CHEMBL626497,,50597,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14239,CHEMBL626498,,22224,,Oral bioavailability after oral tested,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14240,CHEMBL626499,,50597,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14241,CHEMBL626500,,50597,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14242,CHEMBL626501,Plasma,50597,,half life was determined in plasma of rat; NT indicates not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
14243,CHEMBL626502,Plasma,50597,,half life was determined in plasma of rat; NT means not tested,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1969.0,
14244,CHEMBL626503,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14245,CHEMBL626504,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14246,CHEMBL626505,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14247,CHEMBL626506,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14248,CHEMBL626507,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14249,CHEMBL626508,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14250,CHEMBL626509,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14251,CHEMBL875480,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14252,CHEMBL626510,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14253,CHEMBL626511,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14254,CHEMBL626512,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14255,CHEMBL628208,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14256,CHEMBL628209,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14257,CHEMBL628210,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14258,CHEMBL628211,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14259,CHEMBL628212,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14260,CHEMBL628213,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14261,CHEMBL628214,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14262,CHEMBL628215,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14263,CHEMBL628216,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14264,CHEMBL626595,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14265,CHEMBL626596,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14266,CHEMBL626597,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14267,CHEMBL626598,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14268,CHEMBL622242,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14269,CHEMBL622243,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14270,CHEMBL622244,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14271,CHEMBL622245,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14272,CHEMBL622246,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14273,CHEMBL622247,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14274,CHEMBL622248,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14275,CHEMBL877483,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14276,CHEMBL622249,Urine,50597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14277,CHEMBL622250,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14278,CHEMBL622251,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14279,CHEMBL622252,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14280,CHEMBL622253,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14281,CHEMBL622254,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14282,CHEMBL622255,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14283,CHEMBL622256,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14284,CHEMBL622257,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14285,CHEMBL622258,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14286,CHEMBL622259,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14287,CHEMBL622927,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14288,CHEMBL622928,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14289,CHEMBL622929,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14290,CHEMBL623182,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14291,CHEMBL623183,Urine,50588,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14292,CHEMBL623184,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14293,CHEMBL623185,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14294,CHEMBL877484,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14295,CHEMBL627274,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14296,CHEMBL623186,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14297,CHEMBL623187,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14298,CHEMBL623188,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14299,CHEMBL628055,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14300,CHEMBL628056,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14301,CHEMBL628200,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14302,CHEMBL628201,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14303,CHEMBL628202,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14304,CHEMBL628203,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14305,CHEMBL628204,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14306,CHEMBL628205,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14307,CHEMBL628206,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14308,CHEMBL628207,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14309,CHEMBL627220,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14310,CHEMBL627221,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14311,CHEMBL627222,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14312,CHEMBL627223,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14313,CHEMBL632062,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14314,CHEMBL632063,Spleen,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2106.0,
14315,CHEMBL632064,Urinary bladder,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1255.0,
14316,CHEMBL632065,Blood,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
14317,CHEMBL632066,Bone element,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1474.0,
14318,CHEMBL632067,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14319,CHEMBL629188,Kidney,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2113.0,
14320,CHEMBL629189,Liver,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2107.0,
14321,CHEMBL629190,Lung,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2048.0,
14322,CHEMBL629191,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14323,CHEMBL629192,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14324,CHEMBL629193,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14325,CHEMBL629194,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14326,CHEMBL629195,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14327,CHEMBL629373,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14328,CHEMBL629374,Spleen,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2106.0,
14329,CHEMBL629375,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14330,CHEMBL629376,Urinary bladder,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1255.0,
14331,CHEMBL629377,Blood,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
14332,CHEMBL629378,Bone element,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1474.0,
14333,CHEMBL629379,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14334,CHEMBL629151,Kidney,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2113.0,
14335,CHEMBL629152,Liver,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2107.0,
14336,CHEMBL629153,Lung,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2048.0,
14337,CHEMBL629154,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14338,CHEMBL629155,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14339,CHEMBL629156,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14340,CHEMBL629157,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14341,CHEMBL629158,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14342,CHEMBL629159,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14343,CHEMBL629160,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14344,CHEMBL629161,Spleen,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2106.0,
14345,CHEMBL629162,Urinary bladder,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1255.0,
14346,CHEMBL629163,Blood,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
14347,CHEMBL629164,Bone element,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1474.0,
14348,CHEMBL629165,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14349,CHEMBL629166,Liver,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2107.0,
14350,CHEMBL629167,Lung,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2048.0,
14351,CHEMBL629168,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14352,CHEMBL629169,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14353,CHEMBL629170,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14354,CHEMBL631153,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14355,CHEMBL875121,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14356,CHEMBL631154,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14357,CHEMBL631155,,22224,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14358,CHEMBL631156,,22224,,Hydrolysis rate constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14359,CHEMBL631157,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14360,CHEMBL631158,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14361,CHEMBL631159,,22224,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14362,CHEMBL631160,,22224,,Observed second order rate constant,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14363,CHEMBL631161,,22224,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14364,CHEMBL631162,,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14365,CHEMBL630313,,22224,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14366,CHEMBL630314,,22224,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14367,CHEMBL630315,,22224,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14368,CHEMBL630316,,22224,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14369,CHEMBL630986,,22224,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14370,CHEMBL630987,,22224,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14371,CHEMBL630988,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14372,CHEMBL630989,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14373,CHEMBL630990,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14374,CHEMBL630991,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14375,CHEMBL630992,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14376,CHEMBL630993,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14377,CHEMBL630994,,22224,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14378,CHEMBL630995,,50597,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14379,CHEMBL629252,,22224,,Association constant for compound at 31 degree C was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14380,CHEMBL629253,,22224,,Calculated antagonist equilibrium dissociation constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14381,CHEMBL629944,,22224,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14382,CHEMBL629945,Trachea,50512,,Dissociation constants vs LTE4 on guinea pig trachea,N,10141.0,,Intermediate,,1,,A,Cavia porcellus,,1,BAO_0000218,3126.0,
14383,CHEMBL629946,,22224,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14384,CHEMBL629947,,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14385,CHEMBL629948,,22224,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14386,CHEMBL856024,,22224,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14387,CHEMBL629949,,22224,,Affinity constant KD value was derived from TMP,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14388,CHEMBL629950,,22224,,Apparent dissociation (binding) rate constant was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14389,CHEMBL630127,,22224,,Dissociation constant (KD) of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14390,CHEMBL630128,,22224,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14391,CHEMBL630129,,22224,,Dissociation constant from ESR titration experiments,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14392,CHEMBL630130,,22224,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),U,,,Autocuration,,0,,,,,1,BAO_0000019,,
14393,CHEMBL875234,,22224,,Dissociation constant was evaluated.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14394,CHEMBL630131,,22224,,Dissociation constant was reported,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14395,CHEMBL630132,,50597,,Dissociation constant was determined in rat pituitary cells.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14396,CHEMBL630133,,22224,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14397,CHEMBL630134,,22224,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14398,CHEMBL630135,,22224,,Equilibrium dissociation constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14399,CHEMBL630136,,22224,,Equilibrium dissociation constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14400,CHEMBL630137,,22224,,Kinetic constant KD was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14401,CHEMBL630138,,22224,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14402,CHEMBL630139,,22224,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14403,CHEMBL630140,,22224,,Rate constant for hydrolysis in aqueous acetone.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14404,CHEMBL875235,,22224,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14405,CHEMBL876439,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14406,CHEMBL630605,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14407,CHEMBL630606,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14408,CHEMBL630607,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14409,CHEMBL630608,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14410,CHEMBL630609,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14411,CHEMBL630610,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14412,CHEMBL630611,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14413,CHEMBL629552,,50597,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14414,CHEMBL629733,,50597,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14415,CHEMBL629734,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14416,CHEMBL629735,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14417,CHEMBL629736,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14418,CHEMBL629737,,50597,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14419,CHEMBL629738,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14420,CHEMBL629739,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14421,CHEMBL629740,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14422,CHEMBL629741,,50597,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14423,CHEMBL629742,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14424,CHEMBL629743,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14425,CHEMBL629744,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14426,CHEMBL629745,,50597,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14427,CHEMBL629746,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14428,CHEMBL629747,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14429,CHEMBL629748,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14430,CHEMBL629749,,50597,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14431,CHEMBL629750,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14432,CHEMBL629751,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14433,CHEMBL629752,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14434,CHEMBL629753,,50597,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14435,CHEMBL629754,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14436,CHEMBL629755,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14437,CHEMBL629756,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14438,CHEMBL629757,,50597,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14439,CHEMBL629758,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14440,CHEMBL629759,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14441,CHEMBL629760,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14442,CHEMBL876443,,50597,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14443,CHEMBL629761,,50588,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14444,CHEMBL629762,,50588,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14445,CHEMBL629763,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14446,CHEMBL629764,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14447,CHEMBL629765,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14448,CHEMBL629766,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14449,CHEMBL629767,,50594,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14450,CHEMBL629768,,50588,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14451,CHEMBL629769,,50594,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14452,CHEMBL629770,,50588,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14453,CHEMBL629771,,50588,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,,
14454,CHEMBL629772,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14455,CHEMBL629773,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14456,CHEMBL625455,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14457,CHEMBL625456,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14458,CHEMBL625457,,50594,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14459,CHEMBL625458,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14460,CHEMBL625459,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14461,CHEMBL875483,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14462,CHEMBL634779,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14463,CHEMBL625460,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14464,CHEMBL626117,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14465,CHEMBL626118,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14466,CHEMBL628342,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14467,CHEMBL628343,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14468,CHEMBL628344,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14469,CHEMBL628345,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14470,CHEMBL628346,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14471,CHEMBL628347,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14472,CHEMBL628348,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14473,CHEMBL628349,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14474,CHEMBL875611,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14475,CHEMBL628350,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14476,CHEMBL628351,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14477,CHEMBL628352,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14478,CHEMBL628353,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14479,CHEMBL628354,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14480,CHEMBL626667,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14481,CHEMBL626668,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14482,CHEMBL626669,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14483,CHEMBL626670,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14484,CHEMBL626671,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14485,CHEMBL626672,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14486,CHEMBL626673,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14487,CHEMBL626674,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14488,CHEMBL626675,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14489,CHEMBL626676,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14490,CHEMBL626677,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14491,CHEMBL626678,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14492,CHEMBL626679,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14493,CHEMBL875612,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14494,CHEMBL626680,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14495,CHEMBL626681,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14496,CHEMBL626682,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14497,CHEMBL626683,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14498,CHEMBL626684,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14499,CHEMBL626685,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14500,CHEMBL626686,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14501,CHEMBL626687,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14502,CHEMBL624978,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14503,CHEMBL624979,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14504,CHEMBL624980,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14505,CHEMBL624981,Urine,50597,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14506,CHEMBL624982,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14507,CHEMBL627564,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14508,CHEMBL627565,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14509,CHEMBL627566,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14510,CHEMBL627567,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14511,CHEMBL627568,Spleen,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2106.0,
14512,CHEMBL627569,Kidney,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2113.0,
14513,CHEMBL627570,Urinary bladder,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1255.0,
14514,CHEMBL627571,Blood,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,178.0,
14515,CHEMBL627572,Bone element,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,U,,,Autocuration,,0,,A,,,1,BAO_0000218,1474.0,
14516,CHEMBL627573,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14517,CHEMBL627574,Kidney,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2113.0,
14518,CHEMBL627575,Liver,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2107.0,
14519,CHEMBL627576,Lung,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2048.0,
14520,CHEMBL627577,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14521,CHEMBL627578,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14522,CHEMBL627579,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14523,CHEMBL627580,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14524,CHEMBL627581,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14525,CHEMBL627582,,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,,
14526,CHEMBL627583,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14527,CHEMBL627584,Spleen,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2106.0,
14528,CHEMBL627585,Prostate gland,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2367.0,
14529,CHEMBL627586,Muscle tissue,22224,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,U,,,Autocuration,,0,,A,,,1,BAO_0000218,2385.0,
14530,CHEMBL627587,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14531,CHEMBL627588,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14532,CHEMBL628250,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14533,CHEMBL628251,,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14534,CHEMBL628252,Hippocampus,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14535,CHEMBL628253,Hippocampus,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14536,CHEMBL628254,Hypothalamus,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14537,CHEMBL877493,Hypothalamus,50597,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14538,CHEMBL628255,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14539,CHEMBL628256,,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14540,CHEMBL628257,Hippocampus,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14541,CHEMBL628258,Hypothalamus,50597,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14542,CHEMBL628259,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14543,CHEMBL628429,,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14544,CHEMBL626862,Hippocampus,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14545,CHEMBL626863,Hypothalamus,50597,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14546,CHEMBL625886,Cerebellum,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
14547,CHEMBL625887,Cerebellum,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
14548,CHEMBL625888,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14549,CHEMBL625889,,50597,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14550,CHEMBL625890,Hippocampus,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14551,CHEMBL625891,Hippocampus,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14552,CHEMBL625892,Hypothalamus,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14553,CHEMBL625893,Hypothalamus,50597,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14554,CHEMBL625894,Cerebellum,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2037.0,
14555,CHEMBL625895,,50597,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14556,CHEMBL625896,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14557,CHEMBL625897,,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14558,CHEMBL625898,,22224,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14559,CHEMBL625899,,22224,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14560,CHEMBL626124,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14561,CHEMBL628500,,50212,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,N,562.0,,Intermediate,,1,,A,Escherichia coli,,1,BAO_0000218,,
14562,CHEMBL857856,,50597,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14563,CHEMBL628501,,50597,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14564,CHEMBL628502,,22224,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14565,CHEMBL628503,,22224,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14566,CHEMBL628504,,22224,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14567,CHEMBL628505,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14568,CHEMBL874452,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14569,CHEMBL628506,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14570,CHEMBL628507,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14571,CHEMBL628508,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14572,CHEMBL628509,,22224,,Michaelis constant (KM) was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14573,CHEMBL628510,,22224,,Reaction rate parameter value for phosphate with transfer with respect to ATP,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14574,CHEMBL628511,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14575,CHEMBL628512,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14576,CHEMBL628513,,22224,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14577,CHEMBL628514,,22224,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14578,CHEMBL628515,,22224,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14579,CHEMBL628516,,22224,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14580,CHEMBL628517,,22224,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14581,CHEMBL628518,,22224,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14582,CHEMBL628519,,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14583,CHEMBL628520,,22224,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14584,CHEMBL628521,,22224,,Binding constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14585,CHEMBL630443,,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14586,CHEMBL630444,,22224,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14587,CHEMBL857732,,22224,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14588,CHEMBL630445,,22224,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14589,CHEMBL630446,,22224,,Catalytic rate constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14590,CHEMBL630447,,22224,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14591,CHEMBL630448,,22224,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14592,CHEMBL630449,,22224,,Catalytic rate constant against phospholipase A2 was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14593,CHEMBL630450,,22224,,"Compound was evaluated for catalytic constant, Kcat",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14594,CHEMBL630451,,22224,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14595,CHEMBL630452,,22224,,Kcat calculated from 0.693/T1/2,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14596,CHEMBL630453,,22224,,Kcat was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14597,CHEMBL630454,,22224,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14598,CHEMBL630455,,22224,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14599,CHEMBL631487,,22224,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14600,CHEMBL631488,,22224,,Kcat value was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14601,CHEMBL876440,,22224,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14602,CHEMBL631489,,22224,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14603,CHEMBL857742,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14604,CHEMBL631490,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14605,CHEMBL631491,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14606,CHEMBL631492,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14607,CHEMBL631493,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14608,CHEMBL631494,,22224,,Kinetic parameter for rate of conversion to PABA was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14609,CHEMBL631495,,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14610,CHEMBL631496,Feces,50597,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1988.0,
14611,CHEMBL631497,Urine,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14612,CHEMBL631498,Urine,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14613,CHEMBL629776,Urine,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14614,CHEMBL629777,Urine,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14615,CHEMBL629778,Urine,50597,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14616,CHEMBL630456,,50597,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14617,CHEMBL630457,,50597,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14618,CHEMBL630458,,50597,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14619,CHEMBL630459,,50597,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14620,CHEMBL630460,,50597,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14621,CHEMBL876550,,50597,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14622,CHEMBL630461,,50597,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14623,CHEMBL630462,,50597,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14624,CHEMBL630463,,50597,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14625,CHEMBL630464,,50597,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14626,CHEMBL630465,,50597,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14627,CHEMBL630466,,50597,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14628,CHEMBL630467,,50597,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14629,CHEMBL630633,,50597,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14630,CHEMBL630634,,50597,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14631,CHEMBL630635,,50597,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14632,CHEMBL630636,,50597,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14633,CHEMBL630637,,50597,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14634,CHEMBL630638,Feces,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14635,CHEMBL630639,Feces,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14636,CHEMBL630640,Feces,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14637,CHEMBL876551,Feces,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14638,CHEMBL630641,Urine,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14639,CHEMBL630642,Urine,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14640,CHEMBL630643,Urine,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14641,CHEMBL630644,Urine,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14642,CHEMBL630645,Urine,50592,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14643,CHEMBL625599,Feces,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14644,CHEMBL625600,Feces,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14645,CHEMBL625601,Feces,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14646,CHEMBL625602,Feces,50592,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1988.0,
14647,CHEMBL627470,Urine,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14648,CHEMBL627471,Urine,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14649,CHEMBL627472,Urine,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14650,CHEMBL627473,Urine,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14651,CHEMBL627474,Urine,50592,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,1088.0,
14652,CHEMBL627475,Blood,50597,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14653,CHEMBL627476,Blood,50597,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14654,CHEMBL627477,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14655,CHEMBL627478,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14656,CHEMBL627479,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14657,CHEMBL627480,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14658,CHEMBL627481,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14659,CHEMBL627482,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14660,CHEMBL627483,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14661,CHEMBL875636,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14662,CHEMBL625764,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14663,CHEMBL625765,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14664,CHEMBL625766,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14665,CHEMBL625767,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14666,CHEMBL625768,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14667,CHEMBL625769,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14668,CHEMBL625770,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14669,CHEMBL625771,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14670,CHEMBL625772,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14671,CHEMBL625773,Urine,50588,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,N,9615.0,,Intermediate,,1,,A,Canis lupus familiaris,,1,BAO_0000218,1088.0,
14672,CHEMBL625774,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14673,CHEMBL625775,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14674,CHEMBL625776,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14675,CHEMBL625777,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14676,CHEMBL625778,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14677,CHEMBL625779,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14678,CHEMBL625780,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14679,CHEMBL625781,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14680,CHEMBL875637,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14681,CHEMBL626473,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14682,CHEMBL626474,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14683,CHEMBL626475,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14684,CHEMBL626476,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14685,CHEMBL634397,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14686,CHEMBL626477,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14687,CHEMBL631069,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14688,CHEMBL631070,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14689,CHEMBL631071,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14690,CHEMBL631072,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14691,CHEMBL631073,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14692,CHEMBL631074,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14693,CHEMBL631075,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14694,CHEMBL631725,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14695,CHEMBL631726,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14696,CHEMBL631727,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14697,CHEMBL631728,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14698,CHEMBL631729,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14699,CHEMBL631730,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14700,CHEMBL631731,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14701,CHEMBL631910,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14702,CHEMBL631911,Hippocampus,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,10000000.0,
14703,CHEMBL631912,Hypothalamus,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14704,CHEMBL631913,Hypothalamus,50597,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1898.0,
14705,CHEMBL631914,Blood,50597,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14706,CHEMBL631915,Blood,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14707,CHEMBL875778,Blood,50597,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14708,CHEMBL631916,Blood,50597,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14709,CHEMBL631917,Blood,50597,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14710,CHEMBL631918,Blood,50597,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14711,CHEMBL631919,Blood,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14712,CHEMBL631920,Blood,50597,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14713,CHEMBL631921,Blood,50597,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14714,CHEMBL631922,Blood,50597,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14715,CHEMBL631923,Blood,50597,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14716,CHEMBL631924,,50597,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14717,CHEMBL630234,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14718,CHEMBL630235,,50597,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14719,CHEMBL630236,,50597,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14720,CHEMBL630237,,50597,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14721,CHEMBL630238,,50597,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14722,CHEMBL630239,,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14723,CHEMBL630303,,50597,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14724,CHEMBL630304,,50597,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14725,CHEMBL630305,,50597,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14726,CHEMBL630306,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14727,CHEMBL630307,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14728,CHEMBL630308,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14729,CHEMBL630309,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14730,CHEMBL629309,Kidney,50597,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14731,CHEMBL629993,Kidney,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14732,CHEMBL629994,Kidney,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14733,CHEMBL629995,Kidney,50597,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14734,CHEMBL631993,Kidney,50597,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14735,CHEMBL631994,Kidney,50597,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14736,CHEMBL631995,Kidney,50597,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14737,CHEMBL631996,Liver,50597,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14738,CHEMBL631997,Liver,50597,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14739,CHEMBL631998,Liver,50597,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14740,CHEMBL631999,Liver,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14741,CHEMBL632000,Liver,50597,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14742,CHEMBL632001,Liver,50597,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14743,CHEMBL874424,Liver,50597,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14744,CHEMBL632002,Liver,50597,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14745,CHEMBL632003,Liver,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14746,CHEMBL632004,,22224,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14747,CHEMBL632005,,22224,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14748,CHEMBL632006,,22224,,Compound was tested for amidase rate in the presence of N62C screen enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14749,CHEMBL632007,,22224,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14750,CHEMBL632008,,22224,,Compound was tested for amidase rate in the presence of S166C screen enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14751,CHEMBL632009,,22224,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14752,CHEMBL632010,,22224,,Compound was tested for esterase rate in the presence of N62C screen enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14753,CHEMBL857750,,22224,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14754,CHEMBL632011,,22224,,Compound was tested for esterase rate in the presence of S166C screen enzyme,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14755,CHEMBL632012,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14756,CHEMBL632013,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14757,CHEMBL632014,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14758,CHEMBL629622,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14759,CHEMBL629623,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14760,CHEMBL629624,,22224,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14761,CHEMBL629625,,22224,,Ratio of Kcat to that of Km was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14762,CHEMBL629626,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14763,CHEMBL629627,,22224,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14764,CHEMBL629628,,22224,,"Compound was evaluated for constant, Kd",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14765,CHEMBL629629,,22224,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14766,CHEMBL629630,,22224,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14767,CHEMBL856030,,22224,,Dissociation Constant of compound determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14768,CHEMBL629631,,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14769,CHEMBL629632,,22224,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,U,,,Autocuration,,0,,B,,,1,BAO_0000019,,
14770,CHEMBL629633,,22224,,Dissociation constant of compound with Fructose was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14771,CHEMBL629634,,22224,,Dissociation constant of compound with Fructose was determined; Not determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14772,CHEMBL629635,,22224,,Dissociation constant of compound with Lactulose was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14773,CHEMBL629636,,22224,,Dissociation constant of compound with Lactulose was determined; Not determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14774,CHEMBL629637,,22224,,Dissociation constant of the Compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14775,CHEMBL629638,,22224,,Dissociation constant by non-linear regression analysis,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14776,CHEMBL629639,,22224,,Dissociation constant was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14777,CHEMBL629640,,22224,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14778,CHEMBL629641,,22224,,Dissociation constant was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14779,CHEMBL631344,,22224,,Dissociation constant was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14780,CHEMBL631345,Muscle tissue,50597,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14781,CHEMBL631346,,22224,,The dissociation constant determined by fluorescence displacement assay,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14782,CHEMBL631524,,22224,,kd value surface plasmon resonance (SPR) method,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14783,CHEMBL631525,Muscle tissue,50597,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14784,CHEMBL631526,,22224,,First dissociation constant of the binding of compound to V30M TTR,U,,,Autocuration,,0,,F,,,1,BAO_0000019,,
14785,CHEMBL631527,,22224,,Second dissociation constant of the binding of compound to V30M TTR,U,,,Autocuration,,0,,F,,,1,BAO_0000019,,
14786,CHEMBL631528,,22224,,"Compound was evaluated for equilibrium constant, Ke",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14787,CHEMBL631529,Hypothalamus,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1898.0,
14788,CHEMBL631530,Hypothalamus,22224,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1898.0,
14789,CHEMBL631531,,22224,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14790,CHEMBL631532,,22224,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14791,CHEMBL631533,,22224,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14792,CHEMBL876552,,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14793,CHEMBL631534,,50594,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14794,CHEMBL631535,,50594,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14795,CHEMBL631536,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14796,CHEMBL631537,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14797,CHEMBL631538,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14798,CHEMBL631539,,50594,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14799,CHEMBL631540,,50594,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14800,CHEMBL625637,,50597,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14801,CHEMBL625638,,50597,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14802,CHEMBL625639,,50597,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14803,CHEMBL625640,Brain,50597,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14804,CHEMBL625641,Brain,50597,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14805,CHEMBL625642,Heart,50597,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
14806,CHEMBL625643,Heart,50597,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
14807,CHEMBL625644,Kidney,50597,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14808,CHEMBL625645,Kidney,50597,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2113.0,
14809,CHEMBL625646,Liver,50597,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14810,CHEMBL625647,Liver,50597,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14811,CHEMBL625648,Lung,50597,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14812,CHEMBL625649,Lung,50597,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14813,CHEMBL625650,Muscle tissue,50597,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14814,CHEMBL625651,Muscle tissue,50597,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14815,CHEMBL625652,Zone of skin,50597,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
14816,CHEMBL625653,Zone of skin,50597,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,14.0,
14817,CHEMBL625654,Spleen,50597,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14818,CHEMBL625655,Spleen,50597,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14819,CHEMBL625656,Blood,50597,,Biodistribution of Compound in rat blood after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14820,CHEMBL625657,Blood,50597,,Biodistribution of Compound in rat blood after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,178.0,
14821,CHEMBL625658,Brain,50597,,Biodistribution of Compound in rat brain after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14822,CHEMBL625659,Brain,50597,,Biodistribution of Compound in rat brain after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,955.0,
14823,CHEMBL625660,Heart,50597,,Biodistribution of Compound in rat heart after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
14824,CHEMBL625661,Heart,50597,,Biodistribution of Compound in rat heart after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,948.0,
14825,CHEMBL625662,Liver,50597,,Biodistribution of Compound in rat liver after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14826,CHEMBL625663,Liver,50597,,Biodistribution of Compound in rat liver after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14827,CHEMBL875621,Lung,50597,,Biodistribution of Compound in rat lung after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14828,CHEMBL628382,Lung,50597,,Biodistribution of Compound in rat lung after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14829,CHEMBL628383,Muscle tissue,50597,,Biodistribution of Compound in rat muscle after 15 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14830,CHEMBL628384,Muscle tissue,50597,,Biodistribution of Compound in rat muscle after 2 minutes of administration,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14831,CHEMBL628385,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14832,CHEMBL875753,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14833,CHEMBL628386,,50597,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14834,CHEMBL628387,,50597,,Organ distribution in rat blood 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14835,CHEMBL628388,,50597,,Organ distribution in rat blood 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14836,CHEMBL628389,,50597,,Organ distribution in rat blood 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14837,CHEMBL632756,,50597,,Organ distribution in rat blood 30 min after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14838,CHEMBL628390,,50597,,Organ distribution in rat brain 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14839,CHEMBL631811,,50597,,Organ distribution in rat brain 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14840,CHEMBL631812,,50597,,Organ distribution in rat brain 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14841,CHEMBL631813,,50597,,Organ distribution in rat heart 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14842,CHEMBL631814,,50597,,Organ distribution in rat heart 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14843,CHEMBL631815,,50597,,Organ distribution in rat heart 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14844,CHEMBL631816,,50597,,Organ distribution in rat kidney 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14845,CHEMBL875758,,50597,,Organ distribution in rat kidney 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14846,CHEMBL631817,,50597,,Organ distribution in rat kidney 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14847,CHEMBL631818,Liver,50597,,Organ distribution in rat liver 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14848,CHEMBL631819,Liver,50597,,Organ distribution in rat liver 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14849,CHEMBL631820,Liver,50597,,Organ distribution in rat liver 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14850,CHEMBL631821,,50597,,Organ distribution in rat lung 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14851,CHEMBL631822,,50597,,Organ distribution in rat lung 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14852,CHEMBL631823,,50597,,Organ distribution in rat lung 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14853,CHEMBL631824,Muscle tissue,50597,,Organ distribution in rat muscle 2 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14854,CHEMBL631825,Muscle tissue,50597,,Organ distribution in rat muscle 2 hr after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14855,CHEMBL631826,Muscle tissue,50597,,Organ distribution in rat muscle 30 minutes after intravenous injection,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14856,CHEMBL631827,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14857,CHEMBL631828,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14858,CHEMBL631829,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
14859,CHEMBL875759,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14860,CHEMBL631830,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14861,CHEMBL631831,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14862,CHEMBL631832,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14863,CHEMBL631833,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14864,CHEMBL631834,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14865,CHEMBL631835,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14866,CHEMBL631836,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14867,CHEMBL631837,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14868,CHEMBL631838,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14869,CHEMBL631839,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14870,CHEMBL631840,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14871,CHEMBL631841,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14872,CHEMBL631842,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14873,CHEMBL631843,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14874,CHEMBL631844,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14875,CHEMBL631845,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14876,CHEMBL631846,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14877,CHEMBL875760,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14878,CHEMBL632199,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14879,CHEMBL631847,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14880,CHEMBL631848,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14881,CHEMBL628707,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14882,CHEMBL628708,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14883,CHEMBL628709,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14884,CHEMBL628710,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14885,CHEMBL628711,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14886,CHEMBL628712,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14887,CHEMBL628713,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14888,CHEMBL628714,Urine,50597,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,1088.0,
14889,CHEMBL628715,,50597,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14890,CHEMBL629179,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14891,CHEMBL629180,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14892,CHEMBL875108,,22224,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14893,CHEMBL629181,Adrenal cortex,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14894,CHEMBL629182,Adrenal cortex,22224,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14895,CHEMBL629183,,22224,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14896,CHEMBL629184,,22224,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14897,CHEMBL629185,Adrenal cortex,22224,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14898,CHEMBL629186,Adrenal cortex,22224,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14899,CHEMBL629187,,22224,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14900,CHEMBL629887,,22224,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14901,CHEMBL629888,,22224,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14902,CHEMBL629889,,22224,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14903,CHEMBL629890,Adrenal cortex,22224,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14904,CHEMBL629891,,22224,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14905,CHEMBL629892,,22224,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14906,CHEMBL629893,Adrenal cortex,22224,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,1235.0,
14907,CHEMBL629894,,22224,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14908,CHEMBL629895,,22224,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14909,CHEMBL875109,,22224,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",U,9615.0,,Autocuration,,0,,A,Canis lupus familiaris,,1,BAO_0000218,,
14910,CHEMBL629896,,22224,,Absolute bioavailability in male cynomolgus monkeys,U,9541.0,,Autocuration,,0,,A,Macaca fascicularis,,1,BAO_0000218,,
14911,CHEMBL629897,,22224,,Absolute bioavailability in maleSprague-Dawley rats,U,10116.0,,Autocuration,,0,,A,Rattus norvegicus,,1,BAO_0000218,,
14912,CHEMBL629898,Liver,50597,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14913,CHEMBL630057,Liver,50597,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14914,CHEMBL630058,Liver,50597,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2107.0,
14915,CHEMBL630059,Lung,50597,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14916,CHEMBL630060,Lung,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14917,CHEMBL630061,Lung,50597,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14918,CHEMBL630062,Lung,50597,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14919,CHEMBL630063,Lung,50597,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14920,CHEMBL630064,Lung,50597,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14921,CHEMBL630065,Lung,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14922,CHEMBL630066,Lung,50597,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14923,CHEMBL630067,Lung,50597,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14924,CHEMBL630068,Lung,50597,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2048.0,
14925,CHEMBL631113,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14926,CHEMBL631114,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14927,CHEMBL631115,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14928,CHEMBL631116,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14929,CHEMBL630528,Muscle tissue,50597,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14930,CHEMBL630529,Muscle tissue,50597,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14931,CHEMBL630530,Muscle tissue,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14932,CHEMBL630531,Muscle tissue,50597,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14933,CHEMBL630532,Muscle tissue,50597,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14934,CHEMBL630533,Muscle tissue,50597,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2385.0,
14935,CHEMBL630534,Blood,50594,,Biodistribution in normal mice blood after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
14936,CHEMBL630535,Blood,50594,,Biodistribution in normal mice blood after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
14937,CHEMBL630536,Blood,50594,,Biodistribution in normal mice blood after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,178.0,
14938,CHEMBL630537,Bone,50594,,Biodistribution in normal mice bone after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,10000001.0,
14939,CHEMBL630538,Bone,50594,,Biodistribution in normal mice bone after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,10000001.0,
14940,CHEMBL630539,Bone,50594,,Biodistribution in normal mice bone after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,10000001.0,
14941,CHEMBL630540,Heart,50594,,Biodistribution in normal mice heart after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
14942,CHEMBL630541,Heart,50594,,Biodistribution in normal mice heart after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
14943,CHEMBL630542,Heart,50594,,Biodistribution in normal mice heart after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,948.0,
14944,CHEMBL630543,Kidney,50594,,Biodistribution in normal mice kidney after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
14945,CHEMBL630544,Kidney,50594,,Biodistribution in normal mice kidney after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
14946,CHEMBL630545,Kidney,50594,,Biodistribution in normal mice kidney after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2113.0,
14947,CHEMBL630546,Liver,50594,,Biodistribution in normal mice liver after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14948,CHEMBL630547,Liver,50594,,Biodistribution in normal mice liver after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14949,CHEMBL630548,Liver,50594,,Biodistribution in normal mice liver after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2107.0,
14950,CHEMBL630549,Spleen,50594,,Biodistribution in normal mice spleen after 120 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
14951,CHEMBL630550,Spleen,50594,,Biodistribution in normal mice spleen after 24 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
14952,CHEMBL876426,Spleen,50594,,Biodistribution in normal mice spleen after 4 hr,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,2106.0,
14953,CHEMBL630551,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14954,CHEMBL630552,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14955,CHEMBL630553,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14956,CHEMBL630554,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14957,CHEMBL630555,Spleen,50597,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14958,CHEMBL630556,Spleen,50597,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14959,CHEMBL630557,Spleen,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14960,CHEMBL630558,Spleen,50597,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14961,CHEMBL630559,Spleen,50597,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14962,CHEMBL630560,Spleen,50597,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2106.0,
14963,CHEMBL876427,Thyroid gland,50597,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,2046.0,
14964,CHEMBL630561,,50597,,The Kel values in female wistar rats.,N,10116.0,,Intermediate,,1,,A,Rattus norvegicus,,1,BAO_0000218,,
14965,CHEMBL630562,,22224,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14966,CHEMBL630563,,22224,,Hydrolysis rate constant of the compound,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14967,CHEMBL629673,,22229,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14968,CHEMBL629674,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14969,CHEMBL629675,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14970,CHEMBL629676,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14971,CHEMBL629677,,22224,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14972,CHEMBL629678,,22224,,Apparent inactivation rate constant was evaluated,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14973,CHEMBL629679,,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14974,CHEMBL629680,,22224,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14975,CHEMBL629681,,22224,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14976,CHEMBL629682,,22224,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14977,CHEMBL629683,,22224,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14978,CHEMBL629684,,22224,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,U,,,Autocuration,,0,,F,,,1,BAO_0000019,,
14979,CHEMBL629685,,22224,,Dissociation constant was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14980,CHEMBL629686,,22224,,Dissociation constant was determined,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14981,CHEMBL872932,,22224,,Dissociation constant at pH 7.4,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14982,CHEMBL629687,,22224,,Dissociation constant in presence of 1 mM dithiothreitol,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14983,CHEMBL872931,,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14984,CHEMBL628151,,22224,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14985,CHEMBL628152,,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14986,CHEMBL628153,,22224,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14987,CHEMBL628154,,22224,,Kinetic constant for aromatization of androstenedione,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14988,CHEMBL628155,,22224,,Kinetic constant for aromatization of testosterone,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14989,CHEMBL628156,,22224,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14990,CHEMBL628157,,22224,,Local inhibition constant was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14991,CHEMBL857533,,50347,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,N,4932.0,,Intermediate,,1,,A,Saccharomyces cerevisiae,,1,BAO_0000218,,
14992,CHEMBL628158,,22224,,Dissociation constant value of the compound,U,,,Autocuration,,0,,P,,,1,BAO_0000100,,
14993,CHEMBL628159,Cornea,22224,,In vitro permeability through cornea without epithelium,U,,,Autocuration,,0,,A,,,1,BAO_0000019,964.0,
14994,CHEMBL875616,Cornea,22224,,In vitro permeability through intact cornea,U,,,Autocuration,,0,,A,,,1,BAO_0000019,964.0,
14995,CHEMBL628160,Cornea,50592,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,N,9986.0,,Intermediate,,1,,A,Oryctolagus cuniculus,,1,BAO_0000218,964.0,
14996,CHEMBL628161,,22224,,Rate of enzyme inactivation for the compound was determined,U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
14997,CHEMBL628162,Cornea,22224,,In vitro permeability through cornea without epithelium,U,,,Autocuration,,0,,A,,,1,BAO_0000019,964.0,
14998,CHEMBL628163,Cornea,22224,,In vitro permeability through intact cornea,U,,,Autocuration,,0,,A,,,1,BAO_0000019,964.0,
14999,CHEMBL628164,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15000,CHEMBL628165,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15001,CHEMBL628166,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15002,CHEMBL628167,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15003,CHEMBL628168,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15004,CHEMBL628169,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15005,CHEMBL628170,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15006,CHEMBL628171,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15007,CHEMBL627434,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15008,CHEMBL627435,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15009,CHEMBL628110,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15010,CHEMBL628111,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15011,CHEMBL628112,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15012,CHEMBL628260,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15013,CHEMBL628261,,22224,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",U,,,Autocuration,,0,,A,,,1,BAO_0000019,,
15014,CHEMBL628262,,50594,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15015,CHEMBL628263,,50587,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,N,9606.0,,Intermediate,,1,,A,Homo sapiens,,1,BAO_0000218,,
15016,CHEMBL628264,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15017,CHEMBL628265,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15018,CHEMBL628266,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15019,CHEMBL628267,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15020,CHEMBL628268,,50594,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15021,CHEMBL628269,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15022,CHEMBL628270,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15023,CHEMBL628271,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
15024,CHEMBL628272,,50594,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),N,10090.0,,Intermediate,,1,,A,Mus musculus,,1,BAO_0000218,,
